
<html lang="en"     class="pb-page"  data-request-id="4b327d37-b1d6-467a-9fb7-b6ad3d1fcefc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-23;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b00510;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) Series" /></meta><meta name="dc.Creator" content="Mohamed&#xA;S. A.  Elsayed" /></meta><meta name="dc.Creator" content="Jeffery J.  Nielsen" /></meta><meta name="dc.Creator" content="Sungtae  Park" /></meta><meta name="dc.Creator" content="Jeongho  Park" /></meta><meta name="dc.Creator" content="Qingyang  Liu" /></meta><meta name="dc.Creator" content="Chang H.  Kim" /></meta><meta name="dc.Creator" content="Yves  Pommier" /></meta><meta name="dc.Creator" content="Keli  Agama" /></meta><meta name="dc.Creator" content="Philip S.  Low" /></meta><meta name="dc.Creator" content="Mark  Cushman" /></meta><meta name="dc.Description" content="The present account describes the discovery and development of a new benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) JAK inhibitory chemotype that has produced selective JAK inhibitors. Sequent..." /></meta><meta name="Description" content="The present account describes the discovery and development of a new benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) JAK inhibitory chemotype that has produced selective JAK inhibitors. Sequent..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 21, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00510" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00510" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00510" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00510" /></link>
        
    
    

<title>Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) Series | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00510" /></meta><meta property="og:title" content="Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) Series" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0020.jpeg" /></meta><meta property="og:description" content="The present account describes the discovery and development of a new benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) JAK inhibitory chemotype that has produced selective JAK inhibitors. Sequential palladium chemistry was optimized for the rapid access to a focused library of derivatives to explore the structure–activity relationships of the new scaffold. Several compounds from the series displayed potencies in the low nanomolar range against the four members of the JAK family with various selectivity profiles. Compound 20a, with an azetidine amide side chain, showed the best selectivity for JAK1 kinase vs JAK2, JAK3, and TYK2, with low nanomolar potency (IC50 = 3.4 nM). On the other hand, BPNs 17b and 18 had good general activity against the JAK family with excellent kinome selectivity profiles. Many of the new BPNs inhibited JAK3-mediated STAT-5 phosphorylation, the production of inflammatory cytokines, and the proliferation of primary T cells. Moreover, BPN 17b showed very similar in vivo results to tofacitinib in a rheumatoid arthritis animal model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00510"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00510">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00510&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00510&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00510&amp;href=/doi/10.1021/acs.jmedchem.8b00510" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10440-10462</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00392" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00975" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (BPN) Series</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Mohamed S. A. Elsayed</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mohamed S. A. Elsayed</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States</div><div class="loa-info-affiliations-info">The Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mohamed%0AS.+A.++Elsayed">Mohamed S. A. Elsayed</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1353-7259" title="Orcid link">http://orcid.org/0000-0002-1353-7259</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeffery J. Nielsen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeffery J. Nielsen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States</div><div class="loa-info-affiliations-info">The Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeffery+J.++Nielsen">Jeffery J. Nielsen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sungtae Park</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sungtae Park</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, United States</div><div class="loa-info-affiliations-info">The Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sungtae++Park">Sungtae Park</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jeongho Park</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jeongho Park</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, United States</div><div class="loa-info-affiliations-info">The Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jeongho++Park">Jeongho Park</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qingyang Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qingyang Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, United States</div><div class="loa-info-affiliations-info">Department of Pathology and Mary H. Weiser Food Allergy Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qingyang++Liu">Qingyang Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chang H. Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chang H. Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, United States</div><div class="loa-info-affiliations-info">The Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</div><div class="loa-info-affiliations-info">Department of Pathology and Mary H. Weiser Food Allergy Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chang+H.++Kim">Chang H. Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yves Pommier</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yves Pommier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yves++Pommier">Yves Pommier</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Keli Agama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Keli Agama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Keli++Agama">Keli Agama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Philip S. Low</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philip S. Low</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States</div><div class="loa-info-affiliations-info">The Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philip+S.++Low">Philip S. Low</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9042-5528" title="Orcid link">http://orcid.org/0000-0001-9042-5528</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Mark Cushman</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark Cushman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States</div><div class="loa-info-affiliations-info">The Purdue Center for Cancer Research, Purdue University, West Lafayette, Indiana 47907, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: (765)494-1465. Fax: (765)494-6970. E-mail: <a href="/cdn-cgi/l/email-protection#2c4f595f44414d426c5c595e48594902494859"><span class="__cf_email__" data-cfemail="0a697f7962676b644a7a7f786e7f6f246f6e7f">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Cushman">Mark Cushman</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0152-5891" title="Orcid link">http://orcid.org/0000-0002-0152-5891</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00510&amp;href=/doi/10.1021%2Facs.jmedchem.8b00510" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10440–10462</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 21, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 March 2018</li><li><span class="item_label"><b>Published</b> online</span>21 November 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 December 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00510" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00510</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10440%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMohamed%250AS.%2BA.%2BElsayed%252C%2BJeffery%2BJ.%2BNielsen%252C%2BSungtae%2BPark%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D23%26contentID%3Dacs.jmedchem.8b00510%26title%3DApplication%2Bof%2BSequential%2BPalladium%2BCatalysis%2Bfor%2Bthe%2BDiscovery%2Bof%2BJanus%2BKinase%2BInhibitors%2Bin%2Bthe%2BBenzo%255Bc%255Dpyrrolo%255B2%252C3-h%255D%255B1%252C6%255Dnaphthyridin-5-one%2B%2528BPN%2529%2BSeries%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10462%26publicationDate%3DDecember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00510"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2505</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00510" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) Series&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mohamed\nS.&quot;,&quot;last_name&quot;:&quot;A. Elsayed&quot;},{&quot;first_name&quot;:&quot;Jeffery&quot;,&quot;last_name&quot;:&quot;J. Nielsen&quot;},{&quot;first_name&quot;:&quot;Sungtae&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;Jeongho&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;Qingyang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Chang&quot;,&quot;last_name&quot;:&quot;H. Kim&quot;},{&quot;first_name&quot;:&quot;Yves&quot;,&quot;last_name&quot;:&quot;Pommier&quot;},{&quot;first_name&quot;:&quot;Keli&quot;,&quot;last_name&quot;:&quot;Agama&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;S. Low&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Cushman&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;10440-10462&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00510&quot;},&quot;abstract&quot;:&quot;The present account describes the discovery and development of a new benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) JAK inhibitory chemotype that has produced selective JAK inhibitors. Sequential palladium chemistry was optimized for the rapid access to a focused library of derivatives to explore the structure–activity relationships of the new scaffold. Several compounds from the series displayed potencies in the low nanomolar range against the four members of the JAK family with various selectivity profiles. Compound 20a, with an azetidine amide side chain, showed the best selectivity for JAK1 kinase vs JAK2, JAK3, and TYK2, with low nanomolar potency (IC50 = 3.4 nM). On the other hand, BPNs 17b and 18 had good general activity against the JAK family with excellent kinome selectivity profiles. Many of the new BPNs inhibited JAK3-mediated STAT-5 phosphorylation, the production of inflammatory cytokines, and the proliferation of primary T cells. Moreover, BPN 17b showed very similar in vivo results to tof&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00510&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00510" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00510&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00510" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00510&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00510" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00510&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00510&amp;href=/doi/10.1021/acs.jmedchem.8b00510" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00510" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00510" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00510%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DElsayed%26date%3D2018%26atitle%3DApplication%2Bof%2BSequential%2BPalladium%2BCatalysis%2Bfor%2Bthe%2BDiscovery%2Bof%2BJanus%2BKinase%2BInhibitors%2Bin%2Bthe%2BBenzo%255Bc%255Dpyrrolo%255B2%252C3-h%255D%255B1%252C6%255Dnaphthyridin-5-one%2B%2528BPN%2529%2BSeries%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D23%26spage%3D10440%26epage%3D10462%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (8)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/jmcmar.2018.61.issue-23/20181213/jmcmar.2018.61.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The present account describes the discovery and development of a new benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (BPN) JAK inhibitory chemotype that has produced selective JAK inhibitors. Sequential palladium chemistry was optimized for the rapid access to a focused library of derivatives to explore the structure–activity relationships of the new scaffold. Several compounds from the series displayed potencies in the low nanomolar range against the four members of the JAK family with various selectivity profiles. Compound <b>20a</b>, with an azetidine amide side chain, showed the best selectivity for JAK1 kinase vs JAK2, JAK3, and TYK2, with low nanomolar potency (IC<sub>50</sub> = 3.4 nM). On the other hand, BPNs <b>17b</b> and <b>18</b> had good general activity against the JAK family with excellent kinome selectivity profiles. Many of the new BPNs inhibited JAK3-mediated STAT-5 phosphorylation, the production of inflammatory cytokines, and the proliferation of primary T cells. Moreover, BPN <b>17b</b> showed very similar in vivo results to tofacitinib in a rheumatoid arthritis animal model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28376" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28376" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The human immune response is a very complex process involved in defense against external pathogens and foreign tissues.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Abnormalities of the immune system often lead to disease states such as cancer and autoimmune disorders.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In autoimmune diseases, the immune system attacks tissues within the same organism. It is estimated that 24 million people are affected by autoimmune diseases in the United States.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Cytokines regulate the immune responses by mediating gene activation and repression.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The JAK-STAT pathway plays a central role in the signal transduction cascades of many cytokines (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) The JAK-STAT signaling pathway; (B) various biological responses mediated through the JAK pathway.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A, cytokine binding triggers receptor dimerization, which leads to JAK tyrosine kinase activation in which the two JAKs phosphorylate each other on a tyrosine residue in the activation loop. JAK-mediated STAT phosphorylation subsequently induces dimerization of the STAT signal transduction proteins and their translocation to the nucleus, which initiates gene transcription.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The JAK family has four members: JAK1, JAK2, JAK3, and TYK2.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The JAKs are activated in various patterns by different cytokines (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). JAK1 and JAK3 are activated by the members of the γ common (γ<sub>c</sub>) subfamily, namely interleukins IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21, which cannot activate JAK2 or TYK2. On the other hand, another subfamily of cytokines that includes IL-6, IL-11, and IL-17 binds to unique receptors that share a common glycoprotein 130 (gp130) subunit that is required for downstream JAK signaling. Several other cytokines induce JAK1 activation, and JAK2 and TYK2 are also consistently activated. Erythropoietin (EPO) receptors are another subfamily of homodimeric receptors that also includes the receptors for prolactin, thrombopoietin, and growth hormone. The EPO pathway activates JAK2 exclusively and is essential for erythropoiesis.</div><div class="NLM_p">Extensive efforts have been expended over the past decade to identify novel small-molecule JAK inhibitors with various subtype selectivity profiles to address unmet medical needs presented by transplant rejection, rheumatoid arthritis, other autoimmune diseases, and cancer.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The structures of four JAK inhibitors currently approved or in clinical trials are displayed in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Examples of JAK inhibitors (A) and topoisomerase I poisons (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The currently approved drugs are mixed inhibitors of all four JAK kinases with varying potencies against each one.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Tofacitinib is approved by the FDA for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, while ruxolitinib is approved for the treatment of myelofibrosis and polycythemia vera.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These two JAK inhibitors suffer from many side effects, arguing that more selective medications should be developed to overcome them.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a></div><div class="NLM_p">Palladium catalysis has offered new pathways for the preparation of pharmaceuticals.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Tandem catalysis is a process in which the catalyst is used to catalyze more than one reaction for the construction of complex molecules from simple building blocks.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In the present work, autotandem palladium catalysis was applied for the rapid construction of pharmacologically active JAK inhibitors. This approach has made the synthesis of these compounds easier, and it has allowed rapid diversification of newly designed scaffolds to obtain a wide range of derivatives with various activities and selectivities.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Design and Discovery</h3><div class="NLM_p">Potentiation of the effect of topoisomerase I (Top1) inhibition by checkpoint kinase (Chk1) inhibitors has been previously demonstrated for the combination of various Chk1 inhibitors and camptothecin, and it has also been shown for Chk1 siRNA.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> A selective Chk1 inhibitor also displayed dose-dependent potentiation of the antitumor effect of irinotecan in MDA-MB-435 breast cancer xenografts.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Several other studies showed the potentiating effect of Chk1 inhibitors on DNA-acting anticancer agents, including Top1 inhibitors.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> For example, Aris et al. reported the potentiation of the cellular effect of LMP400 by the cell checkpoint and Chk1-Chk2 inhibitor AZD7762.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This encouraged us to attempt the design of potential dual Top1/Chk1 kinase inhibitors.</div><div class="NLM_p">Analogues of our Top1 inhibitors LMP400, LMP776, and LMP744 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B) that have been in phase I clinical trials were designed in an effort to make compounds with dual Top1 and Chk kinase inhibitory activity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The design was guided by the structural similarities between the reported pyrazoloquinoline class of potent Chk1 inhibitors<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> represented in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and the indenoisoquinolines. Both structures have a flat scaffold, a hydrogen bond acceptor that can be oriented in the same direction, and a basic aminopropyl side chain. Hybridization of the two structures and addition of the missing hydrogen bond donor required for hinge binding of kinase inhibitors resulted in the structure of compound <b>1</b> as shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design rationale for the BPN <b>1</b> scaffold. The structural similarity between the two compounds was used in the design. The indenoisoquinoline scaffold was modified by adding an additional hinge-binding element (hydrogen bond donor) to the hydrogen bond acceptor, which was changed from a carbonyl oxygen to the pyridine nitrogen. At the same time, the basic aminopropyl side chain was retained.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">BPN <b>1</b> was prepared (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) and tested against both Chk1 kinase and Top1 and also for cytotoxic activity. It had mild Chk inhibitory activity and no Top1 inhibitory activity. However, BPN <b>7b</b> had selectivity against blood cancer cell lines in the cytotoxicity assay (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Supporting Information</a>). BPN <b>1</b> was therefore tested against a focused library of related tyrosine kinases that were selected on the basis of a similarity search using the ChEMBL database.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">Kinase profiling of BPN <b>1</b> against nine kinases suggested by the similarity search revealed that it has very good affinity and some selectivity against JAK kinases (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Binding assays of <b>1</b> showed high affinities with a <i>K</i><sub>d</sub> = 20 nM against JAK3 and a <i>K</i><sub>d</sub> = 19 nM against JAK2 kinases. This scaffold is a new JAK inhibitory chemotype that encouraged the further exploration of it to see if new JAK inhibitors could be obtained with optimized activity. The design may be considered as an extension of the polycyclic JAK inhibitors that have been reported in the literature.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21−24)</a> These BPNs were conceived as conformationally constrained relatives of tofacitinib that would direct the placement of the side chain in the binding pocket.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzyme Affinity Data for BPN <b>1</b> against Nine Kinases</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">%Ctrl @ 10 μM<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Chk1</td><td class="colsep0 rowsep0" align="char" char=".">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Chk2</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EGFR</td><td class="colsep0 rowsep0" align="char" char=".">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK1</td><td class="colsep0 rowsep0" align="char" char=".">5.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK2</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">JAK3</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MET</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGFR-2</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Values were obtained by comparing the results of the test compounds to a negative control that was assigned a value of 100% (nonbinding). Lower numbers indicate stronger binding.</p></div></div></div><div class="NLM_p">The molecular model in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> shows the predicted binding mode of BPN <b>1</b> in the ATP binding site of JAK3 overlapped with tofacitinib. On the basis of the molecular modeling and comparison with other JAK inhibitors, a series of modifications were made to BPN <b>1</b> to explore the SAR. The azaindole fragment in the new scaffold keeps the essential hinge binding element by forming two hydrogen bonds with Glu903 and Leu905. The side chain in BPN <b>1</b> is basic in nature, which often causes problems of nonselective kinome and hERG binding. Initially, the basic side chain was replaced with simple side chains like the esters as in BPNs <b>13a</b>–<b>c</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). These side chains were originally designed to test whether the binding site can enclose esters and larger groups of this chemical nature. Afterward, BPNs such as <b>17a</b>–<b>d</b> with hydrophobic and alicyclic groups similar to the reported inhibitors were also considered (BPNs <b>17a</b>–<b>d</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Cyclic amines have been reported to be present in some selective JAK inhibitors, and therefore similar side chains were incorporated in the new scaffold (BPNs <b>17e</b>–<b>h</b>).<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> A tofacitinib-like side chain was also incorporated to compare the resulting product to the clinically used compound (BPN <b>18</b>, <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). Finally, the chirality of amino acids was harnessed to make the chiral BPNs <b>19</b>–<b>21</b> with amide side chains to target the two different sides of the binding pocket.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of compound <b>1</b> (orange) aligned with tofacitinib (green) in the active site of JAK3 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>). A surface representation to the right illustrates the binding mode of the side chain of compound <b>1</b> and tofacitinib. The green area represents the methyl pocket occupied by the tofacitinib side chain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">Initially, the synthetic pathway illustrated in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> was investigated for the synthesis of BPN <b>1</b> and two more analogues <b>7a</b> and <b>7b</b> with unsubstituted or with a nitro-substituted ring D. Compound <b>2</b> was protected with MOMCl using NaH in DMF according to literature methodology.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Buchwald chemistry was used to add the amine side chain to afford compound <b>4</b>. The appropriate 2-bromobenzoic acid derivatives are commercially available and were used for the synthesis of compounds <b>5a</b>–<b>c</b>. Each acid was heated at reflux in SOCl<sub>2</sub> to obtain the acid chlorides, which were reacted with compound <b>4</b> in DCM and TEA. The direct intramolecular arylation reaction was used to obtain compounds <b>6a</b>–<b>c</b>. The yield of this reaction was improved by replacing cesium carbonate with potassium carbonate. Finally, compounds <b>1</b> and <b>7a</b>,<b>b</b> were obtained by removing the MOM group by heating in concentrated HCl in THF.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) MOMCl, NaH, DMF, 0– 21 °C, 3 h; (b) (H<sub>3</sub>C)<sub>2</sub>NCH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C, 16 h; (c) ArCOCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0–60 °C, 5 h; (d) Pd(OAc)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, PCy<sub>3</sub>·HBF<sub>4</sub>, DMA, 130 °C, 18 h; (e) concd HCl, THF, 60 °C, 20 h.</p></p></figure><div class="NLM_p">The synthetic methodology used in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> was not very useful for the synthesis of the second batch of compounds with altered side chains because increasing the size of the amine substituents hindered amide formation with the acid chloride. <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> illustrates an alternate synthetic pathway used for the synthesis of BPNs <b>13a</b>–<b>c</b>. First, the protected azaindole compound <b>8</b><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> was converted to the amine <b>9</b> using Buchwald chemistry with benzophenone imine and palladium acetate. The amine <b>9</b> was reacted with the required 2-iodoacyl chloride derivative to provide the common intermediate <b>10</b>, which was alkylated with various reactants using sodium hydride in DMF to afford <b>11a</b>–<b>c</b>. An intramolecular ring coupling reaction yielded intermediates <b>12a</b>–<b>c</b>, which were easily deprotected by TFA to give the target compounds <b>13a</b>–<b>c</b>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) (i) Pd(OAc)<sub>2</sub>, benzophenone imine, Cs<sub>2</sub>CO<sub>3</sub>, xantphos, dioxane, 110 °C, (ii) NH<sub>2</sub>OH·HCl, NaOAc, MeOH, 21 °C; (b) ArCOCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 16 h; (c) R-Br, NaH, DMF, 21 °C, 18 h; (d) Pd(OAc)<sub>2</sub>, PCy<sub>3</sub>·HBF<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DMA, 130 °C, 18 h; (e) (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, (ii) ethylenediamine, NaOH, MeOH.</p></p></figure><div class="NLM_p">The two schemes used for the synthesis of the target BPNs were highly convergent, but they were not successful in making compounds with bulkier side chains as, for example, a cyclohexyl group. Also, the application of the second scheme was limited to reactants that have an α-carbonyl relative to the halide atom that facilitates the S<sub>N</sub>2 reaction. To widen the range of side chains and facilitate scaffold decoration, a new tandem Pd reaction was engineered that can achieve the Buchwald amidation and the intramolecular arylation in just one step.</div><div class="NLM_p">The reaction portrayed in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> is a modification of the Catellani reaction in which the bifunctionalization of aryl halides is facilitated by norbornene. The original conditions reported by Catellani and co-workers failed to provide the required compound in a good yield.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The aryl iodide in the present case is different from <i>o</i>-iodotoluene in the original paper. In addition to optimizing the yield, the versatility of the reaction needed to be augmented in order to facilitate the synthesis of a broad range of JAK inhibitors. The conditions of the Catellani reaction were therefore optimized as reported in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Optimization of the Catellani Reaction</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0019.gif" alt="" id="GRAPHIC-d7e933-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="/" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry*</th><th class="colsep0 rowsep0" align="center">catalyst</th><th class="colsep0 rowsep0" align="center">ligand</th><th class="colsep0 rowsep0" align="center">base</th><th class="colsep0 rowsep0" align="center">solvent</th><th class="colsep0 rowsep0" align="center">additive</th><th class="colsep0 rowsep0" align="center" char="/">temp (C°)/time (h)</th><th class="colsep0 rowsep0" align="center" char=".">yield (%)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">TFP<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">K<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub>CN</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="/">85/18</td><td class="colsep0 rowsep0" align="char" char="."><2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">TFP</td><td class="colsep0 rowsep0" align="center">K<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">DMF</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="char" char="/">105/18</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">TFP</td><td class="colsep0 rowsep0" align="center">K<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub>CN</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">100/18</td><td class="colsep0 rowsep0" align="char" char=".">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">PPh<sub>3</sub></td><td class="colsep0 rowsep0" align="center">K<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">DMA</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">130/18</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">TFP</td><td class="colsep0 rowsep0" align="center">Cs<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">CH<sub>3</sub>CN</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">85/18</td><td class="colsep0 rowsep0" align="char" char=".">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">TFP</td><td class="colsep0 rowsep0" align="center">Cs<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">dioxane</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">95/18</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">TFP</td><td class="colsep0 rowsep0" align="center">Cs<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">THF</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">70/18</td><td class="colsep0 rowsep0" align="char" char=".">34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">TFP</td><td class="colsep0 rowsep0" align="center"><i>t</i>-BuOK</td><td class="colsep0 rowsep0" align="center">toluene</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">100/18</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">TFP</td><td class="colsep0 rowsep0" align="center">Cs<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">toluene</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">100/18</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">TFP</td><td class="colsep0 rowsep0" align="center"><i>t</i>-BuOK</td><td class="colsep0 rowsep0" align="center">tol/CH<sub>3</sub>CN</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">100/18</td><td class="colsep0 rowsep0" align="char" char=".">68</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">xantphos</td><td class="colsep0 rowsep0" align="center">Cs<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">tol/CH<sub>3</sub>CN</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">100/18</td><td class="colsep0 rowsep0" align="char" char=".">52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">PCy<sub>3</sub>·HB<sub>4</sub></td><td class="colsep0 rowsep0" align="center">Cs<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">tol/CH<sub>3</sub>CN</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">100/18</td><td class="colsep0 rowsep0" align="char" char=".">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="center">Pd(OAc)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">S-Phos</td><td class="colsep0 rowsep0" align="center">Cs<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">tol/CH<sub>3</sub>CN</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">100/18</td><td class="colsep0 rowsep0" align="char" char=".">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="center">Pd<sub>2</sub>(dba)<sub>3</sub></td><td class="colsep0 rowsep0" align="center">TFP</td><td class="colsep0 rowsep0" align="center">Cs<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">toluene</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">100/18</td><td class="colsep0 rowsep0" align="char" char=".">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="center">Pd(TFA)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">TFP</td><td class="colsep0 rowsep0" align="center">Na<sub>2</sub>CO<sub>3</sub></td><td class="colsep0 rowsep0" align="center">toluene</td><td class="colsep0 rowsep0" align="center">norbornene</td><td class="colsep0 rowsep0" align="char" char="/">100/8</td><td class="colsep0 rowsep0" align="char" char=".">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center"><b>Pd(TFA)</b><sub>2</sub></td><td class="colsep0 rowsep0" align="center"><b>TFP</b></td><td class="colsep0 rowsep0" align="center"><b>Cs<sub>2</sub>CO<sub>3</sub></b></td><td class="colsep0 rowsep0" align="center"><b>toluene</b></td><td class="colsep0 rowsep0" align="center"><b>norbornene</b></td><td class="colsep0 rowsep0" align="char" char="/"><b>100/20</b></td><td class="colsep0 rowsep0" align="char" char="."><b>78</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">All the numbers are the isolated yields.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Tri(2-furyl)phosphine.</p></div></div></div><div class="NLM_p">The use of DMA as the solvent and PPh<sub>3</sub> as the ligand (entry 4) was not optimal for the reaction as the yield was only 4%. After further investigation of the solvent effect, toluene was found to be the best one with 56% yield (entry 9). The use of potassium carbonate as the base proved to be ineffective, as shown in entries 1–4. After some trials, cesium carbonate was established to be the best base for the reaction with 68% yield (entry 9). TFP [tri(2-furyl)phosphine] provided optimal yields relative to the other ligands that were investigated. Finally, palladium acetate was replaced with palladium trifluoroacetate and this enhanced the yield. Palladium trifluoroacetate has been reported to be more efficient than palladium acetate in nonpolar solvents like toluene.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a></div><div class="NLM_p"><a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> illustrates the new reaction and the versatility of side chain installation that it provides. In this reaction, the amides <b>14a</b>–<b>l</b> were reacted with the iodo compound <b>15</b> to form both of the new C–N and C–C bonds and generate compounds <b>16a</b>–<b>l</b> in a single step instead of the four steps employed in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The amides <b>14a</b>–<b>l</b> can be easily obtained from the commercially available <i>o</i>-bromo acids, and compound <b>15</b> can be prepared from commercially available 4-iodo-7-azaindole.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> A mechanism for the reaction is proposed in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The versatility of this reaction has been recently shown in the construction of related scaffolds.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Pd(TFA)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, norbornene, TFP, toluene, 110 °C; (b) (i) TFA, (ii) H<sub>2</sub>N(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub> or (i) TFA, (ii) NaOH.</p></p></figure><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After optimization of the reaction conditions, the reaction was employed for the synthesis of the target BPNs <b>17a</b>–<b>m</b>. Compounds <b>16a</b>–<b>l</b> were deprotected using TFA and ethylenediamine (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The target compounds <b>18</b>, <b>19a</b>,<b>b</b>, <b>20a</b>,<b>b</b>, and <b>21</b> were synthesized from the corresponding amines or acids using HATU in DMF (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>)</div><figure id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) For <b>18</b>: cyanoacetic acid, HATU, DIPEA, DMF, 21 °C, 18 h. For the rest: the appropriate amines, HATU, DIPEA, DMF, 21 °C, 18 h.</p></p></figure></div><div id="sec1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Biological Results and Discussion</h3><div class="NLM_p">The JAK inhibitory activities of all of the target compounds are listed in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Generally, the BPNs had very good to excellent activity against the four enzymes with various selectivity profiles. Ring D substituents are important, as evidenced by the unsubstituted BPN <b>7a</b>, which showed higher potency against the four members of the JAK family when compared to BPN <b>7b</b> but lower than that of <b>1</b> with a dimethoxy substitution pattern. The dimethoxylated ring D was kept for the rest of the BPNs in the series because the docking calculations supported its importance in the solvent-exposed area. On the other hand, the side chain modifications alter both the potency and selectivity. The elongated basic side chain of BPNs <b>1</b> and <b>7a</b>,<b>b</b> was not optimal for the JAK inhibitory activity when compared to the side chains found in <b>13a</b>–<b>c</b>. Additionally, BPNs <b>17a</b>–<b>d</b> with alicyclic side chains were among the most potent in this series with single-digit nanomolar potency against the different members of the JAK family. On the other hand, BPNs <b>17e</b>–<b>h</b> with cyclic amine side chains had good to moderate activity with no characteristic selectivity profiles. Compound <b>18</b>, with an <i>N</i>-(cyanoacetyl)-3-piperidinyl side chain as found in the clinically used drug tofacitinib, also showed potent activity against the four enzymes with IC<sub>50</sub> values in the low nanomolar range and low selectivity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Janus Kinase Inhibitory Activities of the BPNs</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">JAK1 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">JAK2 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char="±">JAK3 IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">TYK2 IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tofacitinib</td><td class="colsep0 rowsep0" align="char" char="±">1.42 ± 0.07</td><td class="colsep0 rowsep0" align="center">1.09 ± 0.17</td><td class="colsep0 rowsep0" align="char" char="±">0.24 ± 0.02</td><td class="colsep0 rowsep0" align="center">10.38 ± 0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="±">95.62 ± 5.18</td><td class="colsep0 rowsep0" align="center">72.97 ± 2.35</td><td class="colsep0 rowsep0" align="char" char="±">129.75 ± 0.45</td><td class="colsep0 rowsep0" align="center">427.45 ± 11.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="char" char="±">423.8 ± 4.1</td><td class="colsep0 rowsep0" align="center">229.25 ± 8.45</td><td class="colsep0 rowsep0" align="char" char="±">285.9 ± 8.5</td><td class="colsep0 rowsep0" align="center">708.65 ± 34.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="char" char="±">3334 ± 30</td><td class="colsep0 rowsep0" align="center">489.65 ± 2.15</td><td class="colsep0 rowsep0" align="char" char="±">1111.5 ± 53.5</td><td class="colsep0 rowsep0" align="center">4766 ± 207</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="char" char="±">103.15 ± 1.25</td><td class="colsep0 rowsep0" align="center">14.12 ± 0.945</td><td class="colsep0 rowsep0" align="char" char="±">9.94 ± 0.091</td><td class="colsep0 rowsep0" align="center">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="char" char="±">9.89 ± 1.18</td><td class="colsep0 rowsep0" align="center">17.56 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">6.65 ± 0.05</td><td class="colsep0 rowsep0" align="center">18.42 ± 1.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="char" char="±">1.91 ± 0.09</td><td class="colsep0 rowsep0" align="center">10.55 ± 0.41</td><td class="colsep0 rowsep0" align="char" char="±">27.5 ± 0.75</td><td class="colsep0 rowsep0" align="center">17.4 ± 0.88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="char" char="±">4.23 ± 0.34</td><td class="colsep0 rowsep0" align="center">1.07 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">2.92 ± 0.14</td><td class="colsep0 rowsep0" align="center">1.93 ± 0.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="char" char="±">125.1 ± 3.6</td><td class="colsep0 rowsep0" align="center">3.57 ± 0.02</td><td class="colsep0 rowsep0" align="char" char="±">1.65 ± 0.1</td><td class="colsep0 rowsep0" align="center">39.43 ± 3.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="char" char="±">6.59 ± 0.48</td><td class="colsep0 rowsep0" align="center">0.89 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">1.09 ± 0.03</td><td class="colsep0 rowsep0" align="center">2.24 ± 0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17d</b></td><td class="colsep0 rowsep0" align="char" char="±">17.86 ± 0.97</td><td class="colsep0 rowsep0" align="center">1.82 ± 0.01</td><td class="colsep0 rowsep0" align="char" char="±">1.01 ± 0.026</td><td class="colsep0 rowsep0" align="center">8.38 ± 0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17e</b></td><td class="colsep0 rowsep0" align="char" char="±">37.54 ± 1.08</td><td class="colsep0 rowsep0" align="center">37.07 ± 1.55</td><td class="colsep0 rowsep0" align="char" char="±">124.1 ± 7.1</td><td class="colsep0 rowsep0" align="center">166.85 ± 36.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17f</b></td><td class="colsep0 rowsep0" align="char" char="±">11.48 ± 0.61</td><td class="colsep0 rowsep0" align="center">14.70 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">18.31 ± 0.07</td><td class="colsep0 rowsep0" align="center">32.39 ± 3.61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17g</b></td><td class="colsep0 rowsep0" align="char" char="±">10.61 ± 0.22</td><td class="colsep0 rowsep0" align="center">37.91 ± 2.60</td><td class="colsep0 rowsep0" align="char" char="±">143.7 ± 1.3</td><td class="colsep0 rowsep0" align="center">176.3 ± 2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17h</b></td><td class="colsep0 rowsep0" align="char" char="±">5.28 ± 0.19</td><td class="colsep0 rowsep0" align="center">8.91 ± 0.29</td><td class="colsep0 rowsep0" align="char" char="±">23.45 ± 0.11</td><td class="colsep0 rowsep0" align="center">45.10 ± 4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17i</b></td><td class="colsep0 rowsep0" align="char" char="±">58.26 ± 1.92</td><td class="colsep0 rowsep0" align="center">63.04 ± 1.69</td><td class="colsep0 rowsep0" align="char" char="±">28.94 ± 1.55</td><td class="colsep0 rowsep0" align="center">256.5 ± 16.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17j</b></td><td class="colsep0 rowsep0" align="char" char="±">304.45 ± 38.05</td><td class="colsep0 rowsep0" align="center">220.8 ± 16.3</td><td class="colsep0 rowsep0" align="char" char="±">95.56 ± 1.74</td><td class="colsep0 rowsep0" align="center">1502 ± 124</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">1.20 ± 0.22</td><td class="colsep0 rowsep0" align="center">3.12 ± 0.05</td><td class="colsep0 rowsep0" align="char" char="±">2.55 ± 0.02</td><td class="colsep0 rowsep0" align="center">4.35 ± 0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="char" char="±">616.3 ± 20.9</td><td class="colsep0 rowsep0" align="center">1171 ± 128</td><td class="colsep0 rowsep0" align="char" char="±">818.9 ± 20.5</td><td class="colsep0 rowsep0" align="center">5730 ± 80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="char" char="±">138.1 ± 4.2</td><td class="colsep0 rowsep0" align="center">>1000</td><td class="colsep0 rowsep0" align="char" char="±">26.58 ± 0.58</td><td class="colsep0 rowsep0" align="center">1163.5 ± 3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="char" char="±">3.37 ± 0.13</td><td class="colsep0 rowsep0" align="center">29.6 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">114.4 ± 0.6</td><td class="colsep0 rowsep0" align="center">73.66 ± 2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20b</b></td><td class="colsep0 rowsep0" align="char" char="±">43.78 ± 3.1</td><td class="colsep0 rowsep0" align="center">140.2 ± 7</td><td class="colsep0 rowsep0" align="char" char="±">87.03 ± 0.4</td><td class="colsep0 rowsep0" align="center">336.3 ± 12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char="±">30.17 ± 1.73</td><td class="colsep0 rowsep0" align="center">109.95 ± 6.1</td><td class="colsep0 rowsep0" align="char" char="±">75.03 ± 1.57</td><td class="colsep0 rowsep0" align="center">273.4 ± 2.6</td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>13a</b> had very interesting selectivity for JAK2 and JAK3 over JAK1 and TYK2, while <b>13b</b> was not as selective, with good activity against all four enzymes. On the other hand, BPN <b>13c</b> displayed more interesting selectivity for JAK1, with an IC<sub>50</sub> value of 1.9 nM and 5-fold selectivity against JAK2 and 14-fold selectivity for JAK3. However, being an ester, BPN <b>13c</b> is expected to suffer from poor metabolic stability, and it is also racemic in nature. Compounds <b>19a</b> and <b>19b</b> were prepared to replace the ester of <b>17i</b> with amides in order to increase the stability toward metabolic hydrolysis. Unfortunately, BPN <b>19a</b> lost potency and selectivity relative to the ester <b>17i</b>, while BPN <b>19b</b> was less potent than <b>17i</b> vs JAK1, JAK2, and TYK2, but it kept very good potency and selectivity vs JAK3. Comparing the activities of the two enantiomers <b>17i</b> and <b>17j</b> indicates that the <i>R</i> configuration present in <b>17i</b> is much better than the <i>S</i> configuration.</div><div class="NLM_p">The isopropyl group present in <b>19a</b> and <b>19b</b> was changed to an ethyl in <b>20a</b> and <b>20b</b> in order to explore effects on potency and selectivity. Compound <b>20a</b> had very good activity and selectivity vs JAK1 kinase with an IC<sub>50</sub> = 3.37 nM, 10-fold selectivity vs JAK2, and 30-fold selectivity vs JAK3. Although the replacement of the ester group in <b>13c</b> with this amide side chain decreased the activity moderately, it enhanced the selectivity vs JAK1 compared to JAK2, JAK3, and TYK2. Changing the absolute configuration of the side chain of <b>20b</b> did not influence the activity very much, as shown by comparing the activities of <b>20b</b> and <b>21</b> against the four enzymes. Although <b>21</b> was consistently more active than <b>20b</b>, the configurational effect is opposite that observed with <b>17i</b> and <b>17j</b>. The trifluoroethyl amide side chain of <b>20b</b> was not as good as the cyanoazetidine ring of <b>20a</b> in enhancing the selectivity of BPN <b>13c</b>. Compound <b>20a</b> is a very good candidate for further development, with good potency and significant selectivity for JAK1 kinase.</div><div class="NLM_p">To test the performance in a cellular context, six of the more potent compounds representing the whole series were tested for their ability to inhibit the phosphorylation of STAT-5. This assay is selective for JAK3-mediated phosphorylation of STAT-5 in SZ4 cells when activated by IL-2. Compound <b>18</b> showed the best inhibition of STAT-5 phosphorylation, with an IC<sub>50</sub> value of 1.55 μM relative to tofacitinib. Compound <b>17a</b> also showed good activity with 3.72 μM IC<sub>50</sub> value. On the other hand, BPNs <b>17b</b> and <b>17e</b> had very low activity. <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> lists the STAT-5 phosphorylation assay results.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Activities of Selected BPNs for Inhibition of Primary T Cell Proliferation and STAT-5 Phosphorylation in SZ4 Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="±">IC<sub>50</sub> (μM) T cell proliferation</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM) (JAK3/STAT-5) IL2/SZ4 cells<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tofacitinib</td><td class="colsep0 rowsep0" align="char" char="±">0.63 ± 0.26</td><td class="colsep0 rowsep0" align="center">1.21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="char" char="±">1.39 ± 0.57</td><td class="colsep0 rowsep0" align="center">NT<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="char" char="±">4.45 ± 2.18</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="char" char="±">3.97 ± 2.14</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="char" char="±">1.82 ± 0.9</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="char" char="±">0.79 ± 0.26</td><td class="colsep0 rowsep0" align="center">3.72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="char" char="±">0.63 ± 0.18</td><td class="colsep0 rowsep0" align="center">76.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17c</b></td><td class="colsep0 rowsep0" align="char" char="±">3.24 ± 2.40</td><td class="colsep0 rowsep0" align="center">18.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17d</b></td><td class="colsep0 rowsep0" align="char" char="±">0.76 ± 0.21</td><td class="colsep0 rowsep0" align="center">28.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17e</b></td><td class="colsep0 rowsep0" align="char" char="±">0.29 ± 0.08</td><td class="colsep0 rowsep0" align="center">61.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17f</b></td><td class="colsep0 rowsep0" align="char" char="±">1.45 ± 0.53</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17g</b></td><td class="colsep0 rowsep0" align="char" char="±">2.55 ± 1.48</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17h</b></td><td class="colsep0 rowsep0" align="char" char="±">1.15 ± 0.45</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17i</b></td><td class="colsep0 rowsep0" align="char" char="±">1.12 ± 0.42</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17j</b></td><td class="colsep0 rowsep0" align="char" char="±">1.67 ± 0.44</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">0.68 ± 0.22</td><td class="colsep0 rowsep0" align="center">1.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="char" char="±">5.79 ± 2.22</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="char" char="±">5.07 ± 2.03</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20b</b></td><td class="colsep0 rowsep0" align="char" char="±">3.66 ± 2.18</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char="±">4.66 ± 1.85</td><td class="colsep0 rowsep0" align="center">NT</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The numbers listed are the result of two determinations. Please see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Supporting Information</a> for the data.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Not tested.</p></div></div></div><div class="NLM_p">Furthermore, the activities of BPNs <b>17a</b> and <b>18</b> were further confirmed by Western blot analyses of STAT-5 phosphorylation. <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> illustrates Western blot-based determination of the IC<sub>50</sub> values of STAT-5 phosphorylation for BPNs <b>17a</b> and <b>18</b>. Both compounds showed very good activity in this cell-based assay, with IC<sub>50</sub> values of 65.9 and 15.3 nM, respectively, giving further evidence of the JAK3 inhibitory activity. The curves for IC<sub>50</sub> determinations are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Supporting Information</a>.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Western blot analysis of phospho-STAT-5 and anti-α-tubulin for BPNs <b>17a</b> and <b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The JAKs, particularly JAK3 and TYK2, are highly expressed by T cells and mediate cytokine receptor signaling.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> A T cell proliferation assay was performed in order to access the inhibitory activities of the compounds in a functional context (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The prototype JAK inhibitor tofacitinib was effective in suppressing T cell proliferation. Although not particularly active in the enzyme assays, BPN <b>17e</b>, with a methylpiperidine side chain, showed the best activity in the cellular assay with an IC<sub>50</sub> value = 0.29 μM, while BPNs <b>17b</b> and <b>17d</b>, with hydrophobic side chains, had very good activity that was similar to the reference compound tofacitinib, with IC<sub>50</sub> values = 0.63 and 0.76 μM, respectively. A kinome scanning assay for BPN <b>17b</b> showed some off-target activity, and in addition, cytotoxicity of this compound was observed in the NCI-60 cell lines (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Supporting Information</a>), which might explain the higher activity of this compound in the cell proliferation assay.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of BPNs on proliferation of primary murine T cells. Naïve CD4<sup>+</sup> T cells were isolated from mouse spleens and cultured with the indicated BPNs in the presence of T cell activators (antibodies to CD3 and CD28) and IL-2 for 3 days. T cell proliferation was assessed by XTT staining and measured at 475 nm with a microplate reader (SpectraMax i3X, Molecular Devices). The assay was repeated three times (<i>n</i> = 3 for each dose and inhibitor), and mean ± SEM ranges are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The assay results shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> also provide information on the cytotoxicity of the compounds to T cells. Among the compounds, <b>17a</b>, <b>17b</b>, <b>17d</b>, <b>17d</b>, and <b>18</b> displayed relatively high cell killing activity on proliferating T cells at 2 μM or lower. Moreover, eight different representative compounds were assayed for the general cytotoxicity in the NCI-60 cell line panel. Generally speaking, the BPNs were not very cytotoxic, although BPNs <b>1</b>, <b>7b</b>, <b>17d</b>, and <b>17i</b> produced negative growth percentages in a few of the cell lines when tested at a concentration of 10 μM. The results are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Table 1s</a> in Supporting Information. Twelve BPNs were tested for their Top1 inhibitory activity, and none of them displayed significant activity. <a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Figures 1s, 2s, and 3s</a> in the Supporting Information show the DNA fragmentation patterns produced by the 12 compounds.</div><div class="NLM_p">On the other hand, BPNs <b>7a</b> and <b>17f</b>–<b>j</b> displayed good activity when compared to tofacitinib (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). In addition, BPNs <b>13a</b>, <b>13b</b>, <b>17c</b>, <b>19b</b>, <b>20a</b>, <b>20b</b>, and <b>21</b> had moderate inhibitory activity on T cell proliferation when compared to tofacitinib, with IC<sub>50</sub> values higher than 3 μM. The absence of a good correlation between the cellular and enzyme inhibition data may be due to the differential expression of various JAK subtypes in T cells. In addition, the physicochemical properties of the BPNs and differences in cell permeability may also play a major role in the cellular activities as will be discussed shortly.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">Cytokines such as IFNγ and IL-17 play key roles in mediating the inflammatory activities of T cells. These two cytokines are produced by distinct T cell subsets that are antagonistic to each other.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The effects of selected JAK inhibitors on T cell expression of IFNγ and IL-17 were examined. Tofacitinib was effective in suppressing IFNγ production (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). The BPNs <b>17a</b>, <b>17c</b>, <b>17d</b>, <b>18</b>, and <b>20a</b> were also similarly effective in suppressing IFNγ production. In general, there is an inverse relationship between IFNγ and IL-17 production because the IFNγ produced by T cells effectively suppresses IL-17 production. There is much greater T cell production of IL-17 in the presence of tofacitinib (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Similarly, IL-17 production was increased in the presence of <b>17a</b>–<b>e</b>, <b>18</b>, and <b>20a</b>, but it was not increased significantly by <b>19a</b> as expected from the data reported in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>. These results indicate that in general the compounds have potent modulatory activity on the production of T cell effector cytokines.</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of compounds on IFNγ expression by primary murine T cells. Naïve CD4<sup>+</sup> T cells were isolated from mouse spleens and cultured with the indicated compounds in the presence of T cell activators (antibodies to CD3 and CD28) and IL-2 for 5 days. (A) T cell expression of IFNγ was assessed by intracellular staining of activated T cells with an antibody to IFNγ. The cells were analyzed with a Canto II flow cytometer (Becton Dickinson). (B) % IFNγ expression by T cells in the presence of test compounds compared to control. Note that data for <b>17b</b> and <b>19a</b> are presented with different scales on the <i>y</i>-axes of the bar graphs than the other compounds. The assay was repeated three times (<i>n</i> = 3 for each dose and inhibitor), and mean ± SEM are shown in part B. *Significant differences from controls (no inhibitor) by Student <i>t</i> test (paired one-tailed).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effects of compounds on IL-17 expression by primary murine T cells. Naïve CD4<sup>+</sup> T cells were isolated from mouse spleens and cultured with the indicated compounds in the presence of T cell activators (antibodies to CD3 and CD28) and the cytokines listed in the method section for 5 days. (A) T cell expression of IL-17 was assessed by intracellular staining of activated T cells with an antibody to IL-17. The cells were analyzed with a Canto II flow cytometer. (B) Percent IL-17 expression by CD4 T cells in the presence of test compounds compared to control. Note the differing scales on the <i>y</i>-axes of the bar graphs. The assay was repeated three times (<i>n</i> = 3 for each dose and inhibitor), and mean ± SEM are shown in part B. *Significant differences from controls (no inhibitor) by Student <i>t</i> test (paired one-tailed).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The results from the assays for T cell proliferation and cytokine production are generally in line with those expected from the JAK inhibition assay. However, the most potent compounds in the isolated enzyme assay were not necessarily the most potent ones in suppressing T cells. This may be because the compounds need to have additional characteristics such as membrane permeability and metabolic stability to be effective as inhibitors within cells. Also, the differences among the compounds on target or cytokine signaling selectivity can account for such differences among the assays. For example, IL-2 and IL-23 drive T cell proliferation in the assays that were used. IL-2 uses JAK1 and JAK3, whereas IL-23 uses JAK2 and TYK2. If a compound inhibits JAK2 but not JAK1 or JAK3, it would not effectively inhibit IL-2-driven T cell proliferation. Thus, the results from the biochemical inhibition assays would not exactly match the results from cell-based assays or in vivo experiments.</div></div><div id="sec1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Kinome Selectivity</h3><div class="NLM_p">For any new kinase inhibitor scaffold, it is always important to show selectivity against the target of interest to avoid possible side effects and toxicity.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> To investigate the kinome selectivity of the new BPN scaffold, three potent BPNs were tested for their abilities to inhibit various members of the human kinome (468 kinases) (KINOMEscan Assay Platform by DiscoverX). Compounds <b>17b</b>, <b>18</b>, and <b>20a</b> were assayed for their ability to displace an immobilized ATP binding site ligand from 403 normal kinases and 65 mutant kinases (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). These compounds demonstrated excellent selectivity profiles. <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a> shows the selectivity scores and number of hits for the three compounds tested. The selectivity score or S-score is a quantitative measure of compound selectivity. It is calculated by dividing the number of enzyme hits to by the total number of distinct kinases tested, excluding mutant variants. This value can be calculated using %Ctrl as a potency threshold and provides a quantitative method of describing compound selectivity to facilitate comparison of different compounds.</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Technique used for determination of kinome selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Kinome Selectivity Scores of BPNs <b>17b</b>, <b>17d</b>, and <b>18</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">selectivity score type</th><th class="colsep0 rowsep0" align="center">no. of enzyme hits</th><th class="colsep0 rowsep0" align="center" char=".">no. of nonmutant kinases</th><th class="colsep0 rowsep0" align="center" char=".">screening concentration (nM)</th><th class="colsep0 rowsep0" align="center">selectivity score<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="center">S(35)</td><td class="colsep0 rowsep0" align="center">24</td><td class="colsep0 rowsep0" align="char" char=".">403</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">0.06<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="center">S(10)</td><td class="colsep0 rowsep0" align="center">6</td><td class="colsep0 rowsep0" align="char" char=".">403</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">0.015<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="center">S(1)</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="char" char=".">403</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">0<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">S(35)</td><td class="colsep0 rowsep0" align="center">40</td><td class="colsep0 rowsep0" align="char" char=".">403</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">0.099</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">S(10)</td><td class="colsep0 rowsep0" align="center">9</td><td class="colsep0 rowsep0" align="char" char=".">403</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">0.022</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">S(1)</td><td class="colsep0 rowsep0" align="center">5</td><td class="colsep0 rowsep0" align="char" char=".">403</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">0.012</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="center">S(35)</td><td class="colsep0 rowsep0" align="center">4</td><td class="colsep0 rowsep0" align="char" char=".">403</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">0.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="center">S(10)</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="char" char=".">403</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="center">S(1)</td><td class="colsep0 rowsep0" align="center">0</td><td class="colsep0 rowsep0" align="char" char=".">403</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="center">0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">The numbers reflect the abilities of the test compounds to inhibit the binding of the kinases to an immobilized ATP binding site ligand. Lower numbers indicate higher selectivities of the test compounds for the enzymes.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">(Number of nonmutant kinases with %Ctrl <35)/(number of nonmutant kinases tested) where %Ctrl is the percentage of enzymes remaining bound to an immobilized ATP binding site ligand in the presence of 100 nM concentration of the test compound.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">(Number of nonmutant kinases with %Ctrl <10)/(number of nonmutant kinases tested).</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">(Number of nonmutant kinases with %Ctrl <1)/(number of nonmutant kinases tested).</p></div></div></div><div class="NLM_p">BPN <b>20a</b> had outstanding selectivity for the four Janus kinases (Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Figure 4s</a>), and of those, it was most active vs JAK-1 (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). BPNs <b>17b</b> and <b>18</b> affected some additional kinases in the kinome in a potent manner. <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a> lists the <i>K</i><sub>d</sub> values in nM for some of the additional kinases affected by <b>17b</b> and <b>18</b>. Both of them bound to BIKE kinase in the low nanomolar range. Compound <b>17b</b> also showed good binding activity to FLT3(N841I), SNARK, and TrkA<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> in the low nanomolar range, and it had moderate binding to Ark5. Compound <b>18</b> demonstrated potent inhibition of YSK4 kinase. A complete list of kinases tested and the kinome maps are available in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Table 2s and Figure 4s</a> in the Supporting Information.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. <i>K</i><sub>d</sub> (nM) Values for Kinases Identified as Hits During Kinome Scanning</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center"><b>17b</b></th><th class="colsep0 rowsep0" align="center"><b>18</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ARK5</td><td class="colsep0 rowsep0" align="center">42</td><td class="colsep0 rowsep0" align="center">NT<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BIKE</td><td class="colsep0 rowsep0" align="center">7.5</td><td class="colsep0 rowsep0" align="center">0.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT3(D835V)</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT3(N841I)</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SNARK</td><td class="colsep0 rowsep0" align="center">3.5</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TRKA</td><td class="colsep0 rowsep0" align="center">2.3</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">YSK4</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">1.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">NT: Not tested.</p></div></div></div></div><div id="sec1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> ADME Properties</h3><div class="NLM_p">To evaluate the preliminary ADME properties of this new BPN class of JAK inhibitors, five different compounds were tested for solubility, cell permeability, and liver microsomal metabolic stability. <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a> lists the results for BPNs <b>17a</b>, <b>17b</b>, <b>17e</b>, <b>18</b>, and <b>20a</b>. Most of them had low aqueous solubilities (PBS buffer, pH 7.4) with the exception of compound <b>17e</b>, which has a methylpiperidine side chain that is well-known to enhance the solubility. In contrast, with the exception of <b>17e</b>, the compounds displayed enhanced solubilities in gastric and intestinal fluids relative to the PBS buffered media. The Caco-2 cellular permeability profiles of these particular BPNs are relatively unfavorable, with BPNs <b>17e</b> and <b>18</b> being potential substrates for active efflux transport. On the other hand, three of the BPNs (<b>17e</b>, <b>18</b>, and <b>20a</b>) had excellent metabolic stabilities against human liver microsomal enzymes with <i>t</i><sub>1/2</sub> values over 60 min.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Preliminary ADME Properties of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">aqueous solubility (PBS, pH 7.4) (μM)</th><th class="colsep0 rowsep0" align="center">aqueous solubility (simulated intestinal fluid) (μM)</th><th class="colsep0 rowsep0" align="center">aqueous solubility (simulated gastric fluid) (μM)</th><th class="colsep0 rowsep0" align="center">A–B permeability (Caco-2, pH 6.5/7.4) permeability (10 <sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center">B–A permeability (Caco-2, pH 6.5/7.4) permeability (10 <sup>–6</sup> cm/s)</th><th class="colsep0 rowsep0" align="center">human liver microsomes (<i>t</i><sub>1/2</sub>) (min)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17a</b></td><td class="colsep0 rowsep0" align="center">NS<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">12.5</td><td class="colsep0 rowsep0" align="center">NS</td><td class="colsep0 rowsep0" align="center">NP<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">NP</td><td class="colsep0 rowsep0" align="center">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17b</b></td><td class="colsep0 rowsep0" align="center">1.7</td><td class="colsep0 rowsep0" align="center">8.8</td><td class="colsep0 rowsep0" align="center">60.7</td><td class="colsep0 rowsep0" align="center">2.9</td><td class="colsep0 rowsep0" align="center">0.1</td><td class="colsep0 rowsep0" align="center">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17e</b></td><td class="colsep0 rowsep0" align="center">195.8</td><td class="colsep0 rowsep0" align="center">200</td><td class="colsep0 rowsep0" align="center">198.1</td><td class="colsep0 rowsep0" align="center">0.4</td><td class="colsep0 rowsep0" align="center">43.4</td><td class="colsep0 rowsep0" align="center">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">NS</td><td class="colsep0 rowsep0" align="center">NS</td><td class="colsep0 rowsep0" align="center">187.3</td><td class="colsep0 rowsep0" align="center">0.3</td><td class="colsep0 rowsep0" align="center">9.6</td><td class="colsep0 rowsep0" align="center">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20a</b></td><td class="colsep0 rowsep0" align="center">13.6</td><td class="colsep0 rowsep0" align="center">192.9</td><td class="colsep0 rowsep0" align="center">24.2</td><td class="colsep0 rowsep0" align="center">0.1</td><td class="colsep0 rowsep0" align="center">14</td><td class="colsep0 rowsep0" align="center">>60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tamoxifen</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ranitidine</td><td class="colsep0 rowsep0" align="center">NT<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">0.3</td><td class="colsep0 rowsep0" align="center">2</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">propranolol</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">NT</td><td class="colsep0 rowsep0" align="center">33.5</td><td class="colsep0 rowsep0" align="center">36.7</td><td class="colsep0 rowsep0" align="center">>60</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">NS: Not soluble.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">NT: Not tested.</p></div><div class="footnote" id="t7fn3"><sup><sup>c</sup></sup><p class="last">NP: Not permeable.</p></div></div></div></div><div id="sec1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Molecular Modeling</h3><div class="NLM_p">The structures of the inhibitors were docked in the ATP binding sites of the four subtypes of the JAK family. Compounds <b>17b</b>, <b>17d</b>, and <b>18</b> were the most active against the JAK3 enzyme, with IC<sub>50</sub> values of 1.65, 1.01, and 2.55 nM, respectively, while BPNs <b>13c</b>, <b>18</b>, and <b>20a</b> were the most active against JAK1 with IC<sub>50</sub> values of 1.91, 1.20, and 3.37 nM, respectively. <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> illustrates a comparison between the binding modes of compound <b>17d</b> in the ATP binding sites of JAK1 and JAK3. As expected, the pyrrolopyridine part in all of the compounds made the essential hinge binding interactions with Leu-905 and Glu-903 in JAK3 and with Leu-959 and Glu-957 in JAK1 involved in the formation of hydrogen bonds.</div><figure id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Hypothetical binding modes of compound <b>17d</b> in JAK1 (left) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5C">4I5C</a>) and JAK3 (right) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">There is only a minor difference between the structures of the JAK1 and JAK3 ATP binding sites in the activation loop (green) (glycine vs alanine). This can partially explain the difference in the activity between compound <b>17d</b> against JAK1 (IC<sub>50</sub> = 17.86 nM) and JAK3 (IC<sub>50</sub> = 1.01 nM).</div><div class="NLM_p">On the other hand, BPN <b>18</b> had excellent inhibitory activity against both enzymes with very good cellular potency and kinome selectivity. The hypothetical binding modes of BPN <b>18</b> with JAK1 and JAK3 are illustrated in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>. Compound <b>18</b> was calculated to have a hydrophobic interaction with the activation loop (colored green) in both enzymes, but the hydrophobic part of the piperidine side chain is not large enough to cause a significant difference in activity between the two enzymes (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The cyanoacetate side chain is directed toward the phosphate binding loop in both enzymes (colored red in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>), which is a relatively hydrophilic region that plays a role in the potency of this compound.</div><figure id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Hypothetical binding mode of compound <b>18</b> in JAK1 (left) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5C">4I5C</a>) and JAK3 (right) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, compound <b>20a</b> was not very active in the T cell proliferation assay. This can be explained by its good selectivity against JAK1, which is moderately expressed in the cells that were used in the assay, in addition to poor cellular permeability. A clear explanation for the JAK1 selectivity of <b>20a</b> could not be drawn from the molecular modeling, but it can be hypothesized that the nonbonded interaction of the ethyl side chain with the activation loop in JAK1 and JAK3 may contribute to the difference in activity. The presence of the larger Ala966 moiety in JAK3 relative to the Gly1020 residue of JAK1 can limit the free movement of the ethyl group in the hydrophobic pocket of the activation loop while the smaller glycine residue can accommodate the ethyl side chain of <b>20a</b> as shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>.</div><figure id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Hypothetical binding mode of <b>20a</b> in JAK1 l (left) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5C">4I5C</a>) and JAK3 (right) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Determination of Anti-Inflammatory Activity in a Mouse Model</h3><div class="NLM_p">To access anti-inflammatory activity in vivo, compound <b>17b</b>, tofacitinib, or vehicle (in 10% DMSO and 10% Cremophor EL) were each administered to groups of seven mice two months after collagen-induced inflammation, and the activity was measured on each paw using a standard 0–4 rheumatoid arthritis scale. This approach is more realistic than the usual collagen-induced rheumatoid arthritis studies because it measures the ability of the drugs to treat existing inflammation rather than prevent it. The total scores, which reflect the degree of inflammation and ankylosis, are plotted as a function of time (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>). The <i>t</i> test reveals that both tofacitinib and <b>17b</b> cause a significantly different response compared to the vehicle control and that there is not a statistically significant difference between the two drugs.</div><figure id="fig13" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Mean rheumatoid arthritis score. Mouse paw collagen-induced inflammation assay (male DBA-1 <i>n</i> = 7) of compound <b>17b</b>. Daily doses of tofacitinib or <b>17b</b> were administered subcutaneously in 10% DMSO and 10% Cremophor EL to seven mice. Paw inflammation for each paw was expressed on a 0–4 mean rheumatoid arthritis scale. The <i>t</i> test revealed that both tofacitinib and <b>17b</b> caused a significantly different response compared to the vehicle control and that there is not a statistically significant difference between the two drugs. The calculated <i>P</i> values were 0.0481 for week 2, 0.0443 for week 3, 0.0442 for week 4, and 0.0473 for week 5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17337" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17337" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A novel tetracyclic BPN series of JAK inhibitors was discovered by the hybridization of Chk1 inhibitors and Top1 poisons. The new series showed interesting enzymatic activity profiles against the four members of the JAK family with potencies in the low nanomolar range and variable selectivities. Cellular kinase and T-cell proliferation assays revealed promising activity of the new scaffold compared to the clinically used drug tofacitinib. Preliminary testing of the ADME properties of a limited number of compounds in this new class indicated that several of them suffer from low aqueous solubility and poor cellular permeability that might be improved by fine-tuning the side chain. In vivo studies in a mouse rheumatoid arthritis model revealed BPN <b>17a</b> has anti-inflammatory activity that is comparable to that of the clinically used drug tofacitinib. Molecular modeling was used to show the hypothetical JAK1 and JAK3 binding modes of some of the more potent compounds in this class.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General</h3><div class="NLM_p last">Melting points were determined with a Mel-Temp apparatus using capillary tubes and are uncorrected. The proton nuclear magnetic resonance spectra (<sup>1</sup>H NMR) were recorded using Bruker ARX300 300 MHz or Bruker DRX500 500 MHz spectrometers. IR spectra were obtained with a PerkinElmer 1600 series FTIR spectrometer. For biologically tested compounds, the HPLC major peak accounted for ≥95% of the combined total peak area when monitored by a UV detector at 254 nm. HPLC analyses were performed on a Waters 1525 binary HPLC pump/Waters 2487 dual λ absorbance detector system. Analytical thin-layer chromatography was conducted on Baker-flex silica gel IB2-F plates, and compounds were visualized with UV light at 254 nm. Silica gel flash chromatography was performed using 230–400 mesh silica gel.</div></div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 4-(3-(Dimethylamino)propyl)-7,8-dimethoxy-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>1</b>)</h3><div class="NLM_p last">Compound <b>6b</b> (0.05 g, 0.13 mmol) was dissolved in THF (10 mL), and concd HCl (2 mL) was added to the solution. The mixture was heated at 80 °C for 18 h and then cooled to room temperature. The THF was evaporated under reduced pressure, and the residue was treated with saturated aq NaHCO<sub>3</sub> solution until the effervescence ceased. The mixture was extracted with CHCl<sub>3</sub> (3 × 15 mL), and the combined organic layer was washed with water (2 × 10 mL) and brine (1 × 15 mL), dried with sodium sulfate, and evaporated to give a light-brown residue. The residue was purified by silica gel column chromatography using CHCl<sub>3</sub>–MeOH (8.5:1.5) to give the final compound <b>1</b> as a light-brown foam (26 mg, 59%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.11 (s, 1 H), 9.40 (s, 1 H), 8.04 (s, 1 H), 7.73 (s, 1 H), 7.55 (s, 1 H), 6.93 (s, 1 H), 4.69–4.62 (m, 2 H), 4.05 (s, 3 H), 3.91 (s, 3 H), 2.63–2.48 (m, 2 H), 2.26 (s, 6 H), 2.12–1.94 (m, 2 H). MALDIMS <i>m</i>/<i>z</i> 381 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>21</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub> (MH)<sup>+</sup> 381.1927, found 381.1920. C18 HPLC purity: 100% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4-Bromo-1-(methoxymethyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (<b>3</b>)</h3><div class="NLM_p last">This compound was prepared according to a published literature procedure<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and isolated as yellow oil (1.16 g, 96%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.15 (d, <i>J</i> = 5.2 Hz, 1 H), 7.40 (d, <i>J</i> = 3.6 Hz, 1 H), 7.31 (d, <i>J</i> = 5.2 Hz, 1 H), 6.59 (d, <i>J</i> = 3.6 Hz, 1 H), 5.64 (s, 2 H), 3.30 (s, 3 H).</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i><sup>1</sup>-(1-(Methoxymethyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-<i>N</i><sup>3</sup>,<i>N</i><sup>3</sup>-dimethylpropane-1,3-diamine (<b>4</b>)</h3><div class="NLM_p last">Compound <b>3</b> (1 equiv, 0.5 g, 2.01 mmol), <i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>-dimethylpropane-1,3-diamine (0.275 g, 2.7 mol, 1.3 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (95 mg, 5 mol %), xantphos (120 mg, 10 mol %), and cesium carbonate (1.35 g, 4.15 mmol, 2 equiv) were mixed in a 45 mL pressure tube, and anhydrous dioxane (15 mL) was added to the mixture. Argon was bubbled through the reaction mixture for 2 min, and then the pressure tube was capped and placed directly in a preheated oil bath at 110 °C. The mixture was heated for 16 h and then allowed to cool to room temperature. CHCl<sub>3</sub> (20 mL) was added to the mixture and then it was filtered through a bed of Celite and the residue left on the filter pad was washed with additional CHCl<sub>3</sub> (20 mL). The filtrate was evaporated to afford a dark residue that was purified by silica gel column chromatography using a CHCl<sub>3</sub>–MeOH mixture (9:1) as the eluent to provide the amine <b>4</b> as a light-brown oil (0.4 g, 74%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.06 (d, <i>J</i> = 5.5 Hz, 1 H), 7.08–7.02 (m, 1 H), 6.50 (d, <i>J</i> = 3.6 Hz, 1 H), 6.25 (s, 1 H), 6.19 (d, <i>J</i> = 5.6 Hz, 1 H), 5.57 (s, 2 H), 3.51–3.45 (m, 2 H), 3.29 (s, 3 H), 2.73 (t, <i>J</i> = 6.3 Hz, 2 H), 2.48 (s, 6 H), 2.07–1.87 (m, 2 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>22</sub>N<sub>4</sub>O (MH)<sup>+</sup> 263.1866, found 263.1869.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure for the Preparation of the Amides <b>5a</b>–<b>c</b></h3><div class="NLM_p">The appropriate benzoyl chloride derivative was prepared by heating the necessary 2-bromobenzoic acid derivative (0.9 mmol, 1 equiv) and thionyl chloride (5 mL) at reflux for 2 h, followed by removal of excess thionyl chloride under vacuum. The acid chloride (1 equiv, 0.9 mmol) in anhydrous DCM (5 mL) was added dropwise to an ice-cold solution of the amine <b>4</b> (0.25 g, 1 equiv, 0.9 mmol) and TEA (10 equiv) in anhydrous DCM (20 mL). The mixture was heated at reflux for 5 h. After cooling to room temperature, the mixture was washed with saturated NaHCO<sub>3</sub> solution (1 × 20 mL), water (2 × 20 mL), and brine (1 × 20 mL) and dried with anhydrous sodium sulfate. The residue obtained after the evaporation of DCM was subjected to silica gel column chromatography using CHCl<sub>3</sub>–MeOH as eluent to yield the desired amides <b>5a</b>–<b>c</b>.</div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-(3-(Dimethylamino)propyl)-2-bromo-<i>N</i>-(1-(methoxymethyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)benzamide (<b>5a</b>)</h4><div class="NLM_p last">This compound was isolated as a brown gum (0.27 g, 57%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.16–8.08 (m, 1 H), 7.72–7.66 (m, 1 H), 7.38 (d, <i>J</i> = 3.6 Hz, 1 H), 6.91–6.85 (m, 4 H), 6.68–6.61 (m, 1 H), 5.59 (s, 2 H), 4.15–4.09 (m, 2 H), 3.27 (s, 3 H), 2.54–2.48 (m, 2 H), 2.26 (s, 6 H), 1.94–1.88 (m, 2 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>25</sub>BrN<sub>4</sub>O<sub>2</sub> (MH)<sup>+</sup> 445.1234/447.1216, found 445.1231/447.1215.</div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 2-Bromo-<i>N</i>-(3-(dimethylamino)propyl)-4,5-dimethoxy-<i>N</i>-(1-(methoxymethyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)benzamide (<b>5b</b>)</h4><div class="NLM_p last">This compound was isolated as a dark-brown gum (0.26 g, 54%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.16 (s, 1 H), 7.38 (d, <i>J</i> = 3.6 Hz, 1 H), 6.91 (s, 1 H), 6.82 (s, 1 H), 6.62 (d, <i>J</i> = 3.6 Hz, 1 H), 6.47 (s, 1 H), 5.59 (s, 2 H), 4.11–4.04 (m, 2 H), 3.75 (s, 3 H), 3.40 (s, 3 H), 3.26 (s, 3 H), 2.64–2.59 (m, 2 H), 2.31 (s, 6 H), 1.97–1.89 (m, 2 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>29</sub>BrN<sub>4</sub>O<sub>4</sub> (MH)<sup>+</sup> 505.1444/507.1427, found 505.1442/507.1423.</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-Bromo-<i>N</i>-(3-(dimethylamino)propyl)-<i>N</i>-(1-(methoxymethyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)-5-nitrobenzamide (<b>5c</b>)</h4><div class="NLM_p last">This compound was isolated as a dark-brown gum (0.35 g, 74%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.15 (d, <i>J</i> = 5.0 Hz, 1 H), 7.86 (s, 1 H), 7.80 (dd, <i>J</i> = 8.7, 2.6 Hz, 1 H), 7.56 (d, <i>J</i> = 8.7 Hz, 1 H), 7.43 (d, <i>J</i> = 3.6 Hz, 1 H), 6.96 (d, <i>J</i> = 5.1 Hz, 1 H), 6.64 (d, <i>J</i> = 3.7 Hz, 1 H), 5.57 (s, 2 H), 4.12 (s, 2 H), 3.22 (s, 3 H), 2.54 (s, 2 H), 2.30 (s, 6 H), 2.02–1.86 (m, 2 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>24</sub>BrN<sub>5</sub>O<sub>4</sub> (MH)<sup>+</sup> 490.1084/492.1067, found 490.1085/492.1070.</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Procedure for the Direct Intramolecular Arylation Reaction to Afford <b>6a</b>–<b>c</b></h3><div class="NLM_p">The benzamides <b>5a</b>–<b>c</b> (1 equiv, 0.5 mmol) were dissolved in DMA (5 mL), and Pd(OAc)<sub>2</sub> (10 mol %), Cs<sub>2</sub>CO<sub>3</sub> (2 equiv), Ag<sub>2</sub>CO<sub>3</sub> (2 equiv), and PCy<sub>3</sub>·HBF<sub>4</sub> (20 mol %) were added. The reaction mixture was heated at 130 °C under Ar atmosphere for 18 h. The reaction mixture was cooled to room temperature, and EtOAc (10 mL) was then added. The mixture was filtered through a bed of Celite, and the residue left on the filter pad was washed with EtOAc (about 20 mL). The filtrate was transferred to a separatory funnel and washed with water several times (5 × 15 mL) to remove the DMA and brine (1 × 15 mL). The organic layer was dried and evaporated, and the residue was purified with column chromatography using CHCl<sub>3</sub>–MeOH (9:1) as the eluent to give the tetracyclic compounds <b>6a</b>–<b>c</b>.</div><div id="sec3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-(3-(Dimethylamino)propyl)-1-(methoxymethyl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>6a</b>)</h4><div class="NLM_p last">This compound was isolated as a brown semisolid (0.06 g, 32%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.31 (s, 1 H), 8.53 (d, <i>J</i> = 8.1 Hz, 1 H), 8.39 (d, <i>J</i> = 8.2 Hz, 1 H), 7.80 (t, <i>J</i> = 7.7 Hz, 1 H), 7.57 (t, <i>J</i> = 7.6 Hz, 1 H), 7.42 (d, <i>J</i> = 3.8 Hz, 1 H), 7.02 (d, <i>J</i> = 3.8 Hz, 1 H), 5.73 (s, 2 H), 4.82–4.73 (m, 2 H), 3.36 (s, 3 H), 2.73 (t, <i>J</i> = 7.2 Hz, 2 H), 2.42 (s, 6 H), 2.29–2.21 (m, 4 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>24</sub>N<sub>4</sub>O<sub>2</sub> (MH)<sup>+</sup> 365.1972, found 365.1970.</div></div><div id="sec3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 4-(3-(Dimethylamino)propyl)-7,8-dimethoxy-1-(methoxymethyl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>6b</b>)</h4><div class="NLM_p last">This compound was isolated as a light-brown oil (0.06 g, 28%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.19 (s, 1 H), 7.89 (s, 1 H), 7.71 (s, 1 H), 7.41 (d, <i>J</i> = 3.8 Hz, 1 H), 6.99 (d, <i>J</i> = 3.8 Hz, 1 H), 5.73 (s, 2 H), 4.78 (s, 2 H), 4.10 (s, 3 H), 4.04 (s, 3 H), 3.38–3.31 (m, 2 H), 2.81–2.75 (m, 2 H), 2.45 (s, 6 H), 2.30–2.24 (m, 2 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>28</sub>BrN<sub>4</sub>O<sub>4</sub> (MH)<sup>+</sup> 425.2183, found 425.2187.</div></div><div id="sec3_3_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 4-(3-(Dimethylamino)propyl)-1-(methoxymethyl)-7-nitro-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>6c</b>)</h4><div class="NLM_p last">This compound was isolated as a yellow solid (0.03 g, 14%): mp 125–127 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.17 (d, <i>J</i> = 2.5 Hz, 1 H), 8.24 (d, <i>J</i> = 5.6 Hz, 1 H), 8.19 (dd, <i>J</i> = 8.8, 2.5 Hz, 1 H), 7.76 (s, 1 H), 7.71 (d, <i>J</i> = 8.8 Hz, 1 H), 6.80 (d, <i>J</i> = 5.8 Hz, 1 H), 5.66 (s, 2 H), 4.21–4.15 (m, 2 H), 3.37 (s, 3 H), 2.61 (s, 2 H), 2.41 (s, 6 H), 2.11–2.05 (m, 2 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>23</sub>BrN<sub>5</sub>O<sub>4</sub> (MH)<sup>+</sup> 410.1823, found 410.1820.</div></div></div><div id="sec3_3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-(3-(Dimethylamino)propyl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>7a</b>)</h3><div class="NLM_p last">This compound was prepared from <b>6a</b> following the same procedure as for <b>1</b> and isolated as a dark-brown solid (0.026 g, 58%): mp 185–187 °C. IR (thin film) 2950, 1648, 1578, 1418, 1338, 1314, 1036 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.16 (s, 1 H), 9.38 (s, 1 H), 8.68 (d, <i>J</i> = 8.1 Hz, 1 H), 8.36 (d, <i>J</i> = 8.0 Hz, 1 H), 7.85 (t, <i>J</i> = 7.6 Hz, 1 H), 7.66–7.47 (m, 2 H), 6.99–6.92 (m, 1 H), 4.74–4.59 (m, 2 H), 2.66 (s, 2 H), 2.33 (s, 6 H), 2.08–1.99 (m, 2 H). MALDIMS <i>m</i>/<i>z</i> 321 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>19</sub>H<sub>21</sub>N<sub>4</sub>O (MH)<sup>+</sup> 321.1716, found 321.1709. C18 HPLC purity: 99.65% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 4-(3-(Dimethylamino)propyl)-7-nitro-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>7b</b>)</h3><div class="NLM_p last">This compound was prepared from <b>6c</b> following the same procedures as for <b>1</b> and isolated as a yellow powder (0.032 g, 71%): mp 205–207 °C. IR (thin film) 2864, 1667, 1611, 1572, 1519, 1491, 1433, 1403, 1328, 1135, 1077 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.35 (s, 1 H), 9.44 (s, 1 H), 9.04 (d, <i>J</i> = 2.6 Hz, 1 H), 8.93 (d, <i>J</i> = 9.2 Hz, 1 H), 8.54 (dd, <i>J</i> = 9.0, 2.6 Hz, 1 H), 7.64 (s, 1 H), 7.01 (s, 1 H), 4.69–4.62 (m, 2 H), 2.55–2.50 (m, 2 H), 2.24 (s, 6 H), 2.05–1.96 (m, 3 H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 160.94, 150.55, 145.81, 142.17, 139.52, 139.02, 126.94, 125.93, 124.06, 123.93, 123.42, 106.36, 106.02, 102.34, 56.60, 45.50, 43.52, 26.06. MALDIMS <i>m</i>/<i>z</i> 366 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>19</sub>H<sub>20</sub>N<sub>5</sub>O<sub>3</sub> (MH)<sup>+</sup> 366.1566, found 366.1560. C18 HPLC purity: 100% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-((2-(Trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-amine (<b>9</b>)</h3><div class="NLM_p last">SEM-protected 4-bromo-7-azaindole <b>8</b> (2 g, 8.3 mmol) was added to a mixture of xantphos (0.48 g, 0.83 mmol), Pd(OAc)<sub>2</sub> (0.093 g, 0.41 mmol), benzophenone imine (1.8 g, 9.93 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (5.4 g, 16.59 mmol) in anhydrous dioxane (50 mL). The reaction mixture was added to a 150 mL pressure vessel, degassed with Ar for 5 min, and heated at 110 °C for 18 h. The reaction mixture was cooled to room temperature mixed with chloroform (50 mL) and filtered through a bed of Celite. The filterate was evaporated, and the residue was dissolved in MeOH (100 mL). Sodium acetate (1.5 g, 19 mmol) and hydroxylamine hydrochloride (0.95 g, 13.7 mmol) were added to the solution, and the mixture was stirred at room temperature for 10 h. MeOH was evaporated, and the residue was partitioned between NaOH solution (1 N, 100 mL) and DCM (100 mL). The organic layer was washed with water (2 × 50 mL) and brine (1 × 20 mL) and dried. Column chromatography of the residue obtained after evaporation of the solvent (SiO<sub>2</sub>/CHCl<sub>3</sub>:MeOH 9:1) gave <b>9</b> as a yellow solid (1.3 g, 81%): mp 135–137 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.04 (d, <i>J</i> = 5.4 Hz, 1 H), 7.17 (d, <i>J</i> = 3.7 Hz, 1 H), 6.42 (d, <i>J</i> = 3.7 Hz, 1 H), 6.35 (d, <i>J</i> = 5.4 Hz, 1 H), 5.64 (s, 2 H), 4.42 (s, 2 H), 3.59–3.45 (m, 2 H), 0.98–0.85 (m, 2 H), −0.06 (s, 9 H).</div></div><div id="sec3_3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2-Iodo-4,5-dimethoxy-<i>N</i>-(1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)benzamide (<b>10</b>)</h3><div class="NLM_p last">2-Iodo-4,5-dimethoxybenzoyl chloride was prepared by heating a mixture of the acid (0.3 mmol, 1 equiv) and thionyl chloride (7 mL) at reflux for 2 h, followed by the removal of excess thionyl chloride under vacuum. A solution of the acid chloride (0.342 g, 0.3 mmol) in anhydrous DCM (5 mL) was added dropwise to an ice-cold solution of the amine <b>9</b> (0.4 g, 0.3 mmol) and TEA (10 equiv) in anhydrous DCM (20 mL). The mixture was heated at reflux for 5 h. After cooling to room temperature, the mixture was washed with saturated NaHCO<sub>3</sub> solution (1 × 20 mL), water (2 × 20 mL), and brine (1 × 20 mL) and dried with anhydrous sodium sulfate. The residue obtained after the evaporation of DCM was subjected to silica gel column chromatography using CHCl<sub>3</sub>–EtOAc (8:2) as eluent to yield the desired amide <b>10</b> as a creamy white solid (0.43 g, 58%): mp 165–167 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 5.6 Hz, 1 H), 8.20–8.02 (m, 2 H), 7.36 (d, <i>J</i> = 3.8 Hz, 1 H), 7.32 (s, 1 H), 6.66 (s, 1 H), 5.75 (s, 2 H), 3.95 (s, 3 H), 3.93 (s, 3 H), 3.63–2.57 (m, 2 H), 1.04–0.78 (m, 2 H), −0.05 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>28</sub>IN<sub>3</sub>O<sub>4</sub>Si (MH)<sup>+</sup> 554.0967, found 554.0968.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> General Procedures for the Synthesis of Compounds <b>11a</b>–<b>c</b></h3><div class="NLM_p">A suspension of sodium hydride (0.72 mmol) in anhydrous DMF (5 mL) was cooled in an ice bath. A solution of <b>10</b> (0.2 g, 0.36 mmol) in DMF (2 mL) was added dropwise to the sodium hydride suspension over 5 min. The mixture was stirred at 21 °C for 1 h, and then the appropriate alkyl bromide (0.72 mmol) was added all at once. The reaction mixture was stirred at room temperature for 18 h and then quenched with ice-cold water (25 mL). The mixture was extracted with EtOAc (3 × 15 mL), and the combined organic layers were washed with water (2 × 15 mL) and brine (1 × 20 mL) and dried. Purification of the residue obtained after evaporating the EtOAc layer by silica gel column chromatography (CHCl<sub>3</sub>–EtOAc, 8:2) yielded <b>11a</b>–<b>c</b>.</div><div id="sec3_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>tert</i>-Butyl <i>N</i>-(2-Iodo-4,5-dimethoxybenzoyl)-<i>N</i>-(1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)glycinate (<b>11a</b>)</h4><div class="NLM_p last">Compound <b>11a</b> was obtained as a creamy white solid (0.22 g, 91%): mp 113–115 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.17 (s, 1 H), 7.42 (d, <i>J</i> = 3.6 Hz, 1 H), 7.11 (s, 1 H), 7.05–6.99 (m, 1 H), 6.78 (s, 1 H), 6.67 (s, 1 H), 5.76 (s, 2 H), 4.54 (s, 1 H), 3.80 (s, 2 H), 3.61–3.52 (m, 2 H), 3.47 (s, 2 H), 1.50 (s, 9 H), 0.96–0.87 (m, 2 H), −0.06 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>38</sub>IN<sub>3</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 668.1647, found 668.1644.</div></div><div id="sec3_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Methyl <i>N</i>-(2-Iodo-4,5-dimethoxybenzoyl)-<i>N</i>-(1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)glycinate (<b>11b</b>)</h4><div class="NLM_p last">This compound was isolated as a yellow oil (0.2 g, 88%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.17 (d, <i>J</i> = 5.4 Hz, 1 H), 7.41 (d, <i>J</i> = 3.6 Hz, 1 H), 7.09 (s, 1 H), 7.04 (d, <i>J</i> = 5.4 Hz, 1 H), 6.74 (d, <i>J</i> = 3.6 Hz, 1 H), 6.62 (s, 1 H), 5.70 (s, 2 H), 4.67 (s, 2 H), 3.80 (s, 3 H), 3.78 (s, 3 H), 3.58–3.47 (m, 2 H), 3.44 (s, 3 H), 0.97–0.82 (m, 2 H), −0.08 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>32</sub>IN<sub>3</sub>O<sub>4</sub>Si (MH)<sup>+</sup> 626.1177, found 626.1176.</div></div><div id="sec3_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Ethyl 2-(2-Iodo-4,5-dimethoxy-<i>N</i>-(1-((2-(trimethylsilyl)ethoxy)methyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)benzamido)butanoate (<b>11c</b>)</h4><div class="NLM_p last">This compound was isolated as a yellow oil (0.2 g, 83%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.16 (d, <i>J</i> = 5.0 Hz, 1 H), 7.38 (d, <i>J</i> = 3.7 Hz, 1 H), 7.10–7.02 (m, 2 H), 6.92 (d, <i>J</i> = 3.7 Hz, 1 H), 6.53 (s, 1 H), 5.66 (s, 2 H), 4.67–4.56 (m, 1 H), 4.32 (d, <i>J</i> = 7.3 Hz, 3 H), 3.75 (s, 3 H), 3.51–3.45 (m, 2 H), 3.36 (s, 3 H), 1.62–1.53 (m, 5 H), 1.36 (t, <i>J</i> = 7.1 Hz, 3 H), 1.01 (t, <i>J</i> = 7.3 Hz, 3 H), 0.93–0.84 (m, 3 H), −0.09 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>38</sub>IN<sub>3</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 668.1647, found 668.1651.</div></div></div><div id="sec3_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>tert</i>-Butyl 2-(7,8-Dimethoxy-5-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)acetate (<b>12a</b>)</h3><div class="NLM_p last">Pd(OAc)<sub>2</sub> (9 mg, 0.037 mmol), K<sub>2</sub>CO<sub>3</sub> (0.15 g, 1.12 mmol), Ag<sub>2</sub>CO<sub>3</sub> (0.2 g, 0.74 mmol), and PCy<sub>3</sub>·HBF<sub>4</sub> (28 mg, 0.075 mmol) were added to a solution of benzamide <b>11a</b> (0.25 g, 0.37 mmol) in DMA (5 mL). The reaction mixture was heated at 130 °C under Ar atmosphere for 18 h. The reaction mixture was cooled to room temperature, and EtOAc (10 mL) was then added. The mixture was filtered through a bed of Celite, and the residue was washed thoroughly with EtOAc (20 mL). The filtrate was transferred to a separatory funnel and washed with water (5 × 15 mL) and brine (15 mL) to remove DMA. The organic layer was dried and evaporated, and the residue was purified by silica gel column chromatography using CHCl<sub>3</sub>–MeOH (9:1) as the eluent to give the tetracyclic compound <b>12a</b> (0.15 g, 74%) as a yellow solid: mp 156–158 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.18 (s, 1 H), 7.93 (s, 1 H), 7.71 (s, 1 H), 7.40 (d, <i>J</i> = 3.9 Hz, 1 H), 6.81 (d, <i>J</i> = 3.5 Hz, 1 H), 5.79 (s, 2 H), 5.45 (s, 2 H), 4.12 (s, 3 H), 4.04 (s, 3 H), 3.65–3.47 (m, 3 H), 1.53–1.41 (m, 9 H), 1.03–0.78 (m, 2 H), −0.05 (m, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>27</sub>N<sub>3</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 540.2524, found 540.2522.</div></div><div id="sec3_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Methyl 2-(7,8-Dimethoxy-5-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)acetate (<b>12b</b>)</h3><div class="NLM_p last">Using the same procedure used for <b>12a</b>, compound <b>12b</b> was prepared from <b>11b</b> and was isolated as a yellow solid (0.1 g, 62%): mp 136–138 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.18 (s, 1 H), 7.91 (s, 1 H), 7.70 (s, 1 H), 7.40 (d, <i>J</i> = 3.7 Hz, 1 H), 6.76 (d, <i>J</i> = 3.8 Hz, 1 H), 5.81 (s, 2 H), 5.56 (s, 2 H), 4.12 (s, 3 H), 4.04 (s, 3 H), 3.80 (s, 3 H), 3.69–3.54 (m, 2 H), 1.00–0.84 (m, 2 H), −0.04 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>31</sub>N<sub>3</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 498.2055, found 498.2047.</div></div><div id="sec3_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Ethyl 2-(7,8-Dimethoxy-5-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)butanoate (<b>12c</b>)</h3><div class="NLM_p last">This compound was prepared from <b>11c</b> by the same procedure used for <b>12a</b> and isolated as a yellow solid (0.09 g, 44%): mp 152–154 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.19 (s, 1 H), 7.85 (s, 1 H), 7.70 (s, 1 H), 7.42 (d, <i>J</i> = 3.6 Hz, 1 H), 6.83 (s, 1 H), 5.78 (s, 2 H), 4.11 (s, 3 H), 4.01 (s, 3 H), 3.67–3.54 (m, 3 H), 3.48 (q, <i>J</i> = 7.0 Hz, 3 H), 2.54–2.47 (m, 2 H), 0.94–0.87 (m, 2 H), −0.04 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>37</sub>IN<sub>3</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 540.2524, found 540.2523.</div></div><div id="sec3_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>tert</i>-Butyl 2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)acetate (<b>13a</b>)</h3><div class="NLM_p last">Compound <b>12a</b> (0.1 g, 0.18 mmol) was dissolved in DCM (5 mL), and TFA (5 mL) was added to the solution dropwise. The mixture was stirred at room temperature for 2 h, and then the solvent was evaporated. The residue obtained was dissolved in MeOH (5 mL) and NaOH solution (2N, 2 mL). Ethylenediamine (1 mL) was added, and the mixture was stirred overnight at room temperature. The mixture was acidified with TFA and extracted with CHCl<sub>3</sub> (3 × 10 mL). The combined organic layer was washed with water and brine (15 mL each), dried, and evaporated to yield <b>13a</b> as a white solid (20 mg, 26%): mp 212–214 °C. IR (thin film) 2926, 1744, 1647, 1612, 1583, 1462, 1427, 1389, 1244, 1327, 1244, 1225, 1210, 1156, 1107, 1029 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.19–12.08 (s, 1 H), 9.42 (s, 1 H), 8.32 (s, 1 H), 8.12–8.04 (m, 1 H), 7.72 (s, 1 H), 7.58–7.46 (m, 1 H), 6.67–6.58 (m, 1 H), 5.38 (s, 2 H), 4.06 (s, 3 H), 3.91 (s, 3 H), 1.44 (s, 9 H). MALDIMS <i>m</i>/<i>z</i> 410 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub> (MH)<sup>+</sup> 410.1711, found 410.1709. C18 HPLC purity: 96.64% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Methyl 2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)acetate (<b>13b</b>)</h3><div class="NLM_p last">This compound was prepared form <b>12b</b> using the procedure described for <b>13a</b> and was isolated as a white solid (25 mg, 45%): mp 212–214 °C. IR (thin film) 2964, 1752, 1658, 1612, 1575, 1513, 1458, 1427, 1387, 1370, 1351, 1302, 1267, 1242, 1177, 1167, 1143, 1105, 1077, 1003 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.16 (s, 1 H), 9.41 (s, 1 H), 8.06 (s, 1 H), 7.70 (s, 1 H), 7.51 (s, 1 H), 6.59 (s, 1 H), 5.48 (s, 2 H), 4.05 (s, 3 H), 3.90 (d, <i>J</i> = 3.8 Hz, 3 H), 3.71 (d, <i>J</i> = 5.8 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> 368 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>19</sub>H<sub>17</sub>N<sub>3</sub>O<sub>5</sub> (MH)<sup>+</sup> 368.1241, found 368.1243. C18 HPLC purity: 98% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Ethyl 2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)butanoate (<b>13c</b>)</h3><div class="NLM_p last">This compound was prepared form compound <b>12c</b> using the procedure described for <b>13a</b> and was isolated as a white solid (37 mg, 60%): mp 235–237 °C. IR (thin film) 2979, 1725, 1640, 1610, 1572, 1514, 1460, 1420, 1386, 1368, 1339, 1318, 1269, 1244, 1211, 1141, 1110, 1090, 1033, 1014 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.18 (s, 1 H), 9.41 (s, 1 H), 8.04 (s, 1 H), 7.64 (s, 1 H), 7.53 (s, 1 H), 6.95 (s, 1 H), 5.73 (d, <i>J</i> = 7.6 Hz, 1 H), 4.06 (d, <i>J</i> = 4.7 Hz, 1 H), 4.04 (s, 3 H), 3.88 (s, 3 H), 2.37–2.31 (m, 2 H), 1.05 (t, <i>J</i> = 7.1 Hz, 3 H), 0.79 (t, <i>J</i> = 7.5 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> 410 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub> (MH)<sup>+</sup> 410.1711, found 410.1711. C18 HPLC purity: 100% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Preparation of the Amides <b>14a</b>–<b>l</b></h3><div class="NLM_p">2-Bromo-3,4-dimethoxybenzoic acid (0.3 g, 1.14 mmol) was added to thionyl chloride (4 mL) and a catalytic amount of DMF. The reaction mixture was heated at reflux for 3 h, and then the thionyl chloride was evaporated to afford the corresponding acid chloride. The appropriate amine (1.2 mmol) was dissolved in DCM (5 mL) in an ice bath and mixed with TEA (5 mmol) in a vial, and the acid chloride was dissolved in DCM (2 mL) and added dropwise to the amine solution. The reaction mixture was stirred overnight at room temperature, and then the reaction was quenched with a saturated solution of sodium carbonate. The organic layer was then separated, washed with water, dried, and evaporated to give a residue. The residue was purified with silica gel column chromatography using either CHCl<sub>3</sub>–MeOH or EtOAc–hexanes mixtures to give the amides <b>14a</b>–<b>l</b> as white solids.</div><div id="sec3_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-Bromo-<i>N</i>-cyclohexyl-4,5-dimethoxybenzamide (<b>14a</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.35 g, 89%): mp 185–187 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.21 (s, 1 H), 6.98 (s, 1 H), 6.17–6.10 (m, 1 H), 3.99 (s, 1 H), 3.89 (s, 6 H), 2.09–1.99 (m, 2 H), 1.80–1.70 (m, 2 H), 1.50–1.17 (m, 6 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>20</sub>BrNO<sub>3</sub> (MH)<sup>+</sup> 342.0699/344.0681, found 342.0701/344.0683.</div></div><div id="sec3_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-Bromo-<i>N</i>-(cyclohexylmethyl)-4,5-dimethoxybenzamide (<b>14b</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.38 g, 93%): mp 163–165 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.25 (s, 1 H), 6.99 (s, 1 H), 6.33 (s, 1 H), 3.90 (s, 3 H), 3.31 (s, 3 H), 3.31 (t, <i>J</i> = 6.3 Hz, 2 H), 1.89–1.65 (m, 6 H), 1.33–1.12 (m, 4 H), 1.13–0.94 (m, 2 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>22</sub>BrNO<sub>3</sub> (MH)<sup>+</sup> 356.0856/358.0837, found 356.0855/358.0833.</div></div><div id="sec3_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-Bromo-<i>N</i>-cycloheptyl-4,5-dimethoxybenzamide (<b>14c</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.36 g, 88%): mp 157–158 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.20 (s, 1 H), 6.98 (s, 1 H), 6.20 (d, <i>J</i> = 7.8 Hz, 1 H), 4.23–4.12 (m, 1 H), 3.89 (s, 6 H), 2.12–2.01 (m, 2 H), 1.76–1.50 (m, 13 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>16</sub>H<sub>22</sub>BrNO<sub>3</sub> (MH)<sup>+</sup> 356.0856/358.0837, found 356.0855/358.0837.</div></div><div id="sec3_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-Bromo-<i>N</i>-cyclooctyl-4,5-dimethoxybenzamide (<b>14d</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.32 g, 75%): mp 145–147 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.21 (s, 1 H), 6.99 (s, 1 H), 6.23 (d, <i>J</i> = 8.0 Hz, 1 H), 4.27–4.14 (m, 1 H), 3.89 (s, 6 H), 2.03–1.90 (m, 2 H), 1.75–1.50 (m, 15 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>17</sub>H<sub>24</sub>BrNO<sub>3</sub> (MH)<sup>+</sup> 370.1012/372.0994, found 370.1012/372.0997.</div></div><div id="sec3_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-Bromo-4,5-dimethoxy-<i>N</i>-(1-methylpiperidin-4-yl)benzamide (<b>14e</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.35 g, 85%): mp 201–204 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.19 (s, 1 H), 6.99 (s, 1 H), 6.17 (s, 1 H), 4.06–3.96 (m, 1 H), 3.89 (s, 6 H), 2.90–2.79 (m, 2 H), 2.33 (s, 3 H), 2.27–2.18 (m, 2 H), 2.14–2.04 (m, 2 H), 1.74–1.60 (m, 2 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>21</sub>BrN<sub>2</sub>O<sub>3</sub> (MH)<sup>+</sup> 357.0808/359.0789, found 357.0809/359.0791.</div></div><div id="sec3_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>tert</i>-Butyl 4-(2-Bromo-4,5-dimethoxybenzamido)piperidine-1-carboxylate (<b>14f</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.4 g, 79%): mp 210–215 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.19 (s, 1 H), 6.97 (s, 1 H), 6.20 (d, <i>J</i> = 7.9 Hz, 1 H), 4.18–3.98 (m, 3 H), 3.89 (s, 6 H), 3.03–2.91 (m, 2 H), 2.06–1.97 (m, 2 H), 1.46 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>27</sub>BrN<sub>2</sub>O<sub>3</sub> (MNa)<sup>+</sup> 465.0995/467.0977, found 465.0995/467.0977.</div></div><div id="sec3_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>tert</i>-Butyl (<i>R</i>)-3-(2-Bromo-4,5-dimethoxybenzamido)pyrrolidine-1-carboxylate (<b>14g</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.38 g, 77%): mp 241–243 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.23 (s, 1 H), 6.99 (s, 1 H), 6.39 (s, 1 H), 4.68–4.61 (m, 1 H), 3.90 (s, 6 H), 3.68 (dd, <i>J</i> = 11.5, 5.9 Hz, 1 H), 3.53–3.45 (m, 2 H), 3.41–3.37 (m, 1 H), 2.28–2.17 (m, 1 H), 2.08–1.95 (m, 1 H), 1.47 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>25</sub>BrN<sub>2</sub>O<sub>5</sub> (MNa)<sup>+</sup> 451.0839/453.0821, found 451.0836/453.0819.</div></div><div id="sec3_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>tert</i>-Butyl (<i>R</i>)-3-(2-Bromo-4,5-dimethoxybenzamido)piperidine-1-carboxylate (<b>14h</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.41 g, 80%): mp 235–236 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.27 (s, 1 H), 6.99 (s, 1 H), 6.51 (d, <i>J</i> = 7.3 Hz, 1 H), 4.24–4.15 (s, 1 H), 3.90 (s, 6 H), 3.63–3.51 (m, 3 H), 3.35–3.20 (m, 1 H), 1.93–1.71 (m, 3 H), 1.44 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>27</sub>BrN<sub>2</sub>O<sub>5</sub> (MNa)<sup>+</sup> 465.0995/467.0977, found 465.0991/467.0979.</div></div><div id="sec3_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Methyl (2-Bromo-4,5-dimethoxybenzoyl)-<span class="smallcaps smallerCapital">d</span>-valinate (<b>14i</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.38 g, 88%): mp 178–180 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.02 (s, 1 H), 6.86 (d, <i>J</i> = 8.4 Hz, 1 H), 4.78 (dd, <i>J</i> = 8.6, 4.7 Hz, 1 H), 3.91 (s, 3 H), 3.89 (s, 3 H), 3.78 (s, 3 H), 2.37–2.28 (m, 1 H), 1.06 (d, <i>J</i> = 6.9 Hz, 3 H), 1.02 (d, <i>J</i> = 6.9 Hz, 3 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>20</sub>BrNO<sub>5</sub> (MNa)<sup>+</sup> 396.0417/398.0398, found 396.0412/398.0392.</div></div><div id="sec3_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Methyl (2-Bromo-4,5-dimethoxybenzoyl)-<span class="smallcaps smallerCapital">l</span>-valinate (<b>14j</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.37 g, 87%): mp 181–183 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.02 (s, 1 H), 6.86 (d, <i>J</i> = 8.6 Hz, 1 H), 4.78 (dd, <i>J</i> = 8.6, 4.7 Hz, 1 H), 3.91 (s, 3 H), 3.89 (s, 3 H), 3.78 (s, 3 H), 2.38–2.24 (m, 1 H), 1.06 (d, <i>J</i> = 6.9 Hz, 3 H), 1.02 (d, <i>J</i> = 6.9 Hz, 3 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>20</sub>BrNO<sub>5</sub> (MNa)<sup>+</sup> 396.0417/398.0398, found 396.0421/398.0403.</div></div><div id="sec3_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Methyl (<i>R</i>)-2-(2-Bromo-4,5-dimethoxybenzamido)butanoate (<b>14k</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.34 g, 82%): mp 165–168 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.26 (s, 1 H), 7.02 (s, 1 H), 6.91 (d, <i>J</i> = 7.8 Hz, 1 H), 4.79 (dd, <i>J</i> = 13.0, 6.5 Hz, 1 H), 3.91 (s, 3 H), 3.89 (s, 3 H), 3.80 (s, 3 H), 2.13–1.97 (m, 1 H), 1.92–1.85 (m, 1 H), 1.02 (t, <i>J</i> = 7.5 Hz, 3 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>18</sub>BrNO<sub>5</sub> (MNa)<sup>+</sup> 382.0260/384.0241, found 382.0258/384.0237.</div></div><div id="sec3_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Methyl (<i>S</i>)-2-(2-Bromo-4,5-dimethoxybenzamido)butanoate (<b>14l</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (0.37 g, 89%): mp 185–187 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.25 (s, 1 H), 7.01 (s, 1 H), 6.92 (d, <i>J</i> = 7.1 Hz, 1 H), 4.82–4.75 (m, 1 H), 3.91 (s, 3 H), 3.89 (s, 3 H), 3.79 (s, 3 H), 2.12–1.97 (m, 1 H), 1.91–1.85 (m, 1 H), 1.01 (t, <i>J</i> = 7.5 Hz, 3 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>18</sub>BrNO<sub>5</sub> (MNa)<sup>+</sup> 382.0260/384.0241, found 382.0263/384.0246.</div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> General Procedure for the Synthesis of Compounds <b>16a</b>–<b>l</b></h3><div class="NLM_p">A screw-capped vial with a Teflon cap was charged with SEM-protected 4-iodo-7-azaindole (<b>15</b>) (0.26 mmol, 1 equiv), amides <b>14a</b>–<b>l</b> (0.26 mmol, 1.05 equiv), Pd(OTFA)<sub>2</sub> (10 mol %), TFP (20 mol %), norborene (0.26 mmol, 1.05 equiv), and cesium carbonate (3 equiv). The atmosphere of the vial was evacuated and refilled with argon once and then the solvent (4 mL) was added via syringe and the vial was evacuated and refilled with argon twice. The reaction mixture was heated at the stated temperatures and time in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and was then cooled to room temperature. The reaction mixture was filtered through a pad of Celite and the solvent was evaporated and the residue obtained was loaded on a silica gel column and the mixture was purified using EtOAc-hexane mixture to give compounds <b>16a</b>–<b>l</b>.</div><div id="sec3_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 4-Cyclohexyl-7,8-dimethoxy-1-((2-(trimethylsilyl)ethoxy)methyl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>16a</b>)</h4><div class="NLM_p last">Compound <b>16a</b> was isolated as a yellowish powder (0.1 g, 78%): mp 198–200 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.18 (s, 1 H), 7.93 (s, 1 H), 7.71–7.67 (m, 1 H), 7.45 (d, <i>J</i> = 3.7 Hz, 1 H), 6.83 (d, <i>J</i> = 3.8 Hz, 1 H), 5.82 (s, 2 H), 5.02–4.95 (m, 1 H), 4.16 (s, 3 H), 4.09 (s, 3 H), 3.72–3.59 (m, 2 H), 3.08–2.91 (m, 2 H), 2.12–2.01 (m, 4 H), 1.86 (s, 1 H), 1.57–1.49 (m, 3 H), 1.05–0.95 (m, 2 H), 0.02 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>37</sub>N<sub>3</sub>O<sub>4</sub>Si (MH)<sup>+</sup> 508.2626, found 508.2629.</div></div><div id="sec3_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 4-(Cyclohexylmethyl)-7,8-dimethoxy-1-((2-(trimethylsilyl)ethoxy)methyl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>16b</b>)</h4><div class="NLM_p last">This compound was isolated as a yellow solid (0.11 g, 81%): mp 122–123 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.18 (s, 1 H), 7.93 (s, 1 H), 7.70 (s, 1 H), 7.42 (d, <i>J</i> = 3.7 Hz, 1 H), 6.85 (d, <i>J</i> = 3.8 Hz, 1 H), 5.80 (s, 2 H), 4.11 (s, 3 H), 4.05 (s, 3 H), 3.68–3.52 (m, 2 H), 1.73–1.61 (m, 9 H), 1.27–1.18 (m, 3 H), 1.01–0.85 (m, 2 H), −0.04 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>39</sub>N<sub>3</sub>O<sub>4</sub>Si (MH)<sup>+</sup> 522.2782, found 522.2780.</div></div><div id="sec3_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 4-Cycloheptyl-7,8-dimethoxy-1-((2-(trimethylsilyl)ethoxy)methyl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>16c</b>)</h4><div class="NLM_p last">This compound was isolated as a yellowish-white solid (70 mg, 50%): mp 184–186 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.20 (s, 1 H), 7.94 (s, 1 H), 7.73 (s, 1 H), 7.46 (d, <i>J</i> = 3.7 Hz, 1 H), 6.94 (d, <i>J</i> = 3.7 Hz, 1 H), 5.81 (d, <i>J</i> = 8.7 Hz, 2 H), 5.24 (d, <i>J</i> = 10.4 Hz, 1 H), 4.16 (s, 3 H), 4.09 (s, 3 H), 3.71–3.55 (m, 3 H), 2.99–2.85 (m, 2 H), 2.18–2.08 (m, 2 H), 2.01 (s, 2 H), 1.80 (d, <i>J</i> = 4.3 Hz, 4 H), 1.71–1.63 (m, 7 H), 1.06–0.96 (m, 3 H), 0.02 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>29</sub>H<sub>39</sub>N<sub>3</sub>O<sub>4</sub>Si (MH)<sup>+</sup> 522.2782, found 522.2782.</div></div><div id="sec3_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-Cyclooctyl-7,8-dimethoxy-1-((2-(trimethylsilyl)ethoxy)methyl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>16d</b>)</h4><div class="NLM_p last">This compound was isolated as a creamy white powder (84 mg, 58%): mp 166–168 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.20 (s, 1 H), 7.93 (s, 1 H), 7.72 (d, <i>J</i> = 10.5 Hz, 1 H), 7.47 (d, <i>J</i> = 3.7 Hz, 1 H), 6.96 (d, <i>J</i> = 3.8 Hz, 1 H), 5.81 (d, <i>J</i> = 9.8 Hz, 2 H), 5.28–5.22 (m, 1 H), 4.16 (s, 3 H), 4.09 (s, 3 H), 3.71–3.59 (m, 2 H), 3.00–2.89 (m, 2 H), 2.13–2.07 (m, 2 H), 2.05–1.96 (m, 3 H), 1.89–1.78 (m, 2 H), 1.74–1.63 (m, 7 H), 1.05–0.98 (m, 2 H), 0.02 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>30</sub>H<sub>41</sub>N<sub>3</sub>O<sub>4</sub>Si (MH)<sup>+</sup> 536.2939, found 536.2939.</div></div><div id="sec3_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 7,8-Dimethoxy-4-(1-methylpiperidin-4-yl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>16e</b>)</h4><div class="NLM_p last">This compound was isolated as a yellow oil (85 mg, 60%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.18 (s, 1 H), 7.92 (s, 1 H), 7.72 (s, 1 H), 7.47 (d, <i>J</i> = 3.5 Hz, 1 H), 6.80 (s, 1 H), 5.82 (s, 2 H), 5.02 (s, 1 H), 4.16 (s, 3 H), 4.10 (s, 3 H), 3.69–3.61 (m, 2 H), 3.46–3.39 (m, 2 H), 3.24 (s, 2 H), 2.53 (s, 2 H), 2.02–1.96 (m, 2 H), 1.06–0.94 (m, 2 H), 0.02 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>38</sub>N<sub>4</sub>O<sub>4</sub>Si (MH)<sup>+</sup> 523.2735, found 523.2737.</div></div><div id="sec3_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>tert</i>-Butyl 4-(7,8-Dimethoxy-5-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)piperidine-1-carboxylate (<b>16f</b>)</h4><div class="NLM_p last">This compound was isolated as a yellowish white solid (95 mg, 58%): mp 189–192 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.19 (s, 1 H), 7.90 (s, 1 H), 7.72 (s, 1 H), 7.48 (d, <i>J</i> = 3.7 Hz, 1 H), 6.78 (d, <i>J</i> = 3.7 Hz, 1 H), 5.84 (s, 2 H), 5.15–5.11 (m, 1 H), 4.51–4.42 (m, 2 H), 4.16 (s, 3 H), 4.10 (s, 3 H), 3.71–3.62 (m, 2 H), 3.26–3.16 (m, 2 H), 2.98 (s, 2 H), 1.95 (s, 2 H), 1.57 (s, 9 H), 1.05–0.95 (m, 2 H), 0.02 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>44</sub>N<sub>4</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 609.3102, found 609.3102.</div></div><div id="sec3_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>tert</i>-Butyl (<i>R</i>)-3-(7,8-Dimethoxy-5-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)pyrrolidine-1-carboxylate (<b>16g</b>)</h4><div class="NLM_p last">This compound was isolated as a creamy white solid (95 mg, 60%): mp 156–158 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.20 (s, 1 H), 7.91 (s, 1 H), 7.73 (s, 1 H), 7.50 (s, 1 H), 6.88 (s, 1 H), 5.84 (s, 2 H), 4.17 (s, 3 H), 4.10 (s, 3 H), 4.04–4.01 (m, 1 H), 3.93–3.89 (m, 1 H), 3.73–3.69 (m, 1 H), 3.67–3.62 (m, 2 H), 3.09–3.02 (m, 1 H), 2.46–2.42 (m, 1 H), 1.56 (s, 9 H), 1.05–0.96 (m, 2 H), 0.02 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>31</sub>H<sub>42</sub>N<sub>4</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 595.2946, found 595.2949.</div></div><div id="sec3_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>tert</i>-Butyl (<i>R</i>)-3-(7,8-Dimethoxy-5-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)piperidine-1-carboxylate (<b>16h</b>)</h4><div class="NLM_p last">This compound was isolated as a yellowish solid (82 mg, 52%): mp 148–152 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.13 (s, 1 H), 7.82 (s, 1 H), 7.64 (s, 1 H), 7.40 (d, <i>J</i> = 3.7 Hz, 1 H), 7.00–6.92 (m, 1 H), 5.81 (s, 2 H), 4.98–4.92 (m, 1 H), 4.53–4.41 (m, 1 H), 4.28–4.22 (m, 1 H), 4.11 (s, 3 H), 4.03 (s, 3 H), 3.66–3.56 (m, 2 H), 3.08–3.03 (m, 1 H), 2.92–2.79 (m, 2 H), 2.07–2.02 (m, 1 H), 1.89 (s, 2 H), 1.65 (s, 9 H), 1.26 (t, <i>J</i> = 7.2 Hz, 2 H), 0.99–0.89 (m, 1 H), −0.04 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>32</sub>H<sub>44</sub>N<sub>4</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 609.3102, found 609.3104.</div></div><div id="sec3_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Methyl (<i>R</i>)-2-(7,8-Dimethoxy-5-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)-3-methylbutanoate (<b>16i</b>)</h4><div class="NLM_p last">This compound was isolated as a yellow powder (0.1 g, 76%): mp 212–214 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.27 (s, 1 H), 7.91 (s, 1 H), 7.78 (s, 1 H), 7.49 (d, <i>J</i> = 3.8 Hz, 1 H), 6.95 (d, <i>J</i> = 3.8 Hz, 1 H), 5.83 (t, <i>J</i> = 7.1 Hz, 2 H), 5.51 (d, <i>J</i> = 9.3 Hz, 1 H), 4.18 (s, 3 H), 4.09 (s, 3 H), 3.76 (s, 3 H), 3.71–3.62 (m, 2 H), 3.29–3.22 (m, 1 H), 1.49 (d, <i>J</i> = 6.6 Hz, 3 H), 1.35–1.26 (m, 1 H), 1.04–0.93 (m, 2 H), 0.78 (d, <i>J</i> = 7.1 Hz, 3 H), 0.02 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>37</sub>N<sub>3</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 540.2524, found 540.2524.</div></div><div id="sec3_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Methyl (<i>S</i>)-2-(7,8-Dimethoxy-5-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)-3-methylbutanoate (<b>16j</b>)</h4><div class="NLM_p last">This compound was isolated as a yellowish solid (91 mg, 63%): mp 208–210 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.27 (s, 1 H), 7.92 (s, 1 H), 7.78 (s, 1 H), 7.48 (d, <i>J</i> = 3.7 Hz, 1 H), 6.94 (d, <i>J</i> = 3.8 Hz, 1 H), 5.82 (t, <i>J</i> = 6.7 Hz, 2 H), 5.51 (d, <i>J</i> = 9.3 Hz, 1 H), 4.17 (s, 3 H), 4.08 (s, 3 H), 3.76 (d, <i>J</i> = 6.7 Hz, 3 H), 3.72–3.64 (m, 2 H), 3.29–3.21 (m, 1 H), 2.17 (s, 1 H), 1.49 (d, <i>J</i> = 6.6 Hz, 3 H), 1.03–0.95 (m, 2 H), 0.78 (d, <i>J</i> = 7.1 Hz, 3 H), 0.02 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>28</sub>H<sub>37</sub>N<sub>3</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 540.2524, found 540.2524.</div></div><div id="sec3_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Methyl (<i>R</i>)-2-(7,8-Dimethoxy-5-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)butanoate (<b>16k</b>)</h4><div class="NLM_p last">This compound was isolated as a yellowish powder (0.1 g, 68%): mp 189–193 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.19 (s, 1 H), 7.85 (s, 1 H), 7.71 (s, 1 H), 7.42 (d, <i>J</i> = 3.6 Hz, 1 H), 6.81 (d, <i>J</i> = 3.6 Hz, 1 H), 5.80–5.72 (m, 2 H), 5.65 (t, <i>J</i> = 7.2 Hz, 1 H), 4.13 (s, 3 H), 4.04 (s, 3 H), 3.74 (s, 3 H), 3.62–3.55 (m, 2 H), 2.66–2.58 (m, 1 H), 2.42–2.37 (m, 1 H), 1.00 (t, <i>J</i> = 7.5 Hz, 3 H), 0.95–0.89 (m, 2 H), −0.05 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>35</sub>N<sub>3</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 526.2368, found 526.2370.</div></div><div id="sec3_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Methyl (<i>S</i>)-2-(7,8-Dimethoxy-5-oxo-1-((2-(trimethylsilyl)ethoxy)methyl)-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)butanoate (<b>16l</b>)</h4><div class="NLM_p last">This compound was isolated as a yellowish solid (0.072 g, 55%): mp 188–192 °C. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 9.19 (s, 1 H), 7.85 (s, 1 H), 7.71 (s, 1 H), 7.42 (d, <i>J</i> = 3.6 Hz, 1 H), 6.81 (d, <i>J</i> = 3.6 Hz, 1 H), 5.80–5.72 (m, 2 H), 5.65 (t, <i>J</i> = 7.2 Hz, 1 H), 4.13–4.08 (m, 4 H), 4.10–3.98 (m, 3 H), 3.74 (s, 3 H), 3.62–3.55 (m, 2 H), 2.65–2.59 (m, 1 H), 2.43–2.37 (m, 1 H), 1.00 (t, <i>J</i> = 7.5 Hz, 3 H), 0.95–0.89 (m, 2 H), −0.05 (s, 9 H). HRESIMS <i>m</i>/<i>z</i> calcd for C<sub>27</sub>H<sub>35</sub>N<sub>3</sub>O<sub>6</sub>Si (MH)<sup>+</sup> 526.2368, found 526.2370.</div></div></div><div id="sec3_6_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> General Procedure for the Deprotection of Compounds <b>17a</b>–<b>j</b></h3><div class="NLM_p">Compounds <b>16a</b>–<b>j</b> (0.1 mmol) were dissolved in DCM (2 mL), and TFA (2 mL) was added to the solution dropwise. The mixture was stirred at room temperature for 2 h, and then the solvent was evaporated. The residue was dissolved in MeOH (5 mL), and ethylenediamine (1 mL) was added and the mixture was stirred overnight at 50 °C. The mixture was acidified with TFA and extracted with CHCl<sub>3</sub> (3 × 10 mL). The combined organic layer was washed with water and brine (15 mL each), dried, and evaporated to yield <b>17a</b>–<b>j</b> as white solids.</div><div id="sec3_6_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 4-Cyclohexyl-7,8-dimethoxy-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>17a</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (28 mg, 74%): mp 233–235 °C. IR (thin film) 3120, 3002, 2922, 2847, 1654, 1608, 1576, 1509, 1462, 1450, 1417, 1400, 1378, 1357, 1300, 1224, 1207, 1180, 1124, 1040 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.08 (s, 1 H), 9.30 (s, 1 H), 7.95 (s, 1 H), 7.64 (s, 1 H), 7.54–7.45 (m, 1 H), 6.58 (s, 1 H), 4.85 (s, 1 H), 3.99 (s, 3 H), 3.85 (s, 3 H), 2.85–2.71 (m, 2 H), 1.89–1.81 (m, 4 H), 1.75–1.67 (m, 1 H), 1.48–1.38 (m, 2 H), 1.27–1.19 (m, 2 H). MALDIMS <i>m</i>/<i>z</i> 378 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>3</sub> (MH)<sup>+</sup> 378.1812, found 378.1814. C18 HPLC purity: 100% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 4-(Cyclohexylmethyl)-7,8-dimethoxy-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>17b</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (32 mg, 82%): mp 198–199 °C. IR (thin film) 3314, 2922, 2849, 1654, 1634, 1573, 1511, 1463, 1450, 1422, 1385, 1358, 1325, 1259, 1206, 1178, 1124, 1051, 1009 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.09 (s, 1 H), 9.38 (s, 1 H), 8.31 (s, 1 H), 8.02 (s, 1 H), 7.72 (s, 1 H), 7.54 (s, 1 H), 6.76 (s, 1 H), 4.61 (s, 2 H), 4.03 (s, 3 H), 3.89 (s, 3 H), 1.84–1.78 (m, 1 H), 1.68–1.59 (m, 5 H), 1.25–0.94 (m, 6 H). MALDIMS <i>m</i>/<i>z</i> 392 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>23</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub> (MH)<sup>+</sup> 392.1969, found 392.1968. C18 HPLC purity: 97.15% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 4-Cycloheptyl-7,8-dimethoxy-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>17c</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (35 mg, 89%): mp 242–244 °C. IR (thin film) 3120, 2926, 2849, 1651, 1610, 1576, 1508, 1462, 1449, 1397, 1356, 1310, 1258, 1240, 1208, 1175, 1120, 1069 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (s, 1 H), 9.38 (s, 1 H), 8.02 (s, 1 H), 7.71 (s, 1 H), 7.57 (dd, <i>J</i> = 10.7, 7.4 Hz, 1 H), 6.75 (s, 1 H), 5.17 (s, 1 H), 4.05 (s, 3 H), 3.92 (s, 3 H), 2.85–2.63 (m, 2 H), 2.04–1.92 (m, 4 H), 1.71–1.54 (m, 6 H), 1.25 (s, 3 H). <sup>13</sup>C NMR (126 MHz, DMSO) δ 161.75, 153.94, 149.54, 149.27, 141.05, 138.16, 128.85, 124.90, 118.46, 108.07, 107.86, 106.16, 103.20, 100.94, 61.68, 56.51, 55.79, 32.49, 28.21, 26.20. MALDIMS <i>m</i>/<i>z</i> 392 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>23</sub>H<sub>25</sub>N<sub>3</sub>O<sub>3</sub> (MH)<sup>+</sup> 392.1969, found 392.1969. C18 HPLC purity: 96.89% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 4-Cyclooctyl-7,8-dimethoxy-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>17d</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (32 mg, 79%): mp 235–238 °C. IR (thin film) 2918, 1644, 1607, 1571, 1510, 1463, 1416, 1378, 1354, 1334, 1263, 1241, 1207, 1180, 1164, 1062 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.16 (s, 1 H), 9.38 (s, 1 H), 8.02 (s, 1 H), 7.71 (s, 1 H), 7.60 (s, 1 H), 6.75 (s, 1 H), 5.18 (s, 1 H), 4.05 (s, 3 H), 3.92 (s, 3 H), 2.82–2.75 (m, 2 H), 1.98–1.83 (m, 4 H), 1.81–1.71 (m, 2 H), 1.64–1.50 (m, 5 H), 1.29–1.21 (m, 2 H). MALDIMS <i>m</i>/<i>z</i> 406 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>24</sub>H<sub>27</sub>N<sub>3</sub>O<sub>3</sub> (MH)<sup>+</sup> 406.2125, found 406.2127. C18 HPLC purity: 96.27% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 7,8-Dimethoxy-4-(1-methylpiperidin-4-yl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>17e</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (25 mg, 63%): mp 215–217 °C. IR (thin film) 2936, 1633, 1607, 1569, 1512, 1463, 1418, 1353, 1334, 1309, 1258, 1231, 1185, 1143, 1125, 1037, 1011 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.14 (s, 1 H), 9.33 (s, 1 H), 7.97 (s, 1 H), 7.64 (s, 1 H), 7.53 (d, <i>J</i> = 3.4 Hz, 1 H), 6.65 (s, 1 H), 5.04–4.98 (m, 1 H), 4.00 (s, 3 H), 3.86 (s, 3 H), 2.98–2.82 (m, 8 H), 2.57–2.54 (m, 1 H), 2.02–1.80 (m, 2 H). MALDIMS <i>m</i>/<i>z</i> 393 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>22</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub> (MH)<sup>+</sup> 393.1921, found 393.1926. C18 HPLC purity: 99.09% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 7,8-Dimethoxy-4-(piperidin-4-yl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>17f</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (18 mg, 48%): mp 258–259 °C. IR (thin film) 2925, 1635, 1610, 1572, 1515, 1313, 1261, 1210, 1038 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.07 (s, 1 H), 9.31 (s, 1 H), 7.95 (s, 1 H), 7.64 (s, 1 H), 7.51 (s, 1 H), 6.61 (s, 1 H), 4.98–4.89 (m, 1 H), 3.99 (s, 3 H), 3.86 (s, 3 H), 3.21–3.08 (m, 3 H), 2.89 (d, <i>J</i> = 8.6 Hz, 2 H), 2.69–2.58 (m, 4 H), 1.79–1.69 (m, 2 H). MALDIMS <i>m</i>/<i>z</i> 379 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>21</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub> (MH)<sup>+</sup> 379.1764, found 379.1762. C18 HPLC purity: 99.27% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>R</i>)-7,8-Dimethoxy-4-(pyrrolidin-3-yl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>17g</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (10 mg, 27%): mp 274–276 °C. IR (thin film) 2920, 1939, 1608, 1570, 1511, 1455, 1419, 1398, 1379, 1336, 1310, 1262, 1244, 1208, 1161, 1127, 1026 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.16 (s, 1 H), 9.39 (s, 1 H), 8.04 (s, 1 H), 7.72 (s, 1 H), 7.58 (s, 1 H), 6.96 (s, 1 H), 5.72 (s, 1 H), 4.06 (s, 3 H), 3.92 (s, 3 H), 3.31–3.21 (m, 2 H), 3.05–2.91 (m, 1 H), 2.38–2.28 (m, 2 H), 0.95–0.84 (m, 1 H). MALDIMS <i>m</i>/<i>z</i> 365 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>20</sub>H<sub>20</sub>N<sub>4</sub>O<sub>3</sub> (MH)<sup>+</sup> 365.1608, found 365.1610. C18 HPLC purity: 100% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (<i>R</i>)-7,8-Dimethoxy-4-(piperidin-3-yl)-1,4-dihydro-5<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-5-one (<b>17h</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (18 mg, 48%): mp 286–287 °C. IR (thin film) 3130, 2919, 1649, 1610, 1577, 1509, 1463, 1407, 1378, 1334, 1310, 1242, 1209, 1175, 1127, 1022 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.13 (s, 1 H), 9.37 (s, 1 H), 8.02 (s, 1 H), 7.69 (s, 1 H), 7.57 (s, 1 H), 6.86 (s, 1 H), 5.03–4.97 (m, 1 H), 4.06 (s, 3 H), 3.92 (s, 3 H), 3.88–2.84 (m, 1 H), 3.14–3.08 (m, 1 H), 3.02–2.96 (m, 2 H), 1.93–1.85 (m, 1 H), 1.84–1.78 (m, 1 H), 1.68–1.60 (m, 1 H). MALDIMS <i>m</i>/<i>z</i> 379 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>21</sub>H<sub>22</sub>N<sub>4</sub>O<sub>3</sub> (MH)<sup>+</sup> 379.1764, found 379.1765. C18 HPLC purity: 99.29% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> Methyl (<i>R</i>)-2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)-3-methylbutanoate (<b>17i</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (12 mg, 29%): mp 256–258 °C. IR (thin film) 2922, 1726, 1608, 1572, 1514, 1461, 1420, 1386, 1334, 1268, 1184, 1137, 1021 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.29 (s, 1 H), 9.47 (s, 1 H), 8.09 (s, 1 H), 7.69 (s, 1 H), 7.64–7.53 (m, 1 H), 6.91 (s, 1 H), 5.54 (d, <i>J</i> = 9.3 Hz, 1 H), 4.08 (s, 3 H), 3.93 (s, 3 H), 3.57 (s, 3 H), 3.10–2.90 (m, 1 H), 1.37 (d, <i>J</i> = 6.6 Hz, 3 H), 0.61 (d, <i>J</i> = 7.1 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> 410 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub> (MH)<sup>+</sup> 410.1711, found 410.1712. C18 HPLC purity: 100% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> Methyl (<i>S</i>)-2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)-3-methylbutanoate (<b>17j</b>)</h4><div class="NLM_p last">This compound was isolated as a white solid (26 mg, 68%): mp 274–276 °C. IR (thin film) 2956, 1741, 1652, 1608, 1570, 1513, 1461, 1420, 1384, 1365, 1334, 1314, 1264, 1246, 1210, 1145, 1119, 1071, 1028 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.21 (s, 1 H), 9.40 (s, 1 H), 8.03 (s, 1 H), 7.63 (s, 1 H), 7.57–7.47 (m, 1 H), 6.85 (s, 1 H), 5.48 (d, <i>J</i> = 9.2 Hz, 1 H), 4.02 (s, 3 H), 3.87 (s, 3 H), 3.51 (s, 3 H), 3.01–2.91 (m, 1 H), 1.31 (d, <i>J</i> = 6.6 Hz, 3 H), 0.55 (d, <i>J</i> = 7.1 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> 410 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub> (MH)<sup>+</sup> 410.1711, found 410.1710. C18 HPLC purity: 98.30% (MeOH–H<sub>2</sub>O, 85:15).</div></div></div><div id="sec3_6_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> (<i>R</i>)-2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)butanoic Acid (<b>17k</b>)</h3><div class="NLM_p last">Compound <b>16k</b> (0.14 g, 0.226 mmol) was dissolved in DCM (2 mL), and TFA (2 mL) was added to the solution dropwise. The mixture was stirred at room temperature for 2 h, and then the solvent was evaporated. The residue was dissolved in MeOH (5 mL) and THF (5 mL) and ethylenediamine (1 mL) and NaOH (2 mL, 1 M aq solution) were added and the mixture was stirred overnight at 60 °C. The volatile solvents were removed, and the solution was acidified with HCl to pH 3. The mixture was extracted with EtOAc (3 × 10 mL). The combined organic layer was washed with water and brine (15 mL each), dried, and evaporated to yield <b>17k</b> as a white solid (80 mg, 81%): mp 212–214 °C. IR (thin film) 3262, 2921, 1722, 1657, 1608, 1574, 1463, 1422, 1387, 1338, 1314, 1264, 1246, 1211, 1137, 1082 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.15 (s, 1 H), 9.38 (s, 1 H), 8.02 (s, 1 H), 7.63 (s, 1 H), 7.50 (s, 1 H), 6.90 (s, 1 H), 5.64 (s, 1 H), 4.02 (s, 3 H), 3.86 (s, 3 H), 2.30–2.23 (m, 2 H), 0.78 (t, <i>J</i> = 7.5 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> 382 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>20</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub> (MH)<sup>+</sup> 382.1397, found 382.1397.</div></div><div id="sec3_6_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> (<i>S</i>)-2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)butanoic Acid (<b>17l</b>)</h3><div class="NLM_p last">Following the same procedure used for <b>17k</b>, compound <b>17l</b> was isolated as a white solid (84 mg, 85%): mp 217–218 °C. IR (thin film) 3544, 2937, 1704, 1676, 1601, 1515, 1459, 1425, 1390, 1330, 1310, 1264, 1229, 1211, 1181, 1147, 1028 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.24 (s, 1 H), 9.45 (s, 1 H), 8.08 (s, 1 H), 7.69 (s, 1 H), 7.58 (s, 1 H), 6.98 (s, 1 H), 5.70 (s, 1 H), 4.08 (s, 3 H), 3.93 (s, 3 H), 2.48–2.37 (m, 2 H), 2.32 (d, <i>J</i> = 6.6 Hz, 1 H), 0.85 (t, <i>J</i> = 7.5 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> 382 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>20</sub>H<sub>19</sub>N<sub>3</sub>O<sub>5</sub> (MH)<sup>+</sup> 382.1397, found 382.1399.</div></div><div id="sec3_6_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> (<i>R</i>)-2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)-3-methylbutanoic Acid (<b>17m</b>)</h3><div class="NLM_p last">Compound <b>16i</b> (0.1 mmol) was dissolved in DCM (2 mL), and TFA (2 mL) was added to the solution dropwise. The mixture was stirred at room temperature for 2 h, and then the solvent was evaporated. The residue was dissolved in MeOH (5 mL) and THF (5 mL) and ethylenediamine (1 mL) and NaOH (2 mL, 1 M soln) were added and the mixture was stirred overnight at 60 °C. The volatile solvents were removed, and the solution was acidified with HCl to pH 3. The mixture was extracted with EtOAc (3 × 10 mL). The combined organic layer was washed with water and brine (15 mL each), dried, and evaporated to yield <b>17m</b> as a yellow solid (0.11 g, 96%): mp 198–200 °C. IR (thin film) 3513, 2968, 1720, 1665, 1606, 1514, 1459, 1442, 1388, 1329, 1264, 1183, 1136, 1017 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.22 (s, 1 H), 9.40 (s, 1 H), 8.02 (s, 1 H), 7.68 (m, 1 H), 7.60–7.40 (m, 1 H), 6.82 (s, 1 H), 5.35 (d, <i>J</i> = 9.3 Hz, 1 H), 4.02 (s, 3 H), 3.87 (s, 3 H), 3.12–2.94 (m, 1 H), 1.32 (d, <i>J</i> = 8.6 Hz, 3 H), 0.56 (d, <i>J</i> = 7.1 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> 396 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>21</sub>H<sub>21</sub>N<sub>3</sub>O<sub>5</sub> (MH)<sup>+</sup> 396.1554, found 396.1553.</div></div><div id="sec3_6_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (<i>R</i>)-3-(3-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)piperidin-1-yl)-3-oxopropanenitrile (<b>18</b>)</h3><div class="NLM_p last">Compound <b>17h</b> (30 mg, 0.08 mol) was added to a solution of HATU (30 mg, 0.08 mmol), DIPEA (30 mg 0.24 mmol), and cyanoacetic acid (5 mg) in DMF (4 mL). The mixture was stirred at room temperature for 24 h and then quenched with saturated ammonium chloride (15 mL). The solution was extracted with EtOAc (3 × 15 mL). The combined organic layer was washed with saturated sodium bicarbonate (15 mL), water, and brine and dried using anhydrous sodium sulfate. The residue obtained after evaporation of the organic layer was purified using column chromatography (CH<sub>2</sub>Cl<sub>2</sub>–MeOH 9.8:0.2) to give compound <b>18</b> as white solid (26 mg, 73%): mp 185–187 °C. IR (thin film) 2928, 2262, 1645, 1608, 1573, 1512, 1446, 1417, 1378, 1333, 1308, 1261, 1208, 1129, 1063 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.11 (s, 1 H), 9.33 (s, 1 H), 7.98 (s, 1 H), 7.64 (d, <i>J</i> = 4.1 Hz, 1 H), 7.51 (d, <i>J</i> = 12.7 Hz, 1 H), 6.59 (m, 1 H), 4.82 (s, 1 H), 4.68–4.61 (m, 1 H), 4.48–4.42 (m, 1 H), 4.24–4.18 (m, 1 H), 4.13–4.08 (m, 1 H), 3.99 (s, 3 H), 3.86 (s, 3 H), 3.76–3.70 (m, 2 H), 3.11–3.02 (m, 1 H), 2.93–2.84 (m, 2 H), 2.50 (s, 2 H), 1.88–1.84 (m, 1 H), 1.72–1.65 (m, 1 H). MALDIMS <i>m</i>/<i>z</i> 446 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>24</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub> (MH)<sup>+</sup> 446.1823, found 446.1822. C18 HPLC purity: 95.85% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (<i>R</i>)-1-(2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)-3-methylbutanoyl)azetidine-3-carbonitrile (<b>19a</b>)</h3><div class="NLM_p last">Following the same procedure used for compound <b>18</b> and starting with <b>17m</b>, compound <b>19a</b> was isolated as a white solid (48 mg, 86%): mp 236–238 °C. IR (thin film) 3248, 2965, 1649, 1608, 1570, 1514, 1413, 1367, 1332, 1264, 1210, 1138, 1115, 1022 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.25 (s, 1 H), 9.42 (s, 1 H), 8.03 (s, 1 H), 7.66 (s, 1 H), 7.58 (s, 1 H), 7.05–6.88 (m, 1 H), 5.48 (s, 1 H), 4.02 (s, 3 H), 4.00–3.95 (m, 1 H), 3.88 (s, 3 H), 3.83–3.79 (m, 1 H), 3.45–3.41 (m, 1 H), 3.07–3.01 (m, 1 H), 1.26 (d, <i>J</i> = 6.6 Hz, 3 H), 0.50 (d, <i>J</i> = 7.2 Hz, 3 H). <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.95, 154.52, 149.78, 149.44, 141.44, 138.14, 129.34, 126.42, 124.97, 116.50, 108.29, 107.52, 105.77, 103.52, 101.91, 56.63, 55.84, 26.69, 21.76, 18.10. MALDIMS <i>m</i>/<i>z</i> 460 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>25</sub>H<sub>25</sub>N<sub>5</sub>O<sub>4</sub> (MH)<sup>+</sup> 460.1979, found 460.1981. C18 HPLC purity: 100% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (<i>R</i>)-2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)-3-methyl-<i>N</i>-(2,2,2-trifluoroethyl)butanamide (<b>19b</b>)</h3><div class="NLM_p last">Following the same procedure used for compound <b>18</b> and starting with <b>17m</b>, compound <b>19b</b> was isolated as a white solid (45 mg, 74%): mp 247–248 °C. IR (thin film) 3123, 2970, 2878, 1677, 1627, 1608, 1548, 1514, 1465, 1418, 1397, 1387, 1362, 1334, 1309, 1282, 1233, 1213, 1159, 1120, 1063, 1034 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.17 (s, 1 H), 9.40 (s, 1 H), 8.63 (t, <i>J</i> = 6.3 Hz, 1 H), 8.03 (s, 1 H), 7.64 (s, 1 H), 7.53 (s, 1 H), 6.82 (s, 1 H), 5.25 (d, <i>J</i> = 9.5 Hz, 1 H), 4.02 (s, 3 H), 3.99–3.95 (m, 1 H), 3.86 (s, 3 H), 3.73–3.68 (m, 1 H), 3.04–2.96 (m, 1 H), 1.19 (d, <i>J</i> = 6.5 Hz, 3 H), 0.38 (d, <i>J</i> = 6.8 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> 477 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>23</sub>H<sub>23</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> (MH)<sup>+</sup> 477.1744, found 477.1744. C18 HPLC purity: 97.59% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> (<i>R</i>)-1-(2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)butanoyl)azetidine-3-carbonitrile (<b>20a</b>)</h3><div class="NLM_p last">Compound <b>17k</b> (30 mg, 0.08 mmol) was added to a solution of HATU (30 mg, 0.08 mmol) and DIPEA (30 mg 0.24 mmol) in DMF (4 mL). After stirring for 5 min, azetidine-3-carbonitrile hydrochloride (13 mg, 0.09 mmol) was added to the mixture. The mixture was stirred at room temperature for 24 h, and then the reaction was quenched with saturated ammonium chloride (15 mL). The solution was extracted with EtOAc (3 × 15 mL). The combined organic layer was washed with saturated sodium bicarbonate (15 mL), water, and brine and dried using anhydrous sodium sulfate. The residue obtained after evaporation of the organic layer was purified using silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH 9.8:0.2) to yield compound <b>20a</b> as a white solid (28 mg, 60%): mp 257–260 °C. IR (thin film) 3313, 2957, 1649, 1609, 1572, 1514, 1464, 1421, 1385, 1310, 1262, 1209, 1152, 1040 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.26 (s, 1 H), 9.47 (s, 1 H), 8.09 (s, 1 H), 7.72 (s, 1 H), 7.62 (s, 1 H), 7.06 (s, 1 H), 5.77 (s, 1 H), 4.08 (s, 3 H), 4.03–3.97 (m, 1 H), 3.94 (s, 3 H), 3.91–3.86 (m, 1 H), 3.54 (s, 1 H), 2.47–2.36 (m, 2 H), 2.21 (d, <i>J</i> = 7.6 Hz, 1 H), 0.81 (t, <i>J</i> = 7.6 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> 446 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>24</sub>H<sub>23</sub>N<sub>5</sub>O<sub>4</sub> (MH)<sup>+</sup> 446.1823, found 446.1828. C18 HPLC purity: 96.72% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> (<i>R</i>)-2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)-<i>N</i>-(2,2,2-trifluoroethyl)butanamide (<b>20b</b>)</h3><div class="NLM_p last">Compound <b>17k</b> (30 mg, 0.08 mmol) was added to a solution of HATU (30 mg, 0.08 mmol) and DIPEA (30 mg 0.24 mmol) in DMF (4 mL). After stirring for 5 min, trifluoroethylamine hydrochloride (11 mg, 0.09 mmol) was added to the mixture. The mixture was stirred at room temperature for 24 h and then quenched with saturated ammonium chloride (15 mL). The solution was extracted with EtOAc (3 × 15 mL). The combined organic layer was washed with saturated sodium bicarbonate (15 mL), water, and brine and dried using anhydrous sodium sulfate. The residue obtained after evaporation of the organic layer was purified using silica gel column chromatography (CH<sub>2</sub>Cl<sub>2</sub>:MeOH 9.8:0.2) to provide compound <b>20b</b> as a white solid (20 mg, 55%): mp 267–268 °C. IR (thin film) 3508, 2979, 2872, 2249, 1649, 1610, 1572, 1517, 1499, 1416, 1386, 1315, 1247, 1210, 1186, 1166, 1112, 1041 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.10 (s, 1 H), 9.37 (s, 1 H), 8.50 (t, <i>J</i> = 6.4 Hz, 1 H), 8.02 (s, 1 H), 7.62 (s, 1 H), 7.49 (s, 1 H), 6.64 (s, 1 H), 5.56 (t, <i>J</i> = 7.5 Hz, 1 H), 4.01 (s, 3 H), 3.86 (s, 3 H), 3.68–3.61 (m, 2 H), 2.65 (s, 1 H), 2.37–2.29 (m, 2 H), 0.52 (t, <i>J</i> = 7.4 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> (rel intensity) 463 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>22</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> (MH)<sup>+</sup> 463.1588, found 463.1602. C18 HPLC purity: 98.86% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_6_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> (<i>S</i>)-2-(7,8-Dimethoxy-5-oxo-1,5-dihydro-4<i>H</i>-benzo[<i>c</i>]pyrrolo[2,3-<i>h</i>][1,6]naphthyridin-4-yl)-<i>N</i>-(2,2,2-trifluoroethyl)butanamide (<b>21</b>)</h3><div class="NLM_p last">Following the same procedure used for <b>20b</b> but using the acid <b>17l</b>, compound <b>21</b> was isolated as a white solid (24 mg, 60%): mp 235–237 °C. IR (thin film) 3318, 2959, 1699, 1649, 1610, 1572, 1513, 1465, 1421, 1365, 1337, 1310, 1260, 1248, 1208, 1151, 1136 cm<sup>–1</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.16 (s, 1 H), 9.43 (s, 1 H), 8.56 (t, <i>J</i> = 6.3 Hz, 1 H), 8.08 (s, 1 H), 7.68 (s, 1 H), 7.58–7.52 (m, 1 H), 6.70 (s, 1 H), 5.62 (t, <i>J</i> = 7.6 Hz, 1 H), 4.08 (s, 3 H), 4.07–3.99 (m, 1 H), 3.92 (s, 3 H), 3.71 (s, 2 H), 2.39 (t, <i>J</i> = 7.5 Hz, 3 H), 0.59 (t, <i>J</i> = 7.4 Hz, 3 H). MALDIMS <i>m</i>/<i>z</i> 463 (MH)<sup>+</sup>. HRESIMS calcd for C<sub>22</sub>H<sub>21</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> (MH)<sup>+</sup> 463.1588, found 463.1590. C18 HPLC purity: 100% (MeOH–H<sub>2</sub>O, 85:15).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Enzyme Inhibition Assay</h3><div class="NLM_p last">The enzyme assay was performed by Reaction Biology Corporation according to the following protocol: The base reaction buffer consisted of 20 mM Hepes (pH 7.5), 10 mM MgCl<sub>2</sub>, 1 mM EDTA, 0.02% Brij-35, 0.02 mg/mL BSA, 0.1 mM Na<sub>3</sub>VO<sub>4</sub>, 2 mM DTT, and 1% DMSO. The indicated substrate was added to freshly prepared base reaction buffer, and then the required cofactors were added to the substrate solution. Purified JAK kinases were added into the substrate solution and gently mixed. A solution of the compounds in DMSO was then added into the kinase reaction mixture by Acoustic technology (Echo550; nanoliter range), and the mixture was incubated for 20 min at room temperature. <sup>33</sup>P-ATP (specific activity 10 Ci/mmol) was then added into the reaction mixture to initiate the reaction. The kinase reaction was incubated for 2 h at room temperature, and then the mixtures were spotted onto P81 ion exchange paper. Finally, the kinase activity was detected by the filter-binding method.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> STAT-5 Phosphorylation Inhibition Assay</h3><div class="NLM_p last">The experiments performed by Reaction Biology Corporation. SZ4 cells from growing stock were seeded in 96-well plates at 1 × 10<sup>5</sup> cells/well in 100 μL of complete media and then incubated overnight at 37 °C, 5% CO<sub>2</sub>. The cells were treated with test compounds (starting at 30 μM, 8 doses with 3-fold dilution) for 1 h. The cells were then stimulated with hIL-2 at a final concentration of 100 ng/mL for 15 min. The cells were spun down, and the culture medium was aspirated. The cells were lysed with 50 μL of 1× cell lysis buffer. The cell lysates (25 μL) were used for MSD assay immediately or stored at −80 °C. MSD assay was performed according to the kit manual (<a href="https://www.mesoscale.com/~/media/files/product%20inserts/phospho%20tyr694%20total%20stat5a%20b%20wcl.pdf" class="extLink">https://www.mesoscale.com/~/media/files/product%20inserts/phospho%20tyr694%20total%20stat5a%20b%20wcl.pdf</a>). IC<sub>50</sub> values were calculated using GraphPad Prism 4 based on a sigmoidal dose–response equation. Western blot assay experimental details are provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Supporting Information</a>.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Primary T Cell Inhibition Assay</h3><div class="NLM_p last">CD4<sup>+</sup> T cells were isolated from mouse spleen and cultured in vitro with antibodies to CD3 (5 μg/mL) and CD28 (2 μg/mL) in the presence of IL-2 (100 U/mL) for nonpolarizing conditions as described before.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Inhibitors were added to culture at the indicated concentrations. After culture, the cells were stained with XTT (sodium 2,3,-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)-carbonyl]-2<i>H</i>-tetrazolium inner salt) and analyzed at 475 nm by a microplate reader (SpectraMax i3X, Molecular Devices). The cells were cultured for 5 days and stained with antibodies to mouse CD4 (RM4-5). The cells were activated with phorbol myristate acetate (PMA, 50 ng/mL, Sigma-Aldrich), ionomycin (1 μM, Sigma-Aldrich), and monensin (2 mM, Sigma-Aldrich) for 4 h followed by fixation with 4% PFA in PBS and permeabilization in 1% saponins in PBS. The cells were stained with antibodies to mouse IFNγ (XGM1.2) or mouse IL-17 (TC11-18H10.1) for flow cytometry (Canto II, Becton Dickinson). For IL-17 production, the T cells were cultured with anti-IL2, anti-IFNγ, anti-IL-4, IL-23, TNF-α, and IL-1β as previously described.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Kinome Scanning Assay</h3><div class="NLM_p last">Selected compounds were tested for kinome selectivity at Eurofins DiscoverX Corporation, Fremont, California, USA, by applying their KINOMEscan technology. Different kinases were labeled with a unique DNA tag for qPCR. A known kinase ligand was immobilized on a solid support and incubated with the labeled kinase in the presence of either DMSO or a specified concentration of the test compounds. After equilibration, the solid support was washed to remove unbound kinase, and then the kinase captured on solid support was quantified by qPCR. Finally, the captured kinase levels in the test compound and DMSO control samples were compared.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Pharmacokinetic Profiling</h3><div class="NLM_p last">The experiments were performed at Eurofins Scientific Inc., Lancaster, PA, USA.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Caco-2 Permeability</h3><div class="NLM_p last">Caco-2 cells were grown in tissue culture flasks, trypsinized, and suspended in medium, and known concentrations of cell suspensions were seeded onto wells of a Millipore 96-well Caco-2 plate. The cells were allowed to grow and differentiate for 3 weeks, feeding at two-day intervals. For apical to basolateral (A → B) permeability, the test article was added to the apical (A) side and the amount of permeation on the basolateral (B) side was determined; for basolateral to apical (B → A) permeability, the test article was added to the B side and the amount of permeation on the A side was determined. To test tight junctions and monolayer integrity, the A-side buffer contained 100 μM Lucifer yellow dye in transport buffer (1.98 g/L glucose in 10 mM HEPES, 1× Hank’s Balanced Salt Solution) with pH 6.5, while the B-side buffer was transport buffer with pH 7.4. Caco-2 cells were incubated with these buffers for 2 h, and the receiver-side buffer was removed for analysis by LC/MS/MS. To verify the tight junctions and integrity of Caco-2 cell monolayers, aliquots of the cell buffers were analyzed by fluorescence (Lucifer yellow transport ≤2%). Any deviations from control values are reported. Data are expressed as permeability (<i>P</i><sub>app</sub>) = (d<i>Q</i>/d<i>t</i>)/(<i>C</i><sub>0</sub><i>A</i>) where d<i>Q</i>/d<i>t</i> is the rate of permeation, <i>C</i><sub>0</sub> is the initial concentration of test agent, and <i>A</i> is the area of the monolayer. In bidirectional permeability studies, the efflux ratio (<i>R</i><sub>e</sub>) is also calculated: <i>R</i><sub>e</sub> = (<i>P</i><sub>app</sub> B → A)/(<i>P</i><sub>app</sub> A → B); <i>R</i><sup>e</sup> > 2 indicates a potential substrate for P-glycoprotein or other active efflux transporter(s).</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Metabolic Stability Analysis</h3><div class="NLM_p last">The compounds were incubated in duplicate with pooled human liver microsomes at 37 °C. The reaction mixtures contained microsomal protein in 100 mM potassium phosphate buffer (pH 7.4), 2 mM NADPH, and 3 mM MgCl<sub>2</sub>. A control was run for each test article omitting NADPH to detect NADPH-free degradation. At predetermined time points, an aliquot was removed from each experimental and control reaction and mixed with an equal volume of ice-cold methanol containing propranolol as the internal standard to stop the reaction and precipitate proteins. Stopped reactions were kept on ice for at least 10 min followed by an addition of an equal volume of water. The samples were centrifuged to remove precipitated protein, and the supernatants were analyzed by LC-MS/MS to quantify parent remaining. Data was calculated as % parent remaining by assuming zero-minute time point peak area ratio (analyte/IS) as 100% and dividing remaining time point peak area ratios by the zero minute time point peak area ratio. Data were subjected to fit a first-order decay model to calculate slope and thereby half-life.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> PBS Solubility Screen</h3><div class="NLM_p last">Serial dilutions of the tested compounds, reserpine, tamoxifen, and verapamil were prepared in phosphate buffered saline (PBS) at 100× the final concentration. The solutions were diluted 100-fold into PBS in a 96-well plate and mixed. The absorbance of the PBS-containing plate was measured prior to addition of the test agents to determine the background absorbance. After 2 h, the presence of precipitate was detected by turbidity (absorbance at 540 nm). An absorbance value of greater than (mean + 3× standard deviation of the blank), after subtracting the preexperiment background, is indicative of turbidity. The solubility limit is reported as the highest experimental concentration with no evidence of turbidity.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Molecular Modeling</h3><div class="NLM_p last">The X-ray crystal structures of JAK kinases were obtained from the Protein Data Bank (JAK1 PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5C">4I5C</a>; JAK2 PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>). Each protein structure was cleaned, inspected for errors and missing residues, hydrogens were added, and the water molecules were deleted using Accelry’s Discovery studio 2.5 software. Structures of the inhibitors were constructed using ChemBioDraw Ultra 13 and saved in SDF file format and were corrected and optimized using Accelrys Discovery studio 2.5 software. GOLD 4.1 was used for docking with the default parameters except that the iterations were increased to 300000 and the early termination option was disabled. The centroids of the binding sites were defined by the ligands in the cocrystal structures. The top 10 docking poses per ligand were inspected visually following the docking runs. Energy minimizations were performed for selected ligand poses. The CHARMM force field was utilized within the Accelrys Discovery Studio 2.5 for energy minimization.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> Collagen-Induced Inflammation Model</h3><div class="NLM_p last">All procedures performed on live mice were approved by the Purdue Animal Use and Care Committee and conformed with NIH guidelines. Eight-week-old, male DBA-1 mice were obtained from Jackson Laboratories. The mice were kept in housing facilities that maintained a constant temperature of 22 °C and a constant humidity of 50%. The mice were maintained on a 12-h light/dark cycle. Collagen-induced arthritis was induced in the mice after a one-week acclimation period in our housing facility. To induce the inflammation, equal volumes of the following compounds were mixed on ice with a homogenizer until a stable emulsion formed: 2 mg/mL of bovine type II collagen in 0.05 M acetic acid (Chondrix) and Complete Freund’s Adjuvant (Chondrix) containing 4 mg/mL of <i>Mycoplasma tuberculosis</i>. Mice were maintained under anesthesia during the inculcation via inhalation of isoflurane. Each mouse received a 100 μL injection of the emulsion transdermally in the tail. Three weeks later, the mice received a booster inculcation the same way but with an emulsion made from equal parts of Incomplete Freund’s Adjuvant (Chondrix) and type II bovine collagen (Chondrix). After 8 weeks, all mice displayed symptoms of inflammation. They were sorted into one of the three treatment groups so that the mean RA score for each of the treatment groups was the same, and seven mice were assigned to each treatment group. Sorting in this manner controlled for the variability in the response to a CIA induction. The treatment groups consisted of <b>17b</b>, tofacitinib, and vehicle (10% DMSO and 10% Cremophor EL). Daily doses of 5 mg/kg/day were administered subcutaneously in 10% DMSO and 10% Cremophor EL for 5 weeks. Every week inflammation was assessed by measuring paw volume with a digital caliper and scoring all four paws with the 0–4 rheumatoid arthritis score. The paws were scored by a trained technician who was blinded to the treatment groups and who referred to a visual key for scoring every time (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Figure 7s</a>, Supporting Information). Paw volume was calculated as the product of the length, width, and height of the paws. Measurements of height and width were taken at the same location on the paw every time. Mouse weight was monitored throughout the treatment period to watch for any toxicities, and no large fluctuations in weight were seen as a result of any of the treatments (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">Figure 8s</a>, Supporting Information). After 5 weeks of treatment, the mice were euthanized, and the paws were collected for micro CT analysis. The Student’s <i>t</i> test revealed that both tofacitinib and <b>17b</b> cause a significantly different response compared to the vehicle control and that there is not a statistically significant difference between the two drugs. Statistical significance was determined using the Holm–Sidak method, with α = 0.05.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00510" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00510" class="ext-link">10.1021/acs.jmedchem.8b00510</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Table for the % growth of the NCI-60 cell lines, gels monitoring Top1-mediated DNA cleavage, table of kinome selectivity data, kinome maps, EC<sub>50</sub> determination curves and experimental procedure for the JAK3-mediated STAT-5 phosphorylation assay, mouse paw collagen-induced inflammation assay (RA paw volume and percent weight change results) (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_008.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMILES molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_007.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline"><a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> JAK1 molecular model (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline"><a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a> JAK3 molecular model (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_002.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline"><a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> JAK1 molecular model (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline"><a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> JAK3 molecular model (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_004.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline"><a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> JAK1 molecular model (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_005.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline"><a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a> JAK3 molecular model (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_006.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb">jm8b00510_si_001.pdb (186.64 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_002.pdb">jm8b00510_si_002.pdb (357.38 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_003.pdb">jm8b00510_si_003.pdb (186.94 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_004.pdb">jm8b00510_si_004.pdb (357.68 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_005.pdb">jm8b00510_si_005.pdb (188.05 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_006.pdb">jm8b00510_si_006.pdb (358.79 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_007.csv">jm8b00510_si_007.csv (4.26 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_008.pdf">jm8b00510_si_008.pdf (1.52 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00510" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Cushman</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The
Purdue Center for Cancer Research, Purdue
University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-0152-5891" title="Orcid link">http://orcid.org/0000-0002-0152-5891</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#157660667d78747b556560677160703b707160"><span class="__cf_email__" data-cfemail="a1c2d4d2c9ccc0cfe1d1d4d3c5d4c48fc4c5d4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohamed
S. A. Elsayed</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The
Purdue Center for Cancer Research, Purdue
University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1353-7259" title="Orcid link">http://orcid.org/0000-0002-1353-7259</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffery J. Nielsen</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The
Purdue Center for Cancer Research, Purdue
University, West Lafayette, Indiana 47907, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sungtae Park</span> - <span class="hlFld-Affiliation affiliation">Department
of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The
Purdue Center for Cancer Research, Purdue
University, West Lafayette, Indiana 47907, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeongho Park</span> - <span class="hlFld-Affiliation affiliation">Department
of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The
Purdue Center for Cancer Research, Purdue
University, West Lafayette, Indiana 47907, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingyang Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pathology and Mary H. Weiser Food Allergy Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chang H. Kim</span> - <span class="hlFld-Affiliation affiliation">Department
of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The
Purdue Center for Cancer Research, Purdue
University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pathology and Mary H. Weiser Food Allergy Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yves Pommier</span> - <span class="hlFld-Affiliation affiliation">Developmental
Therapeutics Branch and Laboratory of Molecular Pharmacology, Center
for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keli Agama</span> - <span class="hlFld-Affiliation affiliation">Developmental
Therapeutics Branch and Laboratory of Molecular Pharmacology, Center
for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip S. Low</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Purdue University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="hlFld-Affiliation affiliation">The
Purdue Center for Cancer Research, Purdue
University, West Lafayette, Indiana 47907, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9042-5528" title="Orcid link">http://orcid.org/0000-0001-9042-5528</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i102">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We gratefully acknowledge support from the Purdue University Center for Cancer Research, and NIH grants P30 CA023168, NIH 5R01AI080769, and NIH R01AI121302. Mohamed S. A. Elsayed was partially supported by the McKeehan Graduate Scholarship in Pharmacy Award. This investigation was also supported by the NCI Center for Cancer Research (Z01 BC006161).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylacetamide</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">(1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxid hexafluorophosphate)</p></td></tr><tr><td class="NLM_term">MOM</td><td class="NLM_def"><p class="first last">methoxymethyl</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">2-(trimethylsilyl)ethoxymethyl</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i104">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85646" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85646" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. D.</span></span> <span> </span><span class="NLM_article-title">Overview of the Immune Response</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">S3</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2009.12.980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.jaci.2009.12.980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=20176265" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2010&pages=S3-23&author=D.+D.+Chaplin&title=Overview+of+the+Immune+Response&doi=10.1016%2Fj.jaci.2009.12.980"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2009.12.980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2009.12.980%26sid%3Dliteratum%253Aachs%26aulast%3DChaplin%26aufirst%3DD.%2BD.%26atitle%3DOverview%2520of%2520the%2520Immune%2520Response%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2010%26volume%3D125%26spage%3DS3%26epage%3D23%26doi%3D10.1016%2Fj.jaci.2009.12.980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, M.</span></span> <span> </span><span class="NLM_article-title">Heterogeneity of Autoimmune Diseases: Pathophysiologic Insights from Genetics and Implications for New Therapies</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1038/nm.3897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1038%2Fnm.3897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=26121193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeisrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=730-738&author=J.+H.+Choauthor=M.+Feldman&title=Heterogeneity+of+Autoimmune+Diseases%3A+Pathophysiologic+Insights+from+Genetics+and+Implications+for+New+Therapies&doi=10.1038%2Fnm.3897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies</span></div><div class="casAuthors">Cho, Judy H.; Feldman, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">730-738</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recent advances in genome-wide assocn. studies (GWAS) across autoimmune and immune-mediated diseases have augmented our understanding of pathogenic mechanisms underlying these diseases.  This has further highlighted their heterogeneous nature, both within and between diseases.  Furthermore, varying responses to therapy have also served to underline the importance of this heterogeneity in the manner in which these diseases are diagnosed and treated.  Here we discuss our current understanding of the shared pathways of autoimmunity, including the tumor necrosis factor (TNF), major histocompatibility complex (MHC), interleukin 23 receptor (IL23R) and protein tyrosine phosphatase non-receptor type 22 (PTPN22) pathways.  In addn., we summarize effective specific therapies tested across major autoimmune diseases, highlighting the insight they have provided into disease mechanisms and their implications for potential future improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5aYA4lo6Xk7Vg90H21EOLACvtfcHk0liobmWIxI9kFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeisrjO&md5=32a5e2d769a7e2b82dfb5064cf2f67e1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnm.3897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3897%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DFeldman%26aufirst%3DM.%26atitle%3DHeterogeneity%2520of%2520Autoimmune%2520Diseases%253A%2520Pathophysiologic%2520Insights%2520from%2520Genetics%2520and%2520Implications%2520for%2520New%2520Therapies%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D730%26epage%3D738%26doi%3D10.1038%2Fnm.3897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bynum, M. L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, E. C.</span></span> <span> </span><span class="NLM_article-title">Recent Insights in the Epidemiology of Autoimmune Diseases: Improved Prevalence Estimates and Understanding of Clustering of Diseases</span>. <i>J. Autoimmun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1016/j.jaut.2009.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.jaut.2009.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=19819109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A280%3ADC%252BD1MjlslOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=197-207&author=G.+S.+Cooperauthor=M.+L.+K.+Bynumauthor=E.+C.+Somers&title=Recent+Insights+in+the+Epidemiology+of+Autoimmune+Diseases%3A+Improved+Prevalence+Estimates+and+Understanding+of+Clustering+of+Diseases&doi=10.1016%2Fj.jaut.2009.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases</span></div><div class="casAuthors">Cooper Glinda S; Bynum Milele L K; Somers Emily C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autoimmunity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">197-207</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Previous studies have estimated a prevalence of a broad grouping of autoimmune diseases of 3.2%, based on literature review of studies published between 1965 and 1995, and 5.3%, based on national hospitalization registry data in Denmark.  We examine more recent studies pertaining to the prevalence of 29 autoimmune diseases, and use these data to correct for the underascertainment of some diseases in the hospitalization registry data.  This analysis results in an estimated prevalence of 7.6-9.4%, depending on the size of the correction factor used.  The rates for most diseases for which data are available from many geographic regions span overlapping ranges.  We also review studies of the co-occurrence of diseases within individuals and within families, focusing on specific pairs of diseases to better distinguish patterns that may result in insights pertaining to shared etiological pathways.  Overall, data support a tendency for autoimmune diseases to co-occur at greater than expected rates within proband patients and their families, but this does not appear to be a uniform phenomenon across all diseases.  Multiple sclerosis and rheumatoid arthritis is one disease pair that appears to have a decreased chance of coexistence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOyX4HbPmCgBKDYG3bNImrfW6udTcc2ebWzL0RSV3U1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjlslOltQ%253D%253D&md5=a3708273b2183a9cb9e37bd0709a4418</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jaut.2009.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaut.2009.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DG.%2BS.%26aulast%3DBynum%26aufirst%3DM.%2BL.%2BK.%26aulast%3DSomers%26aufirst%3DE.%2BC.%26atitle%3DRecent%2520Insights%2520in%2520the%2520Epidemiology%2520of%2520Autoimmune%2520Diseases%253A%2520Improved%2520Prevalence%2520Estimates%2520and%2520Understanding%2520of%2520Clustering%2520of%2520Diseases%26jtitle%3DJ.%2520Autoimmun.%26date%3D2009%26volume%3D33%26spage%3D197%26epage%3D207%26doi%3D10.1016%2Fj.jaut.2009.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dembic, Z.</span></span> <span> </span><span class="NLM_article-title">Cytokines of the Immune System: Interleukins</span>. In  <i>The Cytokines of the Immune System</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Amsterdam</span>, <span class="NLM_year">2015</span>; Chapter 6, pp  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">239</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2FB978-0-12-419998-9.00006-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=143-239&author=Z.+Dembic&title=The+Cytokines+of+the+Immune+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-419998-9.00006-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-419998-9.00006-7%26sid%3Dliteratum%253Aachs%26aulast%3DDembic%26aufirst%3DZ.%26atitle%3DCytokines%2520of%2520the%2520Immune%2520System%253A%2520Interleukins%26btitle%3DThe%2520Cytokines%2520of%2520the%2520Immune%2520System%26pub%3DAcademic%2520Press%26date%3D2015%26spage%3D143%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rawlings, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosler, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, D. A.</span></span> <span> </span><span class="NLM_article-title">The JAK/STAT Signaling Pathway</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1281</span>– <span class="NLM_lpage">1283</span>, <span class="refDoi"> DOI: 10.1242/jcs.00963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1242%2Fjcs.00963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=15020666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=1281-1283&author=J.+S.+Rawlingsauthor=K.+M.+Roslerauthor=D.+A.+Harrison&title=The+JAK%2FSTAT+Signaling+Pathway&doi=10.1242%2Fjcs.00963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The JAK/STAT signaling pathway</span></div><div class="casAuthors">Rawlings, Jason S.; Rosler, Kristin M.; Harrison, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1281-1283</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in animals.  A general overview of the JAK/STAT pathway and the primary mechanisms of activation and regulation of this essential signaling cascade are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5uv0YS5vNp7Vg90H21EOLACvtfcHk0lj_E23aZ88QFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygtbo%253D&md5=33bb7b48a728a018e931acc120a07dfe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00963%26sid%3Dliteratum%253Aachs%26aulast%3DRawlings%26aufirst%3DJ.%2BS.%26aulast%3DRosler%26aufirst%3DK.%2BM.%26aulast%3DHarrison%26aufirst%3DD.%2BA.%26atitle%3DThe%2520JAK%252FSTAT%2520Signaling%2520Pathway%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2004%26volume%3D117%26spage%3D1281%26epage%3D1283%26doi%3D10.1242%2Fjcs.00963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saharinen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, V. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvennoinen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">The Janus Kinases (JAKs)</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">253</span>, <span class="refDoi"> DOI: 10.1186/gb-2004-5-12-253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1186%2Fgb-2004-5-12-253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=15575979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A280%3ADC%252BD2cngtlKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=253&author=K.+Yamaokaauthor=P.+Saharinenauthor=M.+Pesuauthor=V.+E.+T.+Holtauthor=O.+Silvennoinenauthor=J.+J.+O%E2%80%99Shea&title=The+Janus+Kinases+%28JAKs%29&doi=10.1186%2Fgb-2004-5-12-253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Janus kinases (Jaks)</span></div><div class="casAuthors">Yamaoka Kunihiro; Saharinen Pipsa; Pesu Marko; Holt Vance E T 3rd; Silvennoinen Olli; O'Shea John J</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">253</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Janus kinase (Jak) family is one of ten recognized families of non-receptor tyrosine kinases.  Mammals have four members of this family, Jak1, Jak2, Jak3 and Tyrosine kinase 2 (Tyk2).  Birds, fish and insects also have Jaks.  Each protein has a kinase domain and a catalytically inactive pseudo-kinase domain, and they each bind cytokine receptors through amino-terminal FERM (Band-4.1, ezrin, radixin, moesin) domains.  Upon binding of cytokines to their receptors, Jaks are activated and phosphorylate the receptors, creating docking sites for signaling molecules, especially members of the signal transducer and activator of transcription (Stat) family.  Mutations of the Drosophila Jak (Hopscotch) have revealed developmental defects, and constitutive activation of Jaks in flies and humans is associated with leukemia-like syndromes.  Through the generation of Jak-deficient cell lines and gene-targeted mice, the essential, nonredundant functions of Jaks in cytokine signaling have been established.  Importantly, deficiency of Jak3 is the basis of human autosomal recessive severe combined immunodeficiency (SCID); accordingly, a selective Jak3 inhibitor has been developed, forming a new class of immunosuppressive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0BwDh7EYTsV1C8OJBvdfbfW6udTcc2eZ67ZuZYl6cFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cngtlKktg%253D%253D&md5=4f8335c37dc8c20245e771224c1d5b12</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fgb-2004-5-12-253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2004-5-12-253%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26aulast%3DSaharinen%26aufirst%3DP.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DHolt%26aufirst%3DV.%2BE.%2BT.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Janus%2520Kinases%2520%2528JAKs%2529%26jtitle%3DGenome%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D253%26doi%3D10.1186%2Fgb-2004-5-12-253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5023</span>– <span class="NLM_lpage">5038</span>, <span class="refDoi"> DOI: 10.1021/jm401490p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401490p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5023-5038&author=J.+D.+Clarkauthor=M.+E.+Flanaganauthor=J.-B.+Telliez&title=Discovery+and+Development+of+Janus+Kinase+%28JAK%29+Inhibitors+for+Inflammatory+Diseases&doi=10.1021%2Fjm401490p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span></div><div class="casAuthors">Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the pathogenesis of inflammatory diseases.  As a consequence, the JAKs have received significant attention in recent years from the pharmaceutical and biotechnol. industries as therapeutic targets.  Here, we provide a review of the JAK pathways, the structure, function, and activation of the JAK enzymes followed by a detailed look at the JAK inhibitors currently in the clinic or approved for these indications.  Finally, a perspective is provided on what the past decade of research with JAK inhibitors for inflammatory indications has taught along with thoughts on what the future may hold in terms of addressing the opportunities and challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f7W5g8N6brVg90H21EOLACvtfcHk0lj_E23aZ88QFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D&md5=6763ae2d46f52ddcda23e235a60634ae</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401490p%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Janus%2520Kinase%2520%2528JAK%2529%2520Inhibitors%2520for%2520Inflammatory%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5023%26epage%3D5038%26doi%3D10.1021%2Fjm401490p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furumoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span> <span> </span><span class="NLM_article-title">The Arrival of JAK Inhibitors: Advancing the Treatment of Immune and Hematologic Disorders</span>. <i>BioDrugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1007/s40259-013-0040-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1007%2Fs40259-013-0040-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=23743669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsl2nsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=431-438&author=Y.+Furumotoauthor=M.+Gadina&title=The+Arrival+of+JAK+Inhibitors%3A+Advancing+the+Treatment+of+Immune+and+Hematologic+Disorders&doi=10.1007%2Fs40259-013-0040-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Arrival of JAK Inhibitors: Advancing the Treatment of Immune and Hematologic Disorders</span></div><div class="casAuthors">Furumoto, Yasuko; Gadina, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">BioDrugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">431-438</span>CODEN:
                <span class="NLM_cas:coden">BIDRF4</span>;
        ISSN:<span class="NLM_cas:issn">1173-8804</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Altered prodn. of cytokines can result in pathologies ranging from autoimmune diseases to malignancies.  The Janus kinase family is a small group of receptor-assocd. signaling mols. that is essential to the signal cascade originating from type I and type II cytokine receptors.  Inhibition of tyrosine kinase enzymic activity using small mols. has recently become a powerful tool for treatment of several malignancies.  Twenty years after the discovery of these enzymes, two inhibitors for this class of kinases have been approved for clin. use and others are currently in the final stage of development.  Here we review the principles of cytokines signaling, summarize our current knowledge of the approved inhibitors, and briefly introduce some of the inhibitors that are currently under development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQNQJyHX0EDLVg90H21EOLACvtfcHk0lgBEXawQu8xMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsl2nsbzI&md5=a593c1f01565b3dc3bf3df8c424595a6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs40259-013-0040-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40259-013-0040-7%26sid%3Dliteratum%253Aachs%26aulast%3DFurumoto%26aufirst%3DY.%26aulast%3DGadina%26aufirst%3DM.%26atitle%3DThe%2520Arrival%2520of%2520JAK%2520Inhibitors%253A%2520Advancing%2520the%2520Treatment%2520of%2520Immune%2520and%2520Hematologic%2520Disorders%26jtitle%3DBioDrugs%26date%3D2013%26volume%3D27%26spage%3D431%26epage%3D438%26doi%3D10.1007%2Fs40259-013-0040-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaoka, K.</span></span> <span> </span><span class="NLM_article-title">Janus Kinase Inhibitors for Rheumatoid Arthritis</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2016.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.cbpa.2016.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=26994322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVKlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=29-33&author=K.+Yamaoka&title=Janus+Kinase+Inhibitors+for+Rheumatoid+Arthritis&doi=10.1016%2Fj.cbpa.2016.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinase inhibitors for rheumatoid arthritis</span></div><div class="casAuthors">Yamaoka, Kunihiro</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Treatment of autoimmune diseases, such as rheumatoid arthritis (RA), has advanced substantially over the past decade with the development of biologics targeting inflammatory cytokines.  Recent progress in treating RA has been achieved with janus kinase (JAK) inhibitors (Jakinibs), an orally available disease-modifying anti-rheumatic drug targeting the intracellular kinase JAK and with similar efficacy to biologics.  The first Jakinib approved for RA was tofacitinib, which exerted superiority to methotrexate and non-inferiority to tumor necrosis factor (TNF) inhibitors.  In recent years, the Jakinib baricitinib has demonstrated superiority to both methotrexate and a TNF inhibitor, adalimumab.  Given these promising findings, Jakinibs are expected to represent the next generation compds. for treating RA, and a no. of Jakinibs are currently in clin. trials.  Jakinibs can differ substantially in their selectivity against JAKs; tofacitinib and baricitinib target multiple JAKs, whereas the most recently developed Jakinibs target only a single JAK.  The influence of Jakinib selectivity on efficacy and side effects is of great interest, requiring further careful observation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPC1H4NKUAy7Vg90H21EOLACvtfcHk0lgBEXawQu8xMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVKlsrs%253D&md5=cdf2eeeefd6e9b3ac5064bc341ef1469</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2016.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2016.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26atitle%3DJanus%2520Kinase%2520Inhibitors%2520for%2520Rheumatoid%2520Arthritis%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D32%26spage%3D29%26epage%3D33%26doi%3D10.1016%2Fj.cbpa.2016.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogan, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valle-Oseguera, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dell, K. M.</span></span> <span> </span><span class="NLM_article-title">Impact of Tofacitinib on Patient Outcomes in Rheumatoid Arthritis – Review of Clinical Studies</span>. <i>Patient Related Outcome Measures</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.2147/PROM.S62879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.2147%2FPROM.S62879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=26834501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A280%3ADC%252BC28nmslKhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1-12&author=E.+G.+Boyceauthor=D.+Vyasauthor=E.+L.+Roganauthor=C.+S.+Valle-Osegueraauthor=K.+M.+O%E2%80%99Dell&title=Impact+of+Tofacitinib+on+Patient+Outcomes+in+Rheumatoid+Arthritis+%E2%80%93+Review+of+Clinical+Studies&doi=10.2147%2FPROM.S62879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of tofacitinib on patient outcomes in rheumatoid arthritis - review of clinical studies</span></div><div class="casAuthors">Boyce Eric G; Vyas Deepti; Rogan Edward L; Valle-Oseguera Cynthia S; O'Dell Kate M</div><div class="citationInfo"><span class="NLM_cas:title">Patient related outcome measures</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn">1179-271X</span>.
    </div><div class="casAbstract">Rheumatoid arthritis is a chronic, progressive autoimmune disease associated with inflammation and destruction of joints and systemic effects, which result in significant impact on patient's quality of life and function.  Tofacitinib was approved for the treatment of rheumatoid arthritis in the USA in 2012 and subsequently in other countries, but not by the European Medicines Agency.  The goal of this review was to evaluate the impact of tofacitinib on patient-reported and patient-specific outcomes from prior clinical studies, focusing on quality of life, functionality, pain, global disease assessment, major adverse consequences, and withdrawals.  A total of 13 reports representing 11 clinical studies on tofacitinib in rheumatoid arthritis were identified through PubMed and reference lists in meta-analyses and other reviews.  Data on improvements in patient-driven composite tools to measure disease activity in rheumatoid arthritis, such as the Health Assessment Questionnaire, served as a major outcome evaluated in this review and were extracted from each study.  Additional data extracted from those clinical studies included patient assessment of pain (using a 0-100 mm visual analog scale), patient global assessment of disease (using a 0-100 mm visual analog scale), patient withdrawals, withdrawals due to adverse effects or lack of effect, and risk of serious adverse effects, serious infections, and deaths.  Tofacitinib 5 mg bid appears to have a favorable impact on patient outcomes related to efficacy and safety when compared with baseline values and with comparator disease-modifying antirheumatic drugs and placebo.  Improvements were seen in the composite and individual measures of disease activity.  Serious adverse effects, other adverse consequences, overall withdrawals, and withdrawals due to adverse effects and lack of efficacy are similar or more favorable for tofacitinib versus comparator disease-modifying antirheumatic drugs and placebo.  At this point, tofacitinib appears to have an important role in the treatment of rheumatoid arthritis through improvement in these patient outcomes.  However, it may require years of additional clinical studies and postmarketing surveillance to fully characterize the benefit-to-risk ratio of tofacitinib in a larger and diverse patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOLoFrXPSqu7GbPKh4T9eAfW6udTcc2eZaSsHi46SbGLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nmslKhsg%253D%253D&md5=032727016591a8bb13ab80694ef66e6c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2147%2FPROM.S62879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FPROM.S62879%26sid%3Dliteratum%253Aachs%26aulast%3DBoyce%26aufirst%3DE.%2BG.%26aulast%3DVyas%26aufirst%3DD.%26aulast%3DRogan%26aufirst%3DE.%2BL.%26aulast%3DValle-Oseguera%26aufirst%3DC.%2BS.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DK.%2BM.%26atitle%3DImpact%2520of%2520Tofacitinib%2520on%2520Patient%2520Outcomes%2520in%2520Rheumatoid%2520Arthritis%2520%25E2%2580%2593%2520Review%2520of%2520Clinical%2520Studies%26jtitle%3DPatient%2520Related%2520Outcome%2520Measures%26date%3D2016%26volume%3D7%26spage%3D1%26epage%3D12%26doi%3D10.2147%2FPROM.S62879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biajoli, A. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalm, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claudino, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, A. L.</span></span> <span> </span><span class="NLM_article-title">Recent Progress in the Use of Pd-Catalyzed C-C Cross-Coupling Reactions in the Synthesis of Pharmaceutical Compounds</span>. <i>J. Braz. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2186</span>– <span class="NLM_lpage">2214</span>, <span class="refDoi"> DOI: 10.5935/0103-5053.20140255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.5935%2F0103-5053.20140255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCmtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=2186-2214&author=A.+F.+P.+Biajoliauthor=C.+S.+Schwalmauthor=J.+Limbergerauthor=T.+S.+Claudinoauthor=A.+L.+Monteiro&title=Recent+Progress+in+the+Use+of+Pd-Catalyzed+C-C+Cross-Coupling+Reactions+in+the+Synthesis+of+Pharmaceutical+Compounds&doi=10.5935%2F0103-5053.20140255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Use of Pd-Catalyzed C-C Cross-Coupling Reactions in the Synthesis of Pharmaceutical Compounds</span></div><div class="casAuthors">Biajoli, Andre F. P.; Schwalm, Cristiane S.; Limberger, Jones; Claudino, Thiago S.; Monteiro, Adriano L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Brazilian Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2186-2214</span>CODEN:
                <span class="NLM_cas:coden">JOCSET</span>;
        ISSN:<span class="NLM_cas:issn">0103-5053</span>.
    
            (<span class="NLM_cas:orgname">Sociedade Brasileira de Quimica</span>)
        </div><div class="casAbstract">A review.  The impressive ability of palladium to assemble C-C bonds between appropriately functionalized substrates has allowed synthetic org. chemists to perform transformations that were previously impossible or only possible using multi-step approaches.  In this context, one of the most important and elegant applications of the Pd-catalyzed C-C coupling reactions currently is the synthesis of pharmaceuticals.  This review is intended to give a picture of the applications of Pd-catalyzed C-C cross-coupling reactions for the synthesis of drug components or drug candidates regardless of the scale from 2011 through to the end of July, 2014.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaLxWtR3yWvrVg90H21EOLACvtfcHk0lg90DUanSrijw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCmtLbO&md5=7a786284553766bb71acf81dd559607c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.5935%2F0103-5053.20140255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5935%252F0103-5053.20140255%26sid%3Dliteratum%253Aachs%26aulast%3DBiajoli%26aufirst%3DA.%2BF.%2BP.%26aulast%3DSchwalm%26aufirst%3DC.%2BS.%26aulast%3DLimberger%26aufirst%3DJ.%26aulast%3DClaudino%26aufirst%3DT.%2BS.%26aulast%3DMonteiro%26aufirst%3DA.%2BL.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Use%2520of%2520Pd-Catalyzed%2520C-C%2520Cross-Coupling%2520Reactions%2520in%2520the%2520Synthesis%2520of%2520Pharmaceutical%2520Compounds%26jtitle%3DJ.%2520Braz.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D25%26spage%3D2186%26epage%3D2214%26doi%3D10.5935%2F0103-5053.20140255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lessing, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T.</span></span> <span> </span><span class="NLM_article-title">Sequentially Palladium-Catalyzed Processes in One-Pot Syntheses of Heterocycles</span>. <i>Appl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1803</span>, <span class="refDoi"> DOI: 10.3390/app5041803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.3390%2Fapp5041803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltFCgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=1803&author=T.+Lessingauthor=T.+M%C3%BCller&title=Sequentially+Palladium-Catalyzed+Processes+in+One-Pot+Syntheses+of+Heterocycles&doi=10.3390%2Fapp5041803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Sequentially palladium-catalyzed processes in one-pot syntheses of heterocycles</span></div><div class="casAuthors">Lessing, Timo; Mueller, Thomas J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1803-1836</span>CODEN:
                <span class="NLM_cas:coden">ASPCC7</span>;
        ISSN:<span class="NLM_cas:issn">2076-3417</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Sequentially Pd-catalyzed processes are excellent entries to heterocycle synthesis.  The broad mechanistic variety combined with often very mild reaction conditions allow the concatenation of elementary org. and organometallic steps to novel sequences in the sense of one-pot domino and multicomponent reactions.  Given the numerous opportunities of alkyne coordination and their Pd-mediated transformations, alkynylation and carbometallation play a key role, both for purely organometallic sequences as well as in those processes that are intercepted by cyclocondensation.  Pd-catalyzed aminations also find more and more entry into novel heterocycle syntheses based upon this theme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdcbE8auY1TrVg90H21EOLACvtfcHk0lg90DUanSrijw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltFCgsL0%253D&md5=ce3524488bcbdcef137b2a0af8e67a1a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3390%2Fapp5041803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fapp5041803%26sid%3Dliteratum%253Aachs%26aulast%3DLessing%26aufirst%3DT.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%26atitle%3DSequentially%2520Palladium-Catalyzed%2520Processes%2520in%2520One-Pot%2520Syntheses%2520of%2520Heterocycles%26jtitle%3DAppl.%2520Sci.%26date%3D2015%26volume%3D5%26spage%3D1803%26doi%3D10.3390%2Fapp5041803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stouten, P. F. W.</span></span> <span> </span><span class="NLM_article-title">The Design and Application of Target-Focused Compound Libraries</span>. <i>Comb. Chem. High Throughput Screening</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.2174/138620711795767802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.2174%2F138620711795767802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=21521154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVSmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=521-531&author=C.+J.+Harrisauthor=R.+D.+Hillauthor=D.+W.+Sheppardauthor=M.+J.+Slaterauthor=P.+F.+W.+Stouten&title=The+Design+and+Application+of+Target-Focused+Compound+Libraries&doi=10.2174%2F138620711795767802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The design and application of target-focused compound libraries</span></div><div class="casAuthors">Harris, C. John; Hill, Richard D.; Sheppard, David W.; Slater, Martin J.; Stouten, Pieter F. W.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">521-531</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Target-focused compd. libraries are collections of compds. which are designed to interact with an individual protein target or, frequently, a family of related targets (such as kinases, voltage-gated ion channels, serine/cysteine proteases).  They are used for screening against therapeutic targets in order to find hit compds. that might be further developed into drugs.  The design of such libraries generally utilizes structural information about the target or family of interest.  In the absence of such structural information, a chemogenomic model that incorporates sequence and mutagenesis data to predict the properties of the binding site can be employed.  A third option, usually pursued when no structural data are available, utilizes knowledge of the ligands of the target from' which focused libraries can be developed via scaffold hopping.  Consequently, the methods used for the design of target-focused libraries vary according to the quantity and quality of structural or ligand data that is available for each target family.  This article describes examples of each of these design approaches and illustrates them with case studies, which highlight some of the issues and successes obsd. when screening target-focused libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKS2t0qb2xBbVg90H21EOLACvtfcHk0lj2lnjLhRByTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVSmu70%253D&md5=9070e45f5b842fccfee38c15e6cb6127</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F138620711795767802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620711795767802%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DHill%26aufirst%3DR.%2BD.%26aulast%3DSheppard%26aufirst%3DD.%2BW.%26aulast%3DSlater%26aufirst%3DM.%2BJ.%26aulast%3DStouten%26aufirst%3DP.%2BF.%2BW.%26atitle%3DThe%2520Design%2520and%2520Application%2520of%2520Target-Focused%2520Compound%2520Libraries%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2011%26volume%3D14%26spage%3D521%26epage%3D531%26doi%3D10.2174%2F138620711795767802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Anticancer Therapy with Checkpoint Inhibitors: What, Where and When?</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2011.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.tips.2011.02.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=308-316&author=M.+D.+Garrettauthor=I.+Collins&title=Anticancer+Therapy+with+Checkpoint+Inhibitors%3A+What%2C+Where+and+When%3F&doi=10.1016%2Fj.tips.2011.02.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2011.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2011.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DAnticancer%2520Therapy%2520with%2520Checkpoint%2520Inhibitors%253A%2520What%252C%2520Where%2520and%2520When%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D308%26epage%3D316%26doi%3D10.1016%2Fj.tips.2011.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendahl, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheikh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheema, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aardalen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moler, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes de Menezes, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesner, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, G. K.</span></span> <span> </span><span class="NLM_article-title">Chir-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons in Vitro and in Vivo</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-1424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1158%2F1078-0432.CCR-06-1424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=17255282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=591-602&author=A.+N.+Tseauthor=K.+G.+Rendahlauthor=T.+Sheikhauthor=H.+Cheemaauthor=K.+Aardalenauthor=M.+Embryauthor=S.+Maauthor=E.+J.+Molerauthor=Z.+J.+Niauthor=D.+E.+Lopes+de+Menezesauthor=B.+Hibnerauthor=T.+G.+Gesnerauthor=G.+K.+Schwartz&title=Chir-124%2C+a+Novel+Potent+Inhibitor+of+Chk1%2C+Potentiates+the+Cytotoxicity+of+Topoisomerase+I+Poisons+in+Vitro+and+in+Vivo&doi=10.1158%2F1078-0432.CCR-06-1424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo</span></div><div class="casAuthors">Tse, Archie N.; Rendahl, Katherine G.; Sheikh, Tahir; Cheema, Haider; Aardalen, Kim; Embry, Millicent; Ma, Sylvia; Moler, Edward J.; Ni, Zhi Jie; Lopes de Menezes, Daniel E.; Hibner, Barbara; Gesner, Thomas G.; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chk1 kinase is a crit. regulator of both S and G2-M phase cell cycle checkpoints in response to DNA damage.  This study aimed to evaluate the biochem., cellular, and antitumor effects of a novel Chk1 inhibitor, CHIR124.  CHIR-124 was evaluated for its ability to abrogate cell cycle checkpoints, to potentiate cytotoxicity, and to inhibit Chk1-mediated signaling induced by topoisomerase I poisons in human tumor cell line and xenograft models.  CHIR-124 is a quinolone-based small mol. that is structurally unrelated to other known inhibitors of Chk1.  It potently and selectively inhibits Chk1 in vitro (IC50 = 0.0003 μmol/L).  CHIR-124 interacts synergistically with topoisomerase poisons (e.g., camptothecin or SN-38) in causing growth inhibition in several p53-mutant solid tumor cell lines as detd. by isobologram or response surface anal.  CHIR-124 abrogates the SN-38-induced S and G2-M checkpoints and potentiates apoptosis in MDA-MD-435 breast cancer cells.  The abrogation of the G2-M checkpoint and induction of apoptosis by CHIR-124 are enhanced by the loss of p53.  We have also shown that CHIR-124 treatment can restore the level of cdc25A protein, which is normally targeted by Chk1 for degrdn. following DNA damage, indicating that Chk1 signaling is suppressed in the presence of CHIR-124.  Finally, in an orthotopic breast cancer xenograft model, CHIR-124 potentiates the growth inhibitory effects of irinotecan by abrogating the G2-M checkpoint and increasing tumor apoptosis.  CHIR-124 is a novel and potent Chk1 inhibitor with promising antitumor activities when used in combination with topoisomerase I poisons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tD5w3RW7tbVg90H21EOLACvtfcHk0lj2lnjLhRByTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSktQ%253D%253D&md5=59760855db149f99eba0e10828042816</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1424%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DA.%2BN.%26aulast%3DRendahl%26aufirst%3DK.%2BG.%26aulast%3DSheikh%26aufirst%3DT.%26aulast%3DCheema%26aufirst%3DH.%26aulast%3DAardalen%26aufirst%3DK.%26aulast%3DEmbry%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMoler%26aufirst%3DE.%2BJ.%26aulast%3DNi%26aufirst%3DZ.%2BJ.%26aulast%3DLopes%2Bde%2BMenezes%26aufirst%3DD.%2BE.%26aulast%3DHibner%26aufirst%3DB.%26aulast%3DGesner%26aufirst%3DT.%2BG.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DChir-124%252C%2520a%2520Novel%2520Potent%2520Inhibitor%2520of%2520Chk1%252C%2520Potentiates%2520the%2520Cytotoxicity%2520of%2520Topoisomerase%2520I%2520Poisons%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D591%26epage%3D602%26doi%3D10.1158%2F1078-0432.CCR-06-1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukas, J.</span></span> <span> </span><span class="NLM_article-title">Chk1 and Chk2 Kinases in Checkpoint Control and Cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(03)00110-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2FS1535-6108%2803%2900110-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=12781359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlyiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=421-429&author=J.+Bartekauthor=J.+Lukas&title=Chk1+and+Chk2+Kinases+in+Checkpoint+Control+and+Cancer&doi=10.1016%2FS1535-6108%2803%2900110-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chk1 and Chk2 kinases in checkpoint control and cancer</span></div><div class="casAuthors">Bartek, Jiri; Lukas, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-429</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Accumulation of mutations and chromosomal aberrations is one of the hallmarks of cancer cells.  This enhanced genetic instability is fueled by defects in the genome maintenance mechanisms including DNA repair and cell cycle checkpoint pathways.  Here, we discuss the emerging roles of the mammalian Chk1 and Chk2 kinases as key signal transducers within the complex network of genome integrity checkpoints, as candidate tumor suppressors disrupted in sporadic as well as some hereditary malignancies and as potential targets of new anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWikvk94O98rVg90H21EOLACvtfcHk0lj2lnjLhRByTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlyiurg%253D&md5=95b281b62ec5dc57ed0073693bcfd9fc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900110-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900110-7%26sid%3Dliteratum%253Aachs%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DLukas%26aufirst%3DJ.%26atitle%3DChk1%2520and%2520Chk2%2520Kinases%2520in%2520Checkpoint%2520Control%2520and%2520Cancer%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D421%26epage%3D429%26doi%3D10.1016%2FS1535-6108%2803%2900110-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design, Discovery and Development of Checkpoint Kinase Inhibitors as Potential Anti-Cancer Therapies</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1517/17460441.2013.788496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1517%2F17460441.2013.788496" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=621-640&author=T.+P.+Matthewsauthor=A.+M.+Jonesauthor=I.+Collins&title=Structure-Based+Design%2C+Discovery+and+Development+of+Checkpoint+Kinase+Inhibitors+as+Potential+Anti-Cancer+Therapies&doi=10.1517%2F17460441.2013.788496"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.788496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.788496%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DJones%26aufirst%3DA.%2BM.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DStructure-Based%2520Design%252C%2520Discovery%2520and%2520Development%2520of%2520Checkpoint%2520Kinase%2520Inhibitors%2520as%2520Potential%2520Anti-Cancer%2520Therapies%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D621%26epage%3D640%26doi%3D10.1517%2F17460441.2013.788496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aris, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Potentiation of the Novel Topoisomerase I Inhibitor Indenoisoquinoline LMP-400 by the Cell Checkpoint and Chk1-Chk2 Inhibitor Azd7762</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">979</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-2579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1158%2F0008-5472.CAN-11-2579" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=979-989&author=S.+M.+Arisauthor=Y.+Pommier&title=Potentiation+of+the+Novel+Topoisomerase+I+Inhibitor+Indenoisoquinoline+LMP-400+by+the+Cell+Checkpoint+and+Chk1-Chk2+Inhibitor+Azd7762&doi=10.1158%2F0008-5472.CAN-11-2579"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-2579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-2579%26sid%3Dliteratum%253Aachs%26aulast%3DAris%26aufirst%3DS.%2BM.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DPotentiation%2520of%2520the%2520Novel%2520Topoisomerase%2520I%2520Inhibitor%2520Indenoisoquinoline%2520LMP-400%2520by%2520the%2520Cell%2520Checkpoint%2520and%2520Chk1-Chk2%2520Inhibitor%2520Azd7762%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D979%26epage%3D989%26doi%3D10.1158%2F0008-5472.CAN-11-2579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brnardic, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraley, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasber, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrington, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudkin, V. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stirdivant, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drakas, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobell, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepp-Lorenzino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikuta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreatsoulas, C.</span></span> <span> </span><span class="NLM_article-title">Optimization of a Pyrazoloquinolinone Class of Chk1 Kinase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5989</span>– <span class="NLM_lpage">5994</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.07.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.bmcl.2007.07.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5989-5994&author=E.+J.+Brnardicauthor=R.+M.+Garbaccioauthor=M.+E.+Fraleyauthor=E.+S.+Tasberauthor=J.+T.+Steenauthor=K.+L.+Arringtonauthor=V.+Y.+Dudkinauthor=G.+D.+Hartmanauthor=S.+M.+Stirdivantauthor=B.+A.+Drakasauthor=K.+Rickertauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=J.+Hardwickauthor=W.+Taoauthor=S.+C.+Beckauthor=X.+Maoauthor=R.+B.+Lobellauthor=L.+Sepp-Lorenzinoauthor=Y.+Yanauthor=M.+Ikutaauthor=S.+K.+Munshiauthor=L.+C.+Kuoauthor=C.+Kreatsoulas&title=Optimization+of+a+Pyrazoloquinolinone+Class+of+Chk1+Kinase+Inhibitors&doi=10.1016%2Fj.bmcl.2007.07.051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.07.051%26sid%3Dliteratum%253Aachs%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DTasber%26aufirst%3DE.%2BS.%26aulast%3DSteen%26aufirst%3DJ.%2BT.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DDudkin%26aufirst%3DV.%2BY.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DStirdivant%26aufirst%3DS.%2BM.%26aulast%3DDrakas%26aufirst%3DB.%2BA.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DHardwick%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DKreatsoulas%26aufirst%3DC.%26atitle%3DOptimization%2520of%2520a%2520Pyrazoloquinolinone%2520Class%2520of%2520Chk1%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5989%26epage%3D5994%26doi%3D10.1016%2Fj.bmcl.2007.07.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Light, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGlinchey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalovich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Lazikani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span> <span> </span><span class="NLM_article-title">Chembl: A Large-Scale Bioactivity Database for Drug Discovery</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">D1100</span>– <span class="NLM_lpage">D1107</span>, <span class="refDoi"> DOI: 10.1093/nar/gkr777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1093%2Fnar%2Fgkr777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=21948594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D1100-D1107&author=A.+Gaultonauthor=L.+J.+Bellisauthor=A.+P.+Bentoauthor=J.+Chambersauthor=M.+Daviesauthor=A.+Herseyauthor=Y.+Lightauthor=S.+McGlincheyauthor=D.+Michalovichauthor=B.+Al-Lazikaniauthor=J.+P.+Overington&title=Chembl%3A+A+Large-Scale+Bioactivity+Database+for+Drug+Discovery&doi=10.1093%2Fnar%2Fgkr777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">ChEMBL: a large-scale bioactivity database for drug discovery</span></div><div class="casAuthors">Gaulton, Anna; Bellis, Louisa J.; Bento, A. Patricia; Chambers, Jon; Davies, Mark; Hersey, Anne; Light, Yvonne; McGlinchey, Shaun; Michalovich, David; Al-Lazikani, Bissan; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1100-D1107</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an Open Data database contg. binding, functional and ADMET information for a large no. of drug-like bioactive compds.  These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chem. biol. and drug-discovery research problems.  Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compds. and 5200 protein targets.  Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9e9jRENTtubVg90H21EOLACvtfcHk0ljAaL-Em_R4iw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN&md5=aedf7793e1ca54b6a4fa272ea3ef7d0e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr777%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DMichalovich%26aufirst%3DD.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DChembl%253A%2520A%2520Large-Scale%2520Bioactivity%2520Database%2520for%2520Drug%2520Discovery%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD1100%26epage%3DD1107%26doi%3D10.1093%2Fnar%2Fgkr777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulagowski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bull, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyke, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghilardi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bir Kohli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendonca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narukulla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubhayakar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Abbema, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zak, M.</span></span> <span> </span><span class="NLM_article-title">Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5901</span>– <span class="NLM_lpage">5921</span>, <span class="refDoi"> DOI: 10.1021/jm300438j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300438j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5901-5921&author=J.+J.+Kulagowskiauthor=W.+Blairauthor=R.+J.+Bullauthor=C.+Changauthor=G.+Deshmukhauthor=H.+J.+Dykeauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=T.+K.+Harrisonauthor=P.+R.+Hewittauthor=M.+Liimattaauthor=C.+A.+Hurleyauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=P.+Bir+Kohliauthor=R.+J.+Maxeyauthor=R.+Mendoncaauthor=K.+Mortaraauthor=J.+Murrayauthor=R.+Narukullaauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=B.+Waszkowyczauthor=M.+Zak&title=Identification+of+Imidazo-Pyrrolopyridines+as+Novel+and+Potent+JAK1+Inhibitors&doi=10.1021%2Fjm300438j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span></div><div class="casAuthors">Kulagowski, Janusz J.; Blair, Wade; Bull, Richard J.; Chang, Christine; Deshmukh, Gauri; Dyke, Hazel J.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Harrison, Trevor K.; Hewitt, Peter R.; Liimatta, Marya; Hurley, Christopher A.; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Bir Kohli, Pawan; Maxey, Robert J.; Mendonca, Rohan; Mortara, Kyle; Murray, Jeremy; Narukulla, Raman; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Waszkowycz, Bohdan; Zak, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5901-5921</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway.  Examn. of the preferred binding conformation of clin. effective, pan-JAK inhibitor 1 led to identification of a novel, tricyclic hinge binding scaffold 3.  Exploration of SAR through a series of cycloamino and cycloalkylamino analogs demonstrated this template to be highly tolerant of substitution, with a predisposition to moderate selectivity for the JAK1 isoform over JAK2.  This study culminated in the identification of subnanomolar JAK1 inhibitors such as 22 and 49, having excellent cell potency, good rat pharmacokinetic characteristics, and excellent kinase selectivity.  Detn. of the binding modes of the series in JAK1 and JAK2 by X-ray crystallog. supported the design of analogs to enhance affinity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpamrk0bG1MK7Vg90H21EOLACvtfcHk0liaAhKZV65lxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D&md5=d91bc0e24abf14adcf44caf61e3e879f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm300438j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300438j%26sid%3Dliteratum%253Aachs%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DBull%26aufirst%3DR.%2BJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DT.%2BK.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNarukulla%26aufirst%3DR.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DZak%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Imidazo-Pyrrolopyridines%2520as%2520Novel%2520and%2520Potent%2520JAK1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5901%26epage%3D5921%26doi%3D10.1021%2Fjm300438j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Epps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiamengo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmunds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedken, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotecki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morytko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, N.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Tricyclic Cores for Kinase Inhibition</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.bmcl.2012.11.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=23265875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyiurbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=693-698&author=S.+Van%0AEppsauthor=B.+Fiamengoauthor=J.+Edmundsauthor=A.+Ericssonauthor=K.+Frankauthor=M.+Friedmanauthor=D.+Georgeauthor=J.+Georgeauthor=E.+Goedkenauthor=B.+Koteckiauthor=G.+Martinezauthor=P.+Mertaauthor=M.+Morytkoauthor=S.+Shekharauthor=B.+Skinnerauthor=K.+Stewartauthor=J.+Vossauthor=G.+Wallaceauthor=L.+Wangauthor=N.+Wishart&title=Design+and+Synthesis+of+Tricyclic+Cores+for+Kinase+Inhibition&doi=10.1016%2Fj.bmcl.2012.11.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of tricyclic cores for kinase inhibition</span></div><div class="casAuthors">Van Epps, Stacy; Fiamengo, Bryan; Edmunds, Jeremy; Ericsson, Anna; Frank, Kristine; Friedman, Michael; George, Dawn; George, Jonathan; Goedken, Eric; Kotecki, Brian; Martinez, Gloria; Merta, Philip; Morytko, Michael; Shekhar, Shashank; Skinner, Barbara; Stewart, Kent; Voss, Jeffrey; Wallace, Grier; Wang, Lu; Wishart, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-698</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Interest in therapeutic kinase inhibitors continues to grow beyond success in oncol.  To date, ATP-mimetic kinase inhibitors have focused primarily on monocyclic and bicyclic heterocyclic cores.  We sought to expand on the repertoire of potential cores for kinase inhibition by exploring tricyclic variants of classical bicyclic hinge binding motifs such as pyrrolopyridine and pyrrolopyrazine.  Herein we describe the syntheses of eight alternative tricyclic cores as well as in vitro screening results for representative kinases of potential therapeutic interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw43t_VvXMbbVg90H21EOLACvtfcHk0liaAhKZV65lxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyiurbJ&md5=59cb993b841a73569309f0fca703b4c4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.108%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BEpps%26aufirst%3DS.%26aulast%3DFiamengo%26aufirst%3DB.%26aulast%3DEdmunds%26aufirst%3DJ.%26aulast%3DEricsson%26aufirst%3DA.%26aulast%3DFrank%26aufirst%3DK.%26aulast%3DFriedman%26aufirst%3DM.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DGeorge%26aufirst%3DJ.%26aulast%3DGoedken%26aufirst%3DE.%26aulast%3DKotecki%26aufirst%3DB.%26aulast%3DMartinez%26aufirst%3DG.%26aulast%3DMerta%26aufirst%3DP.%26aulast%3DMorytko%26aufirst%3DM.%26aulast%3DShekhar%26aufirst%3DS.%26aulast%3DSkinner%26aufirst%3DB.%26aulast%3DStewart%26aufirst%3DK.%26aulast%3DVoss%26aufirst%3DJ.%26aulast%3DWallace%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWishart%26aufirst%3DN.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Tricyclic%2520Cores%2520for%2520Kinase%2520Inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D693%26epage%3D698%26doi%3D10.1016%2Fj.bmcl.2012.11.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Tricyclic JAK3 Inhibitors with Picomolar Affinities as Novel Molecular Probes</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1002%2Fcmdc.201300520" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=277-281&author=M.+Gehringerauthor=E.+Pfaffenrotauthor=S.+Bauerauthor=S.+A.+Laufer&title=Design+and+Synthesis+of+Tricyclic+JAK3+Inhibitors+with+Picomolar+Affinities+as+Novel+Molecular+Probes&doi=10.1002%2Fcmdc.201300520"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300520%26sid%3Dliteratum%253Aachs%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DPfaffenrot%26aufirst%3DE.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Tricyclic%2520JAK3%2520Inhibitors%2520with%2520Picomolar%2520Affinities%2520as%2520Novel%2520Molecular%2520Probes%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D277%26epage%3D281%26doi%3D10.1002%2Fcmdc.201300520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritomo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamori, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakami, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of Tricyclic Dipyrrolopyridine Derivatives as Novel JAK Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5311</span>– <span class="NLM_lpage">5326</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.07.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.bmc.2017.07.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=28789911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yrs77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5311-5326&author=H.+Yamagishiauthor=T.+Inoueauthor=Y.+Nakajimaauthor=J.+Maedaauthor=H.+Tominagaauthor=H.+Usudaauthor=T.+Hondoauthor=A.+Moritomoauthor=F.+Nakamoriauthor=M.+Itoauthor=K.+Nakamuraauthor=H.+Morioauthor=Y.+Higashiauthor=M.+Inamiauthor=S.+Shirakami&title=Discovery+of+Tricyclic+Dipyrrolopyridine+Derivatives+as+Novel+JAK+Inhibitors&doi=10.1016%2Fj.bmc.2017.07.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of tricyclic dipyrrolopyridine derivatives as novel JAK inhibitors</span></div><div class="casAuthors">Yamagishi, Hiroaki; Inoue, Takayuki; Nakajima, Yutaka; Maeda, Jun; Tominaga, Hiroaki; Usuda, Hiroyuki; Hondo, Takeshi; Moritomo, Ayako; Nakamori, Fumihiro; Ito, Misato; Nakamura, Koji; Morio, Hiroki; Higashi, Yasuyuki; Inami, Masamichi; Shirakami, Shohei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5311-5326</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) play a crucial role in cytokine mediated signal transduction.  JAK inhibitors have emerged as effective immunomodulative agents for the prevention of transplant rejection.  The authors previously reported that the tricyclic imidazo-pyrrolopyridinone 2 (I) is a potent JAK inhibitor; however, it had poor oral absorption due to low membrane permeability.  Here, the authors report the structural modification of compd. 2 into the tricyclic dipyrrolopyridine 18a (3-[(3R,4R)-3-(dipyrrolo[2,3-b:2',3'-d]pyridin-1(6H)-yl)-4-methyl- piperidin-1-yl]-3-oxopropanenitrile ) focusing on redn. of polar surface area (PSA), which exhibits potent in vitro activity, improved membrane permeability and good oral bioavailability.  Compd. 18a showed efficacy in rat heterotopic cardiac transplants model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzFUxnoMs5O7Vg90H21EOLACvtfcHk0lgog8qSnKaQtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yrs77M&md5=24fc8058c7ca2091c3b2c980c21161a9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.07.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.07.043%26sid%3Dliteratum%253Aachs%26aulast%3DYamagishi%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DTominaga%26aufirst%3DH.%26aulast%3DUsuda%26aufirst%3DH.%26aulast%3DHondo%26aufirst%3DT.%26aulast%3DMoritomo%26aufirst%3DA.%26aulast%3DNakamori%26aufirst%3DF.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DMorio%26aufirst%3DH.%26aulast%3DHigashi%26aufirst%3DY.%26aulast%3DInami%26aufirst%3DM.%26aulast%3DShirakami%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Tricyclic%2520Dipyrrolopyridine%2520Derivatives%2520as%2520Novel%2520JAK%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D5311%26epage%3D5326%26doi%3D10.1016%2Fj.bmc.2017.07.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-s.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Y.</span></span> <span> </span><span class="NLM_article-title">Benzimidazole Derivatives as Potent JAK1-Selective Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7596</span>– <span class="NLM_lpage">7602</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01263</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7596-7602&author=M.+K.+Kimauthor=H.+Shinauthor=K.-s.+Parkauthor=H.+Kimauthor=J.+Parkauthor=K.+Kimauthor=J.+Namauthor=H.+Chooauthor=Y.+Chong&title=Benzimidazole+Derivatives+as+Potent+JAK1-Selective+Inhibitors&doi=10.1021%2Facs.jmedchem.5b01263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01263%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DK.-s.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DNam%26aufirst%3DJ.%26aulast%3DChoo%26aufirst%3DH.%26aulast%3DChong%26aufirst%3DY.%26atitle%3DBenzimidazole%2520Derivatives%2520as%2520Potent%2520JAK1-Selective%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7596%26epage%3D7602%26doi%3D10.1021%2Facs.jmedchem.5b01263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendonca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balazs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragovich, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghilardi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanan, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harstad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M. F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bir
Kohli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulagowski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labadie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubhayakar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Abbema, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6176</span>– <span class="NLM_lpage">6193</span>, <span class="refDoi"> DOI: 10.1021/jm300628c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300628c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1SmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6176-6193&author=M.+Zakauthor=R.+Mendoncaauthor=M.+Balazsauthor=K.+Barrettauthor=P.+Bergeronauthor=W.+S.+Blairauthor=C.+Changauthor=G.+Deshmukhauthor=J.+DeVossauthor=P.+S.+Dragovichauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=S.+Gradlauthor=C.+Hammanauthor=E.+J.+Hananauthor=E.+Harstadauthor=P.+R.+Hewittauthor=C.+A.+Hurleyauthor=T.+Jinauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=M.+F.+T.+Koehlerauthor=P.+Bir%0AKohliauthor=J.+J.+Kulagowskiauthor=S.+Labadieauthor=J.+Liaoauthor=M.+Liimattaauthor=Z.+Linauthor=P.+J.+Lupardusauthor=R.+J.+Maxeyauthor=J.+M.+Murrayauthor=R.+Pulkauthor=M.+Rodriguezauthor=S.+Savageauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=L.+Xiaoauthor=Y.+Xiao&title=Discovery+and+Optimization+of+C-2+Methyl+Imidazopyrrolopyridines+as+Potent+and+Orally+Bioavailable+JAK1+Inhibitors+with+Selectivity+over+JAK2&doi=10.1021%2Fjm300628c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2</span></div><div class="casAuthors">Zak, Mark; Mendonca, Rohan; Balazs, Mercedesz; Barrett, Kathy; Bergeron, Philippe; Blair, Wade S.; Chang, Christine; Deshmukh, Gauri; DeVoss, Jason; Dragovich, Peter S.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Gradl, Stefan; Hamman, Chris; Hanan, Emily J.; Harstad, Eric; Hewitt, Peter R.; Hurley, Christopher A.; Jin, Tian; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Koehler, Michael F. T.; Bir Kohli, Pawan; Kulagowski, Janusz J.; Labadie, Sharada; Liao, Jiangpeng; Liimatta, Marya; Lin, Zhonghua; Lupardus, Patrick J.; Maxey, Robert J.; Murray, Jeremy M.; Pulk, Rebecca; Rodriguez, Madeleine; Savage, Scott; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Xiao, Ling; Xiao, Yisong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6176-6193</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we report the discovery of the C-2 Me substituted imidazopyrrolopyridine series and its optimization to provide potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2.  The C-2 Me substituted inhibitor 4 exhibited not only improved JAK1 potency relative to unsubstituted compd. 3 but also notable JAK1 vs JAK2 selectivity (20-fold and >33-fold in biochem. and cell-based assays, resp.).  Features of the X-ray structures of 4 in complex with both JAK1 and JAK2 are delineated.  Efforts to improve the in vitro and in vivo ADME properties of 4 while maintaining JAK1 selectivity are described, culminating in the discovery of a highly optimized and balanced inhibitor (20).  Details of the biol. characterization of 20 are disclosed including JAK1 vs JAK2 selectivity levels, preclin. in vivo PK profiles, performance in an in vivo JAK1-mediated PK/PD model, and attributes of an X-ray structure in complex with JAK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpogQqQMRvwKbVg90H21EOLACvtfcHk0lgog8qSnKaQtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1SmtLg%253D&md5=8c57a4cb02fc245ed12f6f4efdb82318</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm300628c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300628c%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DM.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGradl%26aufirst%3DS.%26aulast%3DHamman%26aufirst%3DC.%26aulast%3DHanan%26aufirst%3DE.%2BJ.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520C-2%2520Methyl%2520Imidazopyrrolopyridines%2520as%2520Potent%2520and%2520Orally%2520Bioavailable%2520JAK1%2520Inhibitors%2520with%2520Selectivity%2520over%2520JAK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6176%26epage%3D6193%26doi%3D10.1021%2Fjm300628c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnett, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frauchiger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hekmat-Nejad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendricks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henningsen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenkamp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Figueroa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahangir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutach, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Railkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vu, M. D.</span></span> <span> </span><span class="NLM_article-title">3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1021/jm301646k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301646k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSqtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=345-356&author=M.+Sothauthor=J.+C.+Hermannauthor=C.+Yeeauthor=M.+Alamauthor=J.+W.+Barnettauthor=P.+Berryauthor=M.+F.+Brownerauthor=K.+Frankauthor=S.+Frauchigerauthor=S.+Harrisauthor=Y.+Heauthor=M.+Hekmat-Nejadauthor=T.+Hendricksauthor=R.+Henningsenauthor=R.+Hilgenkampauthor=H.+Hoauthor=A.+Hoffmanauthor=P.-Y.+Hsuauthor=D.-Q.+Huauthor=A.+Itanoauthor=S.+Jaime-Figueroaauthor=A.+Jahangirauthor=S.+Jinauthor=A.+Kuglstatterauthor=A.+K.+Kutachauthor=C.+Liaoauthor=S.+Lynchauthor=J.+Menkeauthor=L.+Niuauthor=V.+Patelauthor=A.+Railkarauthor=D.+Royauthor=A.+Shaoauthor=D.+Shawauthor=S.+Steinerauthor=Y.+Sunauthor=S.-L.+Tanauthor=S.+Wangauthor=M.+D.+Vu&title=3-Amido+Pyrrolopyrazine+JAK+Kinase+Inhibitors%3A+Development+of+a+JAK3+vs+JAK1+Selective+Inhibitor+and+Evaluation+in+Cellular+and+in+Vivo+Models&doi=10.1021%2Fjm301646k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models</span></div><div class="casAuthors">Soth, Michael; Hermann, Johannes C.; Yee, Calvin; Alam, Muzaffar; Barnett, Jim W.; Berry, Pamela; Browner, Michelle F.; Frank, Karl; Frauchiger, Sandra; Harris, Seth; He, Yang; Hekmat-Nejad, Mohammad; Hendricks, Than; Henningsen, Robert; Hilgenkamp, Ramona; Ho, Hoangdung; Hoffman, Ann; Hsu, Pei-Yuan; Hu, Dong-Qing; Itano, Andrea; Jaime-Figueroa, Saul; Jahangir, Alam; Jin, Sue; Kuglstatter, Andreas; Kutach, Alan K.; Liao, Cheng; Lynch, Stephen; Menke, John; Niu, Linghao; Patel, Vaishali; Railkar, Aruna; Roy, Douglas; Shao, Ada; Shaw, David; Steiner, Sandra; Sun, Yongliang; Tan, Seng-Lai; Wang, Sandra; Vu, Minh Diem</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">345-356</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Janus kinases (JAKs) are involved in multiple signaling networks relevant to inflammatory diseases, and inhibition of one or more members of this class may modulate disease activity or progression.  We optimized a new inhibitor scaffold, 3-amido-5-cyclopropylpyrrolopyrazines, to a potent example with reasonable kinome selectivity, including selectivity for JAK3 vs. JAK1, and good biopharmaceutical properties.  Evaluation of this analog in cellular and in vivo models confirmed functional selectivity for modulation of a JAK3/JAK1-dependent IL-2 stimulated pathway over a JAK1/JAK2/Tyk2-dependent IL-6 stimulated pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd-C6Aby3wN7Vg90H21EOLACvtfcHk0lisGdWLCa7cSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSqtrrP&md5=026b7d9b52cb5e374617ac2e5863eda4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301646k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301646k%26sid%3Dliteratum%253Aachs%26aulast%3DSoth%26aufirst%3DM.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DYee%26aufirst%3DC.%26aulast%3DAlam%26aufirst%3DM.%26aulast%3DBarnett%26aufirst%3DJ.%2BW.%26aulast%3DBerry%26aufirst%3DP.%26aulast%3DBrowner%26aufirst%3DM.%2BF.%26aulast%3DFrank%26aufirst%3DK.%26aulast%3DFrauchiger%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHekmat-Nejad%26aufirst%3DM.%26aulast%3DHendricks%26aufirst%3DT.%26aulast%3DHenningsen%26aufirst%3DR.%26aulast%3DHilgenkamp%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DA.%26aulast%3DHsu%26aufirst%3DP.-Y.%26aulast%3DHu%26aufirst%3DD.-Q.%26aulast%3DItano%26aufirst%3DA.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DJahangir%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DKutach%26aufirst%3DA.%2BK.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DS.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DD.%26aulast%3DShao%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DSteiner%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DS.-L.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DVu%26aufirst%3DM.%2BD.%26atitle%3D3-Amido%2520Pyrrolopyrazine%2520JAK%2520Kinase%2520Inhibitors%253A%2520Development%2520of%2520a%2520JAK3%2520vs%2520JAK1%2520Selective%2520Inhibitor%2520and%2520Evaluation%2520in%2520Cellular%2520and%2520in%2520Vivo%2520Models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D345%26epage%3D356%26doi%3D10.1021%2Fjm301646k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juchum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döring, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sievers-Engler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lämmerhofer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span> <span> </span><span class="NLM_article-title">Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act as Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4636</span>– <span class="NLM_lpage">4656</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00178</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00178" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnt1Ciu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4636-4656&author=M.+Juchumauthor=M.+G%C3%BCntherauthor=E.+D%C3%B6ringauthor=A.+Sievers-Englerauthor=M.+L%C3%A4mmerhoferauthor=S.+Laufer&title=Trisubstituted+Imidazoles+with+a+Rigidized+Hinge+Binding+Motif+Act+as+Single+Digit+nM+Inhibitors+of+Clinically+Relevant+EGFR+L858R%2FT790M+and+L858R%2FT790M%2FC797S+Mutants%3A+An+Example+of+Target+Hopping&doi=10.1021%2Facs.jmedchem.7b00178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act As Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping</span></div><div class="casAuthors">Juchum, Michael; Guenther, Marcel; Doering, Eva; Sievers-Engler, Adrian; Laemmerhofer, Michael; Laufer, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4636-4656</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trisubstituted imidazoles with a rigidized 7-azaindole hinge binding motif such as I were prepd. as inhibitors of EGFR tyrosine kinase with L858R/T790M/C797S mutations (against which current EGFR inhibitors are ineffective) for potential use in the treatment of non-small-cell lung cancer.  II [X = (CH2)2, (CH2)4] reversibly inhibited the clin. challenging EGFR tyrosine kinase triple mutant L858R/T790M/C797S with IC50 values in the low nanomolar range.  I inhibited EGFR tyrosine kinase irreversibly with IC50 value of 1 nM against the EGFR L858R/T790M double mutant; I was selective for EGFR tyrosine kinase over other related kinases except for MAP4K4, MAP4K5, and MINK.  The kinetics of target inhibition, aq. soly, and metabolites were detd. for I and for selected compds.; mol. docking calcns. were also performed for selected compds. with EGFR isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzeDYy9aSCrLVg90H21EOLACvtfcHk0lisGdWLCa7cSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnt1Ciu78%253D&md5=a7003c8160b506ce964edce6adf7c3ff</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00178%26sid%3Dliteratum%253Aachs%26aulast%3DJuchum%26aufirst%3DM.%26aulast%3DG%25C3%25BCnther%26aufirst%3DM.%26aulast%3DD%25C3%25B6ring%26aufirst%3DE.%26aulast%3DSievers-Engler%26aufirst%3DA.%26aulast%3DL%25C3%25A4mmerhofer%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3DTrisubstituted%2520Imidazoles%2520with%2520a%2520Rigidized%2520Hinge%2520Binding%2520Motif%2520Act%2520as%2520Single%2520Digit%2520nM%2520Inhibitors%2520of%2520Clinically%2520Relevant%2520EGFR%2520L858R%252FT790M%2520and%2520L858R%252FT790M%252FC797S%2520Mutants%253A%2520An%2520Example%2520of%2520Target%2520Hopping%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4636%26epage%3D4656%26doi%3D10.1021%2Facs.jmedchem.7b00178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W. C. F.</span>; <span class="NLM_string-name">Burns, D. M.</span>; <span class="NLM_string-name">Zhuo</span></span> <span> </span><span class="NLM_article-title">Azetidinyl Phenyl, Pyridyl or Pyrazinyl Carboxamide Derivatives as JAK Inhibitors</span>. U.S. Patent <span class="NLM_patent">US20170253598</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=W.+C.+F.+Yao&author=D.+M.+Burns&author=+Zhuo&title=Azetidinyl+Phenyl%2C+Pyridyl+or+Pyrazinyl+Carboxamide+Derivatives+as+JAK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DW.%2BC.%2BF.%26atitle%3DAzetidinyl%2520Phenyl%252C%2520Pyridyl%2520or%2520Pyrazinyl%2520Carboxamide%2520Derivatives%2520as%2520JAK%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferraccioli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carenzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombolà, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catellani, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 6-Phenanthridinones and Their Heterocyclic Analogues through Palladium-Catalyzed Sequential Aryl–Aryl and <i>N</i>-Aryl Coupling</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">4759</span>– <span class="NLM_lpage">4762</span>, <span class="refDoi"> DOI: 10.1021/ol0479949</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0479949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlSgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4759-4762&author=R.+Ferraccioliauthor=D.+Carenziauthor=O.+Rombol%C3%A0author=M.+Catellani&title=Synthesis+of+6-Phenanthridinones+and+Their+Heterocyclic+Analogues+through+Palladium-Catalyzed+Sequential+Aryl%E2%80%93Aryl+and+N-Aryl+Coupling&doi=10.1021%2Fol0479949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-phenanthridinones and their heterocyclic analogues through palladium-catalyzed sequential aryl-aryl and N-aryl coupling</span></div><div class="casAuthors">Ferraccioli, Raffaella; Carenzi, Davide; Rombola, Ottavio; Catellani, Marta</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4759-4762</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">6-Phenanthridinones, e.g., I, and their heterocyclic analogs were synthesized through a one-pot procedure based on consecutive Pd-catalyzed aryl-aryl and N-aryl coupling from iodoarenes ortho-substituted by electron-releasing substituents and amides of o-bromoarene- and heteroarenecarboxylic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEYy1SEXPfOrVg90H21EOLACvtfcHk0liqVKmGIXBYqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlSgtbk%253D&md5=f9208feb3a8a8f58aaa6cb08e2392278</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol0479949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0479949%26sid%3Dliteratum%253Aachs%26aulast%3DFerraccioli%26aufirst%3DR.%26aulast%3DCarenzi%26aufirst%3DD.%26aulast%3DRombol%25C3%25A0%26aufirst%3DO.%26aulast%3DCatellani%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25206-Phenanthridinones%2520and%2520Their%2520Heterocyclic%2520Analogues%2520through%2520Palladium-Catalyzed%2520Sequential%2520Aryl%25E2%2580%2593Aryl%2520and%2520N-Aryl%2520Coupling%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4759%26epage%3D4762%26doi%3D10.1021%2Fol0479949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yip, K.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, K.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, N.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span> <span> </span><span class="NLM_article-title">Pd(II)-Catalyzed Enantioselective Oxidative Tandem Cyclization Reactions. Synthesis of Indolines through C–N and C–C Bond Formation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">3130</span>– <span class="NLM_lpage">3131</span>, <span class="refDoi"> DOI: 10.1021/ja060291x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja060291x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlOrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=3130-3131&author=K.-T.+Yipauthor=M.+Yangauthor=K.-L.+Lawauthor=N.-Y.+Zhuauthor=D.+Yang&title=Pd%28II%29-Catalyzed+Enantioselective+Oxidative+Tandem+Cyclization+Reactions.+Synthesis+of+Indolines+through+C%E2%80%93N+and+C%E2%80%93C+Bond+Formation&doi=10.1021%2Fja060291x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pd(II)-Catalyzed Enantioselective Oxidative Tandem Cyclization Reactions. Synthesis of Indolines through C-N and C-C Bond Formation</span></div><div class="casAuthors">Yip, Kai-Tai; Yang, Min; Law, Ka-Lun; Zhu, Nian-Yong; Yang, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3130-3131</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient Pd(II)-catalyzed enantioselective oxidative tandem cyclization strategy using mol. oxygen as a green oxidant for the double 5-exo-trig cyclizations of N-(2-allylaryl) amides to afford a variety of indolines in good yields without the formation of undesired monocyclization products ir reported.  By employing Pd(TFA)2/(-)-sparteine as the chiral catalyst, tandem cyclization products with high enantioselectivity (up to 91% ee) were obtained .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2OYS_FCT0DrVg90H21EOLACvtfcHk0liqVKmGIXBYqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlOrsrg%253D&md5=a41a0cfa8d0acba22fcf3388d44caf47</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja060291x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja060291x%26sid%3Dliteratum%253Aachs%26aulast%3DYip%26aufirst%3DK.-T.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DLaw%26aufirst%3DK.-L.%26aulast%3DZhu%26aufirst%3DN.-Y.%26aulast%3DYang%26aufirst%3DD.%26atitle%3DPd%2528II%2529-Catalyzed%2520Enantioselective%2520Oxidative%2520Tandem%2520Cyclization%2520Reactions.%2520Synthesis%2520of%2520Indolines%2520through%2520C%25E2%2580%2593N%2520and%2520C%25E2%2580%2593C%2520Bond%2520Formation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D3130%26epage%3D3131%26doi%3D10.1021%2Fja060291x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trend, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramtohul, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltz, B. M.</span></span> <span> </span><span class="NLM_article-title">Oxidative Cyclizations in a Nonpolar Solvent Using Molecular Oxygen and Studies on the Stereochemistry of Oxypalladation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">17778</span>– <span class="NLM_lpage">17788</span>, <span class="refDoi"> DOI: 10.1021/ja055534k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja055534k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SrsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=17778-17788&author=R.+M.+Trendauthor=Y.+K.+Ramtohulauthor=B.+M.+Stoltz&title=Oxidative+Cyclizations+in+a+Nonpolar+Solvent+Using+Molecular+Oxygen+and+Studies+on+the+Stereochemistry+of+Oxypalladation&doi=10.1021%2Fja055534k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Cyclizations in a Nonpolar Solvent Using Molecular Oxygen and Studies on the Stereochemistry of Oxypalladation</span></div><div class="casAuthors">Trend, Raissa M.; Ramtohul, Yeeman K.; Stoltz, Brian M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">17778-17788</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oxidative cyclizations of a variety of heteroatom nucleophiles onto unactivated olefins are catalyzed by palladium(II) and pyridine in the presence of mol. oxygen as the sole stoichiometric oxidant in a nonpolar solvent (toluene).  Reactivity studies of a no. of N-ligated palladium complexes show that chelating ligands slow the reaction.  Nearly identical conditions are applicable to five different types of nucleophiles: phenols, primary alcs., carboxylic acids, a vinylogous acid, and amides.  Electron-rich phenols are excellent substrates, and multiple olefin substitution patterns are tolerated.  Primary alcs. undergo oxidative cyclization without significant oxidn. to the aldehyde, a fact that illustrates the range of reactivity available from various Pd(II) salts under differing conditions.  Alcs. can form both fused and spirocyclic ring systems, depending on the position of the olefin relative to the tethered alc.; the same is true of the acid derivs.  The racemic conditions served as a platform for the development of an enantioselective reaction.  Expts. with stereospecifically deuterated primary alc. substrates rule out a Wacker-type mechanism involving anti oxypalladation and suggest that the reaction proceeds by syn oxypalladation for both mono- and bidentate ligands.  But cyclizations of deuterium-labeled carboxylic acid substrates undergo anti oxypalladation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBG5bvitLQtrVg90H21EOLACvtfcHk0lhBuU3G-4krmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SrsLrL&md5=2f2860e14e79e8eaa482326f332b6983</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja055534k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja055534k%26sid%3Dliteratum%253Aachs%26aulast%3DTrend%26aufirst%3DR.%2BM.%26aulast%3DRamtohul%26aufirst%3DY.%2BK.%26aulast%3DStoltz%26aufirst%3DB.%2BM.%26atitle%3DOxidative%2520Cyclizations%2520in%2520a%2520Nonpolar%2520Solvent%2520Using%2520Molecular%2520Oxygen%2520and%2520Studies%2520on%2520the%2520Stereochemistry%2520of%2520Oxypalladation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D17778%26epage%3D17788%26doi%3D10.1021%2Fja055534k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagihara, M.</span>; <span class="NLM_string-name">Izumi, N.</span>; <span class="NLM_string-name">Tsuzaki, Y.</span>; <span class="NLM_string-name">Matsugi, T.</span>; <span class="NLM_string-name">Nakajima, T.</span>; <span class="NLM_string-name">Hatano, M.</span>; <span class="NLM_string-name">Hara, H.</span></span> <span> </span><span class="NLM_article-title">Novel Olefin Derivative</span>. <span class="NLM_patent">WO2005035501A1</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+Hagihara&author=N.+Izumi&author=Y.+Tsuzaki&author=T.+Matsugi&author=T.+Nakajima&author=M.+Hatano&author=H.+Hara&title=Novel+Olefin+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHagihara%26aufirst%3DM.%26atitle%3DNovel%2520Olefin%2520Derivative%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elsayed, M.
S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griggs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Benzo[1,6]naphthyridinones Using the Catellani Reaction</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5228</span>– <span class="NLM_lpage">5232</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.8b02171</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.8b02171" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOksLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=5228-5232&author=M.%0AS.+A.+Elsayedauthor=B.+Griggsauthor=M.+Cushman&title=Synthesis+of+Benzo%5B1%2C6%5Dnaphthyridinones+Using+the+Catellani+Reaction&doi=10.1021%2Facs.orglett.8b02171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Benzo[1,6]naphthyridinones Using the Catellani Reaction</span></div><div class="casAuthors">Elsayed, Mohamed S. A.; Griggs, Brittany; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5228-5232</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the presence of Pd(TFA)2, norbornene, and XPhos, bromoaryl amides such as 2-BrC6H4CONHR underwent Catellani reactions with 4-bromoquinoline and fused bromopyridines to yield benzonaphthyridinones such as I in 67-98% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCsM7MtzwtaLVg90H21EOLACvtfcHk0lhBuU3G-4krmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOksLfJ&md5=45100be43be33417b1687b8dcb1adf48</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.8b02171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.8b02171%26sid%3Dliteratum%253Aachs%26aulast%3DElsayed%26aufirst%3DM.%2BS.%2BA.%26aulast%3DGriggs%26aufirst%3DB.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520Benzo%255B1%252C6%255Dnaphthyridinones%2520Using%2520the%2520Catellani%2520Reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D5228%26epage%3D5232%26doi%3D10.1021%2Facs.orglett.8b02171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferdinand, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of JAK/STAT Signaling in Immunity and Disease</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1401867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.4049%2Fjimmunol.1401867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=25527793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWls7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2015&pages=21-27&author=A.+V.+Villarinoauthor=Y.+Kannoauthor=J.+R.+Ferdinandauthor=J.+J.+O%E2%80%99Shea&title=Mechanisms+of+JAK%2FSTAT+Signaling+in+Immunity+and+Disease&doi=10.4049%2Fjimmunol.1401867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Jak/STAT Signaling in Immunity and Disease</span></div><div class="casAuthors">Villarino, Alejandro V.; Kanno, Yuka; Ferdinand, John R.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-27</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">A review.  More than two decades ago, expts. on the antiviral mechanisms of IFNs led to the discovery of JAKs and their downstream effectors, the STAT proteins.  This pathway has since become a paradigm for membrane-to-nucleus signaling and explains how a broad range of sol. factors, including cytokines and hormones, mediate their diverse functions.  Jak/STAT research has not only impacted basic science, particularly in the context of intercellular communication and cell-extrinsic control of gene expression, it also has become a prototype for transition from bench to bedside, culminating in the development and clin. implementation of pathway-specific therapeutics.  This brief review synthesizes our current understanding of Jak/STAT biol. while taking stock of the lessons learned and the challenges that lie ahead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOsFFpF-ChLVg90H21EOLACvtfcHk0ljMjKUb4vVNdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWls7rF&md5=777f0f64db038ca8a7f17554931e0655</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1401867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1401867%26sid%3Dliteratum%253Aachs%26aulast%3DVillarino%26aufirst%3DA.%2BV.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DFerdinand%26aufirst%3DJ.%2BR.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DMechanisms%2520of%2520JAK%252FSTAT%2520Signaling%2520in%2520Immunity%2520and%2520Disease%26jtitle%3DJ.%2520Immunol.%26date%3D2015%26volume%3D194%26spage%3D21%26epage%3D27%26doi%3D10.4049%2Fjimmunol.1401867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Y.</span></span> <span> </span><span class="NLM_article-title">Novel JAK1-Selective Benzimidazole Inhibitors with Enhanced Membrane Permeability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3213</span>– <span class="NLM_lpage">3215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.05.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.bmcl.2016.05.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=27261178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3213-3215&author=H.+Kimauthor=M.+K.+Kimauthor=H.+Chooauthor=Y.+Chong&title=Novel+JAK1-Selective+Benzimidazole+Inhibitors+with+Enhanced+Membrane+Permeability&doi=10.1016%2Fj.bmcl.2016.05.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel JAK1-selective benzimidazole inhibitors with enhanced membrane permeability</span></div><div class="casAuthors">Kim, Hyungmi; Kim, Mi Kyoung; Choo, Hyunah; Chong, Youhoon</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3213-3215</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The previously identified Janus kinase 1 (JAK1)-selective inhibitor, 1-(2-aminoethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole-5-carboxamide, suffered from low cell permeability, which resulted in poor pharmacokinetic properties.  In this study, by introducing less polar hydrogen bond donors at N1 (a hydroxyalkyl or a methylaminoalkyl group) and C2 (a cyclohexanol group) positions, a series of novel benzimidazole derivs. I (R 1 = (CH2)2OH, (CH2)3OH, (CH2)2NHMe, (CH2)3NH2, (R)-CH2CHOHMe) and II (R2 = (CH2)2NHMe, (CH2)3NH2) were prepd., which exhibited selective JAK1 inhibitory activity (IC50 against JAK1 = 0.08-0.15 μM; JAK1-selectivity = 26-40 fold vs JAK2, 12-23 fold vs JAK3, and 38-54 fold vs Tyk2) along with significantly increased lipophilicity (3.3-15.8 times) as well as membrane permeability (6.3-12 times).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHBsrUVqqnmbVg90H21EOLACvtfcHk0ljMjKUb4vVNdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVymsbc%253D&md5=8c7888e1b158c7fed9f84a47b43984bf</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.05.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.05.078%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DChoo%26aufirst%3DH.%26aulast%3DChong%26aufirst%3DY.%26atitle%3DNovel%2520JAK1-Selective%2520Benzimidazole%2520Inhibitors%2520with%2520Enhanced%2520Membrane%2520Permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3213%26epage%3D3215%26doi%3D10.1016%2Fj.bmcl.2016.05.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oukka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettelli, E.</span></span> <span> </span><span class="NLM_article-title">Th17 Cells: Effector T Cells with Inflammatory Properties</span>. <i>Semin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1016/j.smim.2007.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.smim.2007.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=18035554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVSrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=362-371&author=T.+Kornauthor=M.+Oukkaauthor=V.+Kuchrooauthor=E.+Bettelli&title=Th17+Cells%3A+Effector+T+Cells+with+Inflammatory+Properties&doi=10.1016%2Fj.smim.2007.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Th17 cells: Effector T cells with inflammatory properties</span></div><div class="casAuthors">Korn, Thomas; Oukka, Mohamed; Kuchroo, Vijay; Bettelli, Estelle</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">362-371</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Upon activation, naive CD4+ T cells differentiate into effector T cells with specific effector functions and cytokine profiles.  The Th1/Th2 paradigm has recently been reevaluated to include a third population of T helper cells, producing IL-17 and designated Th17.  The differentiation of Th17 cells requires the coordinate and specific action of the proinflammatory cytokine IL-6 and the immunosuppressive cytokine TGF-β.  In addn., the IL-12 family member IL-23 is involved in the maintenance of these cells.  Analogous to other T helper cell subsets, Th17 commitment is initiated by sequential involvement of STAT mols., i.e.  STAT3 downstream of cytokine receptors, and specific transcription factors, i.e.  ROR-γt.  Recent data also support the existence of a complex network of cytokines regulating Th17 cells.  Clearly, the specific effector functions of Th17 cells expand beyond previously described effects of Th1 and Th2 immunity, with specific roles in host defense against certain pathogens and in organ-specific autoimmunity.  The potential dynamics of Th17 cell populations and their interplay with other inflammatory cells in the induction of tissue inflammation in host defense and organ-specific autoimmunity are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR5FYZfodfSrVg90H21EOLACvtfcHk0lg4WZXNYBR36w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVSrsLs%253D&md5=e2af9e1d737ac9573876631aab9ff1b5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.smim.2007.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.smim.2007.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DKorn%26aufirst%3DT.%26aulast%3DOukka%26aufirst%3DM.%26aulast%3DKuchroo%26aufirst%3DV.%26aulast%3DBettelli%26aufirst%3DE.%26atitle%3DTh17%2520Cells%253A%2520Effector%2520T%2520Cells%2520with%2520Inflammatory%2520Properties%26jtitle%3DSemin.%2520Immunol.%26date%3D2007%26volume%3D19%26spage%3D362%26epage%3D371%26doi%3D10.1016%2Fj.smim.2007.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whyte, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudarsanam, S.</span></span> <span> </span><span class="NLM_article-title">The Protein Kinase Complement of the Human Genome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span>,  <span class="NLM_fpage">1912</span>– <span class="NLM_lpage">1934</span>, <span class="refDoi"> DOI: 10.1126/science.1075762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+Protein+Kinase+Complement+of+the+Human+Genome&doi=10.1126%2Fscience.1075762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lg4WZXNYBR36w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520Protein%2520Kinase%2520Complement%2520of%2520the%2520Human%2520Genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934%26doi%3D10.1126%2Fscience.1075762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Measuring and Interpreting the Selectivity of Protein Kinase Inhibitors</span>. <i>J. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1007/s12154-009-0023-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1007%2Fs12154-009-0023-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=19568781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=131-151&author=L.+A.+Smythauthor=I.+Collins&title=Measuring+and+Interpreting+the+Selectivity+of+Protein+Kinase+Inhibitors&doi=10.1007%2Fs12154-009-0023-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Measuring and interpreting the selectivity of protein kinase inhibitors</span></div><div class="casAuthors">Smyth Lynette A; Collins Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of chemical biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-51</span>
        ISSN:<span class="NLM_cas:issn">1864-6158</span>.
    </div><div class="casAbstract">Protein kinase inhibitors are a well-established class of clinically useful drugs, particularly for the treatment of cancer.  Achieving inhibitor selectivity for particular protein kinases often remains a significant challenge in the development of new small molecules as drugs or as tools for chemical biology research.  This review summarises the methodologies available for measuring kinase inhibitor selectivity, both in vitro and in cells.  The interpretation of kinase inhibitor selectivity data is discussed, particularly with reference to the structural biology of the protein targets.  Measurement and prediction of kinase inhibitor selectivity will be important for the development of new multi-targeted kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzU9rA5WZcz9FxYDaSSP8XfW6udTcc2eZBrYTMLZkN6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D&md5=f78ff1202a949a71ffd65e804298c37f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs12154-009-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12154-009-0023-9%26sid%3Dliteratum%253Aachs%26aulast%3DSmyth%26aufirst%3DL.%2BA.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMeasuring%2520and%2520Interpreting%2520the%2520Selectivity%2520of%2520Protein%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D2%26spage%3D131%26epage%3D151%26doi%3D10.1007%2Fs12154-009-0023-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marlin, M. C.</span>; <span class="NLM_string-name">Li, G.</span></span> <span> </span><span class="NLM_article-title">Biogenesis and Function of the NGF/TrkA Signaling Endosome</span>. In  <i>International Review of Cell and Molecular Biology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, K. W.</span></span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Amsterdam</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">314</span>, Chapter Six, pp  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">257</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=239-257&author=M.+C.+Marlin&author=G.+Liauthor=K.+W.+Jeon&title=International+Review+of+Cell+and+Molecular+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMarlin%26aufirst%3DM.%2BC.%26atitle%3DBiogenesis%2520and%2520Function%2520of%2520the%2520NGF%252FTrkA%2520Signaling%2520Endosome%26btitle%3DInternational%2520Review%2520of%2520Cell%2520and%2520Molecular%2520Biology%26aulast%3DJeon%26aufirst%3DK.%2BW.%26pub%3DAcademic%2520Press%26date%3D2015%26volume%3D314%26spage%3D239%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jannasch, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span> <span> </span><span class="NLM_article-title">Short-Chain Fatty Acids Induce Both Effector and Regulatory T Cells by Suppression of Histone Deacetylases and Regulation of the mTOR-S6K Pathway</span>. <i>Mucosal Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1038/mi.2014.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1038%2Fmi.2014.44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=24917457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFCjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=80-93&author=J.+Parkauthor=M.+Kimauthor=S.+G.+Kangauthor=A.+H.+Jannaschauthor=B.+Cooperauthor=J.+Pattersonauthor=C.+H.+Kim&title=Short-Chain+Fatty+Acids+Induce+Both+Effector+and+Regulatory+T+Cells+by+Suppression+of+Histone+Deacetylases+and+Regulation+of+the+mTOR-S6K+Pathway&doi=10.1038%2Fmi.2014.44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway</span></div><div class="casAuthors">Park, J.; Kim, M.; Kang, S. G.; Jannasch, A. H.; Cooper, B.; Patterson, J.; Kim, C. H.</div><div class="citationInfo"><span class="NLM_cas:title">Mucosal Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-93</span>CODEN:
                <span class="NLM_cas:coden">MIUMAK</span>;
        ISSN:<span class="NLM_cas:issn">1933-0219</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microbial metabolites, such as short-chain fatty acids (SCFAs), are highly produced in the intestine and potentially regulate the immune system.  We studied the function of SCFAs in the regulation of T-cell differentiation into effector and regulatory T cells.  We report that SCFAs can directly promote T-cell differentiation into T cells producing interleukin-17 (IL-17), interferon-γ, and/or IL-10 depending on cytokine milieu.  This effect of SCFAs on T cells is independent of GPR41 or GPR43, but dependent on direct histone deacetylase (HDAC) inhibitor activity.  Inhibition of HDACs in T cells by SCFAs increased the acetylation of p70 S6 kinase and phosphorylation rS6, regulating the mTOR pathway required for generation of Th17 (T helper type 17), Th1, and IL-10+ T cells.  Acetate (C2) administration enhanced the induction of Th1 and Th17 cells during Citrobacter rodentium infection, but decreased anti-CD3-induced inflammation in an IL-10-dependent manner.  Our results indicate that SCFAs promote T-cell differentiation into both effector and regulatory T cells to promote either immunity or immune tolerance depending on immunol. milieu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolvxiBTpZ0Q7Vg90H21EOLACvtfcHk0lgTqcpBqH55Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFCjtr4%253D&md5=8204251b262779d7297131d404f4b46b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fmi.2014.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmi.2014.44%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DS.%2BG.%26aulast%3DJannasch%26aufirst%3DA.%2BH.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DC.%2BH.%26atitle%3DShort-Chain%2520Fatty%2520Acids%2520Induce%2520Both%2520Effector%2520and%2520Regulatory%2520T%2520Cells%2520by%2520Suppression%2520of%2520Histone%2520Deacetylases%2520and%2520Regulation%2520of%2520the%2520mTOR-S6K%2520Pathway%26jtitle%3DMucosal%2520Immunol.%26date%3D2015%26volume%3D8%26spage%3D80%26epage%3D93%26doi%3D10.1038%2Fmi.2014.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Junheng Liu, Guangyang Xu, Shengbiao Tang, Qun Chen, <span class="NLM_string-name hlFld-ContribAuthor">Jiangtao Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Site-Selective Functionalization of 7-Azaindoles via Carbene Transfer and Isolation of N-Aromatic Zwitterions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2020,</strong> <em>22 </em>
                                    (23)
                                     , 9376-9380. <a href="https://doi.org/10.1021/acs.orglett.0c03653" title="DOI URL">https://doi.org/10.1021/acs.orglett.0c03653</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.0c03653&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.0c03653%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSite-Selective%252BFunctionalization%252Bof%252B7-Azaindoles%252Bvia%252BCarbene%252BTransfer%252Band%252BIsolation%252Bof%252BN-Aromatic%252BZwitterions%26aulast%3DLiu%26aufirst%3DJunheng%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03112020%26date%3D24112020%26volume%3D22%26issue%3D23%26spage%3D9376%26epage%3D9380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Minjian Yang, Bingzhong Tao, Chengjuan Chen, Wenqiang Jia, Shaolei Sun, Tiantai Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojian Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Machine Learning Models Based on Molecular Fingerprints and an Extreme Gradient Boosting Method Lead to the Discovery of JAK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (12)
                                     , 5002-5012. <a href="https://doi.org/10.1021/acs.jcim.9b00798" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00798%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DMachine%252BLearning%252BModels%252BBased%252Bon%252BMolecular%252BFingerprints%252Band%252Ban%252BExtreme%252BGradient%252BBoosting%252BMethod%252BLead%252Bto%252Bthe%252BDiscovery%252Bof%252BJAK2%252BInhibitors%26aulast%3DYang%26aufirst%3DMinjian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15092019%26date%3D04122019%26date%3D20112019%26volume%3D59%26issue%3D12%26spage%3D5002%26epage%3D5012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mallu  Lavanya</span>, <span class="hlFld-ContribAuthor ">Chong  Lin</span>, <span class="hlFld-ContribAuthor ">Jincheng  Mao</span>, <span class="hlFld-ContribAuthor ">Dhakshanamurthy  Thirumalai</span>, <span class="hlFld-ContribAuthor ">Sreenath Reddy  Aabaka</span>, <span class="hlFld-ContribAuthor ">Xiaojiang  Yang</span>, <span class="hlFld-ContribAuthor ">Jinhua  Mao</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Huang</span>, <span class="hlFld-ContribAuthor ">Jinzhou  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Anticancer Properties of Functionalized 1,6-Naphthyridines. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2021,</strong> <em>379 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-020-00314-6" title="DOI URL">https://doi.org/10.1007/s41061-020-00314-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-00314-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-00314-6%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DSynthesis%252Band%252BAnticancer%252BProperties%252Bof%252BFunctionalized%252B1%25252C6-Naphthyridines%26aulast%3DLavanya%26aufirst%3DMallu%26date%3D2021%26date%3D2021%26volume%3D379%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">You-Guang  Zheng</span>, <span class="hlFld-ContribAuthor ">Jin-An  Wang</span>, <span class="hlFld-ContribAuthor ">Long  Meng</span>, <span class="hlFld-ContribAuthor ">Xin  Pei</span>, <span class="hlFld-ContribAuthor ">Ling  Zhang</span>, <span class="hlFld-ContribAuthor ">Lin  An</span>, <span class="hlFld-ContribAuthor ">Cheng-Lin  Li</span>, <span class="hlFld-ContribAuthor ">Ying-Long  Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological activity evaluation of 3-(4-phenyl-1H-imidazol-2-yl)-1H-pyrazole derivatives as potent JAK 2/3 and aurora A/B kinases multi-targeted inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112934. <a href="https://doi.org/10.1016/j.ejmech.2020.112934" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112934</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112934%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bactivity%252Bevaluation%252Bof%252B3-%2525284-phenyl-1H-imidazol-2-yl%252529-1H-pyrazole%252Bderivatives%252Bas%252Bpotent%252BJAK%252B2%25252F3%252Band%252Baurora%252BA%25252FB%252Bkinases%252Bmulti-targeted%252Binhibitors%26aulast%3DZheng%26aufirst%3DYou-Guang%26date%3D2021%26volume%3D209%26spage%3D112934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  He</span>, <span class="hlFld-ContribAuthor ">Wen‐Yong  Han</span>, <span class="hlFld-ContribAuthor ">Bao‐Dong  Cui</span>, <span class="hlFld-ContribAuthor ">Nan‐Wei  Wan</span>, <span class="hlFld-ContribAuthor ">Yong‐Zheng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Assembly of Molecular Complexity Enabled by Palladium‐Catalyzed Heck Coupling/C(
              sp
              2
              )−H Activation/ C(
              sp
              3
              )−H Activation Cascade. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (17)
                                     , 3655-3661. <a href="https://doi.org/10.1002/adsc.202000488" title="DOI URL">https://doi.org/10.1002/adsc.202000488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000488%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DEfficient%252BAssembly%252Bof%252BMolecular%252BComplexity%252BEnabled%252Bby%252BPalladium%2525E2%252580%252590Catalyzed%252BHeck%252BCoupling%25252FC%252528%252Bsp%252B2%252B%252529%2525E2%252588%252592H%252BActivation%25252F%252BC%252528%252Bsp%252B3%252B%252529%2525E2%252588%252592H%252BActivation%252BCascade%26aulast%3DHe%26aufirst%3DChen%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D17%26spage%3D3655%26epage%3D3661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Urvashi</span>, <span class="hlFld-ContribAuthor ">Mohammad Ovais  Dar</span>, <span class="hlFld-ContribAuthor ">Prasad V.  Bharatam</span>, <span class="hlFld-ContribAuthor ">Parthasarathi  Das</span>, <span class="hlFld-ContribAuthor ">Shrikant  Kukreti</span>, <span class="hlFld-ContribAuthor ">Vibha  Tandon</span>. </span><span class="cited-content_cbyCitation_article-title">Cu(II)-catalyzed sulfonylation of 7-azaindoles using DABSO as SO2-Source and its mechanistic study. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (28-29)
                                     , 131337. <a href="https://doi.org/10.1016/j.tet.2020.131337" title="DOI URL">https://doi.org/10.1016/j.tet.2020.131337</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.131337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.131337%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCu%252528II%252529-catalyzed%252Bsulfonylation%252Bof%252B7-azaindoles%252Busing%252BDABSO%252Bas%252BSO2-Source%252Band%252Bits%252Bmechanistic%252Bstudy%26aulast%3DUrvashi%26date%3D2020%26volume%3D76%26issue%3D28-29%26spage%3D131337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Animesh  Das</span>, <span class="hlFld-ContribAuthor ">Akash  Jana</span>, <span class="hlFld-ContribAuthor ">Biplab  Maji</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-catalyzed remote C–H functionalization of 2-aminopyrimidines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (31)
                                     , 4284-4287. <a href="https://doi.org/10.1039/D0CC00575D" title="DOI URL">https://doi.org/10.1039/D0CC00575D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC00575D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC00575D%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DPalladium-catalyzed%252Bremote%252BC%2525E2%252580%252593H%252Bfunctionalization%252Bof%252B2-aminopyrimidines%26aulast%3DDas%26aufirst%3DAnimesh%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D31%26spage%3D4284%26epage%3D4287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Shen</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Raoling  Ge</span>, <span class="hlFld-ContribAuthor ">Xinying  Cheng</span>, <span class="hlFld-ContribAuthor ">Qiuyu  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">JuBo  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112155. <a href="https://doi.org/10.1016/j.ejmech.2020.112155" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112155%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DJanus%252Bkinases%252B%252528JAKs%252529%25253A%252BThe%252Befficient%252Btherapeutic%252Btargets%252Bfor%252Bautoimmune%252Bdiseases%252Band%252Bmyeloproliferative%252Bdisorders%26aulast%3DXu%26aufirst%3DPengfei%26date%3D2020%26volume%3D192%26spage%3D112155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) The JAK-STAT signaling pathway; (B) various biological responses mediated through the JAK pathway.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Examples of JAK inhibitors (A) and topoisomerase I poisons (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design rationale for the BPN <b>1</b> scaffold. The structural similarity between the two compounds was used in the design. The indenoisoquinoline scaffold was modified by adding an additional hinge-binding element (hydrogen bond donor) to the hydrogen bond acceptor, which was changed from a carbonyl oxygen to the pyridine nitrogen. At the same time, the basic aminopropyl side chain was retained.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Binding mode of compound <b>1</b> (orange) aligned with tofacitinib (green) in the active site of JAK3 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>). A surface representation to the right illustrates the binding mode of the side chain of compound <b>1</b> and tofacitinib. The green area represents the methyl pocket occupied by the tofacitinib side chain.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) MOMCl, NaH, DMF, 0– 21 °C, 3 h; (b) (H<sub>3</sub>C)<sub>2</sub>NCH<sub>2</sub>CH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>, Pd<sub>2</sub>(dba)<sub>3</sub>, xantphos, Cs<sub>2</sub>CO<sub>3</sub>, dioxane, 110 °C, 16 h; (c) ArCOCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0–60 °C, 5 h; (d) Pd(OAc)<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, PCy<sub>3</sub>·HBF<sub>4</sub>, DMA, 130 °C, 18 h; (e) concd HCl, THF, 60 °C, 20 h.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) (i) Pd(OAc)<sub>2</sub>, benzophenone imine, Cs<sub>2</sub>CO<sub>3</sub>, xantphos, dioxane, 110 °C, (ii) NH<sub>2</sub>OH·HCl, NaOAc, MeOH, 21 °C; (b) ArCOCl, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 23 °C, 16 h; (c) R-Br, NaH, DMF, 21 °C, 18 h; (d) Pd(OAc)<sub>2</sub>, PCy<sub>3</sub>·HBF<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, DMA, 130 °C, 18 h; (e) (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, (ii) ethylenediamine, NaOH, MeOH.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) Pd(TFA)<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, norbornene, TFP, toluene, 110 °C; (b) (i) TFA, (ii) H<sub>2</sub>N(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub> or (i) TFA, (ii) NaOH.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) For <b>18</b>: cyanoacetic acid, HATU, DIPEA, DMF, 21 °C, 18 h. For the rest: the appropriate amines, HATU, DIPEA, DMF, 21 °C, 18 h.</p></p></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Western blot analysis of phospho-STAT-5 and anti-α-tubulin for BPNs <b>17a</b> and <b>18</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of BPNs on proliferation of primary murine T cells. Naïve CD4<sup>+</sup> T cells were isolated from mouse spleens and cultured with the indicated BPNs in the presence of T cell activators (antibodies to CD3 and CD28) and IL-2 for 3 days. T cell proliferation was assessed by XTT staining and measured at 475 nm with a microplate reader (SpectraMax i3X, Molecular Devices). The assay was repeated three times (<i>n</i> = 3 for each dose and inhibitor), and mean ± SEM ranges are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of compounds on IFNγ expression by primary murine T cells. Naïve CD4<sup>+</sup> T cells were isolated from mouse spleens and cultured with the indicated compounds in the presence of T cell activators (antibodies to CD3 and CD28) and IL-2 for 5 days. (A) T cell expression of IFNγ was assessed by intracellular staining of activated T cells with an antibody to IFNγ. The cells were analyzed with a Canto II flow cytometer (Becton Dickinson). (B) % IFNγ expression by T cells in the presence of test compounds compared to control. Note that data for <b>17b</b> and <b>19a</b> are presented with different scales on the <i>y</i>-axes of the bar graphs than the other compounds. The assay was repeated three times (<i>n</i> = 3 for each dose and inhibitor), and mean ± SEM are shown in part B. *Significant differences from controls (no inhibitor) by Student <i>t</i> test (paired one-tailed).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effects of compounds on IL-17 expression by primary murine T cells. Naïve CD4<sup>+</sup> T cells were isolated from mouse spleens and cultured with the indicated compounds in the presence of T cell activators (antibodies to CD3 and CD28) and the cytokines listed in the method section for 5 days. (A) T cell expression of IL-17 was assessed by intracellular staining of activated T cells with an antibody to IL-17. The cells were analyzed with a Canto II flow cytometer. (B) Percent IL-17 expression by CD4 T cells in the presence of test compounds compared to control. Note the differing scales on the <i>y</i>-axes of the bar graphs. The assay was repeated three times (<i>n</i> = 3 for each dose and inhibitor), and mean ± SEM are shown in part B. *Significant differences from controls (no inhibitor) by Student <i>t</i> test (paired one-tailed).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Technique used for determination of kinome selectivity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Hypothetical binding modes of compound <b>17d</b> in JAK1 (left) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5C">4I5C</a>) and JAK3 (right) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Hypothetical binding mode of compound <b>18</b> in JAK1 (left) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5C">4I5C</a>) and JAK3 (right) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Hypothetical binding mode of <b>20a</b> in JAK1 l (left) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5C">4I5C</a>) and JAK3 (right) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK">3LXK</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/medium/jm-2018-005107_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Mean rheumatoid arthritis score. Mouse paw collagen-induced inflammation assay (male DBA-1 <i>n</i> = 7) of compound <b>17b</b>. Daily doses of tofacitinib or <b>17b</b> were administered subcutaneously in 10% DMSO and 10% Cremophor EL to seven mice. Paw inflammation for each paw was expressed on a 0–4 mean rheumatoid arthritis scale. The <i>t</i> test revealed that both tofacitinib and <b>17b</b> caused a significantly different response compared to the vehicle control and that there is not a statistically significant difference between the two drugs. The calculated <i>P</i> values were 0.0481 for week 2, 0.0443 for week 3, 0.0442 for week 4, and 0.0473 for week 5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-23/acs.jmedchem.8b00510/20181207/images/large/jm-2018-005107_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00510&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i104">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaplin, D. D.</span></span> <span> </span><span class="NLM_article-title">Overview of the Immune Response</span>. <i>J. Allergy Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">S3</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1016/j.jaci.2009.12.980</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.jaci.2009.12.980" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=20176265" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2010&pages=S3-23&author=D.+D.+Chaplin&title=Overview+of+the+Immune+Response&doi=10.1016%2Fj.jaci.2009.12.980"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2009.12.980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2009.12.980%26sid%3Dliteratum%253Aachs%26aulast%3DChaplin%26aufirst%3DD.%2BD.%26atitle%3DOverview%2520of%2520the%2520Immune%2520Response%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2010%26volume%3D125%26spage%3DS3%26epage%3D23%26doi%3D10.1016%2Fj.jaci.2009.12.980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feldman, M.</span></span> <span> </span><span class="NLM_article-title">Heterogeneity of Autoimmune Diseases: Pathophysiologic Insights from Genetics and Implications for New Therapies</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">730</span>– <span class="NLM_lpage">738</span>, <span class="refDoi"> DOI: 10.1038/nm.3897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1038%2Fnm.3897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=26121193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFeisrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=730-738&author=J.+H.+Choauthor=M.+Feldman&title=Heterogeneity+of+Autoimmune+Diseases%3A+Pathophysiologic+Insights+from+Genetics+and+Implications+for+New+Therapies&doi=10.1038%2Fnm.3897"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies</span></div><div class="casAuthors">Cho, Judy H.; Feldman, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">730-738</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Recent advances in genome-wide assocn. studies (GWAS) across autoimmune and immune-mediated diseases have augmented our understanding of pathogenic mechanisms underlying these diseases.  This has further highlighted their heterogeneous nature, both within and between diseases.  Furthermore, varying responses to therapy have also served to underline the importance of this heterogeneity in the manner in which these diseases are diagnosed and treated.  Here we discuss our current understanding of the shared pathways of autoimmunity, including the tumor necrosis factor (TNF), major histocompatibility complex (MHC), interleukin 23 receptor (IL23R) and protein tyrosine phosphatase non-receptor type 22 (PTPN22) pathways.  In addn., we summarize effective specific therapies tested across major autoimmune diseases, highlighting the insight they have provided into disease mechanisms and their implications for potential future improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5aYA4lo6Xk7Vg90H21EOLACvtfcHk0lgxipx-9Y55lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFeisrjO&md5=32a5e2d769a7e2b82dfb5064cf2f67e1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnm.3897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3897%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DJ.%2BH.%26aulast%3DFeldman%26aufirst%3DM.%26atitle%3DHeterogeneity%2520of%2520Autoimmune%2520Diseases%253A%2520Pathophysiologic%2520Insights%2520from%2520Genetics%2520and%2520Implications%2520for%2520New%2520Therapies%26jtitle%3DNat.%2520Med.%26date%3D2015%26volume%3D21%26spage%3D730%26epage%3D738%26doi%3D10.1038%2Fnm.3897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bynum, M. L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, E. C.</span></span> <span> </span><span class="NLM_article-title">Recent Insights in the Epidemiology of Autoimmune Diseases: Improved Prevalence Estimates and Understanding of Clustering of Diseases</span>. <i>J. Autoimmun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">207</span>, <span class="refDoi"> DOI: 10.1016/j.jaut.2009.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.jaut.2009.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=19819109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A280%3ADC%252BD1MjlslOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2009&pages=197-207&author=G.+S.+Cooperauthor=M.+L.+K.+Bynumauthor=E.+C.+Somers&title=Recent+Insights+in+the+Epidemiology+of+Autoimmune+Diseases%3A+Improved+Prevalence+Estimates+and+Understanding+of+Clustering+of+Diseases&doi=10.1016%2Fj.jaut.2009.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases</span></div><div class="casAuthors">Cooper Glinda S; Bynum Milele L K; Somers Emily C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of autoimmunity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">197-207</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Previous studies have estimated a prevalence of a broad grouping of autoimmune diseases of 3.2%, based on literature review of studies published between 1965 and 1995, and 5.3%, based on national hospitalization registry data in Denmark.  We examine more recent studies pertaining to the prevalence of 29 autoimmune diseases, and use these data to correct for the underascertainment of some diseases in the hospitalization registry data.  This analysis results in an estimated prevalence of 7.6-9.4%, depending on the size of the correction factor used.  The rates for most diseases for which data are available from many geographic regions span overlapping ranges.  We also review studies of the co-occurrence of diseases within individuals and within families, focusing on specific pairs of diseases to better distinguish patterns that may result in insights pertaining to shared etiological pathways.  Overall, data support a tendency for autoimmune diseases to co-occur at greater than expected rates within proband patients and their families, but this does not appear to be a uniform phenomenon across all diseases.  Multiple sclerosis and rheumatoid arthritis is one disease pair that appears to have a decreased chance of coexistence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOyX4HbPmCgBKDYG3bNImrfW6udTcc2eaxNEzGJKY6arntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjlslOltQ%253D%253D&md5=a3708273b2183a9cb9e37bd0709a4418</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jaut.2009.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaut.2009.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DG.%2BS.%26aulast%3DBynum%26aufirst%3DM.%2BL.%2BK.%26aulast%3DSomers%26aufirst%3DE.%2BC.%26atitle%3DRecent%2520Insights%2520in%2520the%2520Epidemiology%2520of%2520Autoimmune%2520Diseases%253A%2520Improved%2520Prevalence%2520Estimates%2520and%2520Understanding%2520of%2520Clustering%2520of%2520Diseases%26jtitle%3DJ.%2520Autoimmun.%26date%3D2009%26volume%3D33%26spage%3D197%26epage%3D207%26doi%3D10.1016%2Fj.jaut.2009.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dembic, Z.</span></span> <span> </span><span class="NLM_article-title">Cytokines of the Immune System: Interleukins</span>. In  <i>The Cytokines of the Immune System</i>; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Amsterdam</span>, <span class="NLM_year">2015</span>; Chapter 6, pp  <span class="NLM_fpage">143</span>– <span class="NLM_lpage">239</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2FB978-0-12-419998-9.00006-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=143-239&author=Z.+Dembic&title=The+Cytokines+of+the+Immune+System"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-419998-9.00006-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-419998-9.00006-7%26sid%3Dliteratum%253Aachs%26aulast%3DDembic%26aufirst%3DZ.%26atitle%3DCytokines%2520of%2520the%2520Immune%2520System%253A%2520Interleukins%26btitle%3DThe%2520Cytokines%2520of%2520the%2520Immune%2520System%26pub%3DAcademic%2520Press%26date%3D2015%26spage%3D143%26epage%3D239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rawlings, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosler, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, D. A.</span></span> <span> </span><span class="NLM_article-title">The JAK/STAT Signaling Pathway</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">1281</span>– <span class="NLM_lpage">1283</span>, <span class="refDoi"> DOI: 10.1242/jcs.00963</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1242%2Fjcs.00963" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=15020666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs1ygtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2004&pages=1281-1283&author=J.+S.+Rawlingsauthor=K.+M.+Roslerauthor=D.+A.+Harrison&title=The+JAK%2FSTAT+Signaling+Pathway&doi=10.1242%2Fjcs.00963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">The JAK/STAT signaling pathway</span></div><div class="casAuthors">Rawlings, Jason S.; Rosler, Kristin M.; Harrison, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1281-1283</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  The Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway is one of a handful of pleiotropic cascades used to transduce a multitude of signals for development and homeostasis in animals.  A general overview of the JAK/STAT pathway and the primary mechanisms of activation and regulation of this essential signaling cascade are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5uv0YS5vNp7Vg90H21EOLACvtfcHk0lh4pL662nJd_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs1ygtbo%253D&md5=33bb7b48a728a018e931acc120a07dfe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00963%26sid%3Dliteratum%253Aachs%26aulast%3DRawlings%26aufirst%3DJ.%2BS.%26aulast%3DRosler%26aufirst%3DK.%2BM.%26aulast%3DHarrison%26aufirst%3DD.%2BA.%26atitle%3DThe%2520JAK%252FSTAT%2520Signaling%2520Pathway%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2004%26volume%3D117%26spage%3D1281%26epage%3D1283%26doi%3D10.1242%2Fjcs.00963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saharinen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, V. E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvennoinen, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">The Janus Kinases (JAKs)</span>. <i>Genome Biol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">253</span>, <span class="refDoi"> DOI: 10.1186/gb-2004-5-12-253</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1186%2Fgb-2004-5-12-253" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=15575979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A280%3ADC%252BD2cngtlKktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=253&author=K.+Yamaokaauthor=P.+Saharinenauthor=M.+Pesuauthor=V.+E.+T.+Holtauthor=O.+Silvennoinenauthor=J.+J.+O%E2%80%99Shea&title=The+Janus+Kinases+%28JAKs%29&doi=10.1186%2Fgb-2004-5-12-253"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The Janus kinases (Jaks)</span></div><div class="casAuthors">Yamaoka Kunihiro; Saharinen Pipsa; Pesu Marko; Holt Vance E T 3rd; Silvennoinen Olli; O'Shea John J</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">253</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The Janus kinase (Jak) family is one of ten recognized families of non-receptor tyrosine kinases.  Mammals have four members of this family, Jak1, Jak2, Jak3 and Tyrosine kinase 2 (Tyk2).  Birds, fish and insects also have Jaks.  Each protein has a kinase domain and a catalytically inactive pseudo-kinase domain, and they each bind cytokine receptors through amino-terminal FERM (Band-4.1, ezrin, radixin, moesin) domains.  Upon binding of cytokines to their receptors, Jaks are activated and phosphorylate the receptors, creating docking sites for signaling molecules, especially members of the signal transducer and activator of transcription (Stat) family.  Mutations of the Drosophila Jak (Hopscotch) have revealed developmental defects, and constitutive activation of Jaks in flies and humans is associated with leukemia-like syndromes.  Through the generation of Jak-deficient cell lines and gene-targeted mice, the essential, nonredundant functions of Jaks in cytokine signaling have been established.  Importantly, deficiency of Jak3 is the basis of human autosomal recessive severe combined immunodeficiency (SCID); accordingly, a selective Jak3 inhibitor has been developed, forming a new class of immunosuppressive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS0BwDh7EYTsV1C8OJBvdfbfW6udTcc2eaxNEzGJKY6arntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cngtlKktg%253D%253D&md5=4f8335c37dc8c20245e771224c1d5b12</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1186%2Fgb-2004-5-12-253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb-2004-5-12-253%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26aulast%3DSaharinen%26aufirst%3DP.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DHolt%26aufirst%3DV.%2BE.%2BT.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520Janus%2520Kinases%2520%2528JAKs%2529%26jtitle%3DGenome%2520Biol.%26date%3D2004%26volume%3D5%26spage%3D253%26doi%3D10.1186%2Fgb-2004-5-12-253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5023</span>– <span class="NLM_lpage">5038</span>, <span class="refDoi"> DOI: 10.1021/jm401490p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401490p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5023-5038&author=J.+D.+Clarkauthor=M.+E.+Flanaganauthor=J.-B.+Telliez&title=Discovery+and+Development+of+Janus+Kinase+%28JAK%29+Inhibitors+for+Inflammatory+Diseases&doi=10.1021%2Fjm401490p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases</span></div><div class="casAuthors">Clark, James D.; Flanagan, Mark E.; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5023-5038</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The Janus kinases (JAKs) are a family of intracellular tyrosine kinases that play an essential role in the signaling of numerous cytokines that have been implicated in the pathogenesis of inflammatory diseases.  As a consequence, the JAKs have received significant attention in recent years from the pharmaceutical and biotechnol. industries as therapeutic targets.  Here, we provide a review of the JAK pathways, the structure, function, and activation of the JAK enzymes followed by a detailed look at the JAK inhibitors currently in the clinic or approved for these indications.  Finally, a perspective is provided on what the past decade of research with JAK inhibitors for inflammatory indications has taught along with thoughts on what the future may hold in terms of addressing the opportunities and challenges that remain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f7W5g8N6brVg90H21EOLACvtfcHk0lihtrie6hJHrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVCjsA%253D%253D&md5=6763ae2d46f52ddcda23e235a60634ae</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401490p%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Janus%2520Kinase%2520%2528JAK%2529%2520Inhibitors%2520for%2520Inflammatory%2520Diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5023%26epage%3D5038%26doi%3D10.1021%2Fjm401490p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Furumoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadina, M.</span></span> <span> </span><span class="NLM_article-title">The Arrival of JAK Inhibitors: Advancing the Treatment of Immune and Hematologic Disorders</span>. <i>BioDrugs</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">431</span>– <span class="NLM_lpage">438</span>, <span class="refDoi"> DOI: 10.1007/s40259-013-0040-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1007%2Fs40259-013-0040-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=23743669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsl2nsbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=431-438&author=Y.+Furumotoauthor=M.+Gadina&title=The+Arrival+of+JAK+Inhibitors%3A+Advancing+the+Treatment+of+Immune+and+Hematologic+Disorders&doi=10.1007%2Fs40259-013-0040-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The Arrival of JAK Inhibitors: Advancing the Treatment of Immune and Hematologic Disorders</span></div><div class="casAuthors">Furumoto, Yasuko; Gadina, Massimo</div><div class="citationInfo"><span class="NLM_cas:title">BioDrugs</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">431-438</span>CODEN:
                <span class="NLM_cas:coden">BIDRF4</span>;
        ISSN:<span class="NLM_cas:issn">1173-8804</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Altered prodn. of cytokines can result in pathologies ranging from autoimmune diseases to malignancies.  The Janus kinase family is a small group of receptor-assocd. signaling mols. that is essential to the signal cascade originating from type I and type II cytokine receptors.  Inhibition of tyrosine kinase enzymic activity using small mols. has recently become a powerful tool for treatment of several malignancies.  Twenty years after the discovery of these enzymes, two inhibitors for this class of kinases have been approved for clin. use and others are currently in the final stage of development.  Here we review the principles of cytokines signaling, summarize our current knowledge of the approved inhibitors, and briefly introduce some of the inhibitors that are currently under development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQNQJyHX0EDLVg90H21EOLACvtfcHk0lihtrie6hJHrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsl2nsbzI&md5=a593c1f01565b3dc3bf3df8c424595a6</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs40259-013-0040-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40259-013-0040-7%26sid%3Dliteratum%253Aachs%26aulast%3DFurumoto%26aufirst%3DY.%26aulast%3DGadina%26aufirst%3DM.%26atitle%3DThe%2520Arrival%2520of%2520JAK%2520Inhibitors%253A%2520Advancing%2520the%2520Treatment%2520of%2520Immune%2520and%2520Hematologic%2520Disorders%26jtitle%3DBioDrugs%26date%3D2013%26volume%3D27%26spage%3D431%26epage%3D438%26doi%3D10.1007%2Fs40259-013-0040-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamaoka, K.</span></span> <span> </span><span class="NLM_article-title">Janus Kinase Inhibitors for Rheumatoid Arthritis</span>. <i>Curr. Opin. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.cbpa.2016.03.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.cbpa.2016.03.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=26994322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC28XksVKlsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=29-33&author=K.+Yamaoka&title=Janus+Kinase+Inhibitors+for+Rheumatoid+Arthritis&doi=10.1016%2Fj.cbpa.2016.03.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinase inhibitors for rheumatoid arthritis</span></div><div class="casAuthors">Yamaoka, Kunihiro</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">29-33</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Treatment of autoimmune diseases, such as rheumatoid arthritis (RA), has advanced substantially over the past decade with the development of biologics targeting inflammatory cytokines.  Recent progress in treating RA has been achieved with janus kinase (JAK) inhibitors (Jakinibs), an orally available disease-modifying anti-rheumatic drug targeting the intracellular kinase JAK and with similar efficacy to biologics.  The first Jakinib approved for RA was tofacitinib, which exerted superiority to methotrexate and non-inferiority to tumor necrosis factor (TNF) inhibitors.  In recent years, the Jakinib baricitinib has demonstrated superiority to both methotrexate and a TNF inhibitor, adalimumab.  Given these promising findings, Jakinibs are expected to represent the next generation compds. for treating RA, and a no. of Jakinibs are currently in clin. trials.  Jakinibs can differ substantially in their selectivity against JAKs; tofacitinib and baricitinib target multiple JAKs, whereas the most recently developed Jakinibs target only a single JAK.  The influence of Jakinib selectivity on efficacy and side effects is of great interest, requiring further careful observation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPC1H4NKUAy7Vg90H21EOLACvtfcHk0lgtpuDcHsEmdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XksVKlsrs%253D&md5=cdf2eeeefd6e9b3ac5064bc341ef1469</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2016.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2016.03.006%26sid%3Dliteratum%253Aachs%26aulast%3DYamaoka%26aufirst%3DK.%26atitle%3DJanus%2520Kinase%2520Inhibitors%2520for%2520Rheumatoid%2520Arthritis%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2016%26volume%3D32%26spage%3D29%26epage%3D33%26doi%3D10.1016%2Fj.cbpa.2016.03.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyce, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyas, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogan, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valle-Oseguera, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dell, K. M.</span></span> <span> </span><span class="NLM_article-title">Impact of Tofacitinib on Patient Outcomes in Rheumatoid Arthritis – Review of Clinical Studies</span>. <i>Patient Related Outcome Measures</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.2147/PROM.S62879</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.2147%2FPROM.S62879" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=26834501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A280%3ADC%252BC28nmslKhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1-12&author=E.+G.+Boyceauthor=D.+Vyasauthor=E.+L.+Roganauthor=C.+S.+Valle-Osegueraauthor=K.+M.+O%E2%80%99Dell&title=Impact+of+Tofacitinib+on+Patient+Outcomes+in+Rheumatoid+Arthritis+%E2%80%93+Review+of+Clinical+Studies&doi=10.2147%2FPROM.S62879"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of tofacitinib on patient outcomes in rheumatoid arthritis - review of clinical studies</span></div><div class="casAuthors">Boyce Eric G; Vyas Deepti; Rogan Edward L; Valle-Oseguera Cynthia S; O'Dell Kate M</div><div class="citationInfo"><span class="NLM_cas:title">Patient related outcome measures</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-12</span>
        ISSN:<span class="NLM_cas:issn">1179-271X</span>.
    </div><div class="casAbstract">Rheumatoid arthritis is a chronic, progressive autoimmune disease associated with inflammation and destruction of joints and systemic effects, which result in significant impact on patient's quality of life and function.  Tofacitinib was approved for the treatment of rheumatoid arthritis in the USA in 2012 and subsequently in other countries, but not by the European Medicines Agency.  The goal of this review was to evaluate the impact of tofacitinib on patient-reported and patient-specific outcomes from prior clinical studies, focusing on quality of life, functionality, pain, global disease assessment, major adverse consequences, and withdrawals.  A total of 13 reports representing 11 clinical studies on tofacitinib in rheumatoid arthritis were identified through PubMed and reference lists in meta-analyses and other reviews.  Data on improvements in patient-driven composite tools to measure disease activity in rheumatoid arthritis, such as the Health Assessment Questionnaire, served as a major outcome evaluated in this review and were extracted from each study.  Additional data extracted from those clinical studies included patient assessment of pain (using a 0-100 mm visual analog scale), patient global assessment of disease (using a 0-100 mm visual analog scale), patient withdrawals, withdrawals due to adverse effects or lack of effect, and risk of serious adverse effects, serious infections, and deaths.  Tofacitinib 5 mg bid appears to have a favorable impact on patient outcomes related to efficacy and safety when compared with baseline values and with comparator disease-modifying antirheumatic drugs and placebo.  Improvements were seen in the composite and individual measures of disease activity.  Serious adverse effects, other adverse consequences, overall withdrawals, and withdrawals due to adverse effects and lack of efficacy are similar or more favorable for tofacitinib versus comparator disease-modifying antirheumatic drugs and placebo.  At this point, tofacitinib appears to have an important role in the treatment of rheumatoid arthritis through improvement in these patient outcomes.  However, it may require years of additional clinical studies and postmarketing surveillance to fully characterize the benefit-to-risk ratio of tofacitinib in a larger and diverse patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOLoFrXPSqu7GbPKh4T9eAfW6udTcc2eaNRdkqsny39bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28nmslKhsg%253D%253D&md5=032727016591a8bb13ab80694ef66e6c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2147%2FPROM.S62879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FPROM.S62879%26sid%3Dliteratum%253Aachs%26aulast%3DBoyce%26aufirst%3DE.%2BG.%26aulast%3DVyas%26aufirst%3DD.%26aulast%3DRogan%26aufirst%3DE.%2BL.%26aulast%3DValle-Oseguera%26aufirst%3DC.%2BS.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DK.%2BM.%26atitle%3DImpact%2520of%2520Tofacitinib%2520on%2520Patient%2520Outcomes%2520in%2520Rheumatoid%2520Arthritis%2520%25E2%2580%2593%2520Review%2520of%2520Clinical%2520Studies%26jtitle%3DPatient%2520Related%2520Outcome%2520Measures%26date%3D2016%26volume%3D7%26spage%3D1%26epage%3D12%26doi%3D10.2147%2FPROM.S62879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biajoli, A. F. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalm, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claudino, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, A. L.</span></span> <span> </span><span class="NLM_article-title">Recent Progress in the Use of Pd-Catalyzed C-C Cross-Coupling Reactions in the Synthesis of Pharmaceutical Compounds</span>. <i>J. Braz. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">2186</span>– <span class="NLM_lpage">2214</span>, <span class="refDoi"> DOI: 10.5935/0103-5053.20140255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.5935%2F0103-5053.20140255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFCmtLbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=2186-2214&author=A.+F.+P.+Biajoliauthor=C.+S.+Schwalmauthor=J.+Limbergerauthor=T.+S.+Claudinoauthor=A.+L.+Monteiro&title=Recent+Progress+in+the+Use+of+Pd-Catalyzed+C-C+Cross-Coupling+Reactions+in+the+Synthesis+of+Pharmaceutical+Compounds&doi=10.5935%2F0103-5053.20140255"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Progress in the Use of Pd-Catalyzed C-C Cross-Coupling Reactions in the Synthesis of Pharmaceutical Compounds</span></div><div class="casAuthors">Biajoli, Andre F. P.; Schwalm, Cristiane S.; Limberger, Jones; Claudino, Thiago S.; Monteiro, Adriano L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Brazilian Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2186-2214</span>CODEN:
                <span class="NLM_cas:coden">JOCSET</span>;
        ISSN:<span class="NLM_cas:issn">0103-5053</span>.
    
            (<span class="NLM_cas:orgname">Sociedade Brasileira de Quimica</span>)
        </div><div class="casAbstract">A review.  The impressive ability of palladium to assemble C-C bonds between appropriately functionalized substrates has allowed synthetic org. chemists to perform transformations that were previously impossible or only possible using multi-step approaches.  In this context, one of the most important and elegant applications of the Pd-catalyzed C-C coupling reactions currently is the synthesis of pharmaceuticals.  This review is intended to give a picture of the applications of Pd-catalyzed C-C cross-coupling reactions for the synthesis of drug components or drug candidates regardless of the scale from 2011 through to the end of July, 2014.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaLxWtR3yWvrVg90H21EOLACvtfcHk0lg8q55OaXsWHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCmtLbO&md5=7a786284553766bb71acf81dd559607c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.5935%2F0103-5053.20140255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5935%252F0103-5053.20140255%26sid%3Dliteratum%253Aachs%26aulast%3DBiajoli%26aufirst%3DA.%2BF.%2BP.%26aulast%3DSchwalm%26aufirst%3DC.%2BS.%26aulast%3DLimberger%26aufirst%3DJ.%26aulast%3DClaudino%26aufirst%3DT.%2BS.%26aulast%3DMonteiro%26aufirst%3DA.%2BL.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Use%2520of%2520Pd-Catalyzed%2520C-C%2520Cross-Coupling%2520Reactions%2520in%2520the%2520Synthesis%2520of%2520Pharmaceutical%2520Compounds%26jtitle%3DJ.%2520Braz.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D25%26spage%3D2186%26epage%3D2214%26doi%3D10.5935%2F0103-5053.20140255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lessing, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, T.</span></span> <span> </span><span class="NLM_article-title">Sequentially Palladium-Catalyzed Processes in One-Pot Syntheses of Heterocycles</span>. <i>Appl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1803</span>, <span class="refDoi"> DOI: 10.3390/app5041803</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.3390%2Fapp5041803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltFCgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=1803&author=T.+Lessingauthor=T.+M%C3%BCller&title=Sequentially+Palladium-Catalyzed+Processes+in+One-Pot+Syntheses+of+Heterocycles&doi=10.3390%2Fapp5041803"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Sequentially palladium-catalyzed processes in one-pot syntheses of heterocycles</span></div><div class="casAuthors">Lessing, Timo; Mueller, Thomas J. J.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Sciences</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1803-1836</span>CODEN:
                <span class="NLM_cas:coden">ASPCC7</span>;
        ISSN:<span class="NLM_cas:issn">2076-3417</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Sequentially Pd-catalyzed processes are excellent entries to heterocycle synthesis.  The broad mechanistic variety combined with often very mild reaction conditions allow the concatenation of elementary org. and organometallic steps to novel sequences in the sense of one-pot domino and multicomponent reactions.  Given the numerous opportunities of alkyne coordination and their Pd-mediated transformations, alkynylation and carbometallation play a key role, both for purely organometallic sequences as well as in those processes that are intercepted by cyclocondensation.  Pd-catalyzed aminations also find more and more entry into novel heterocycle syntheses based upon this theme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdcbE8auY1TrVg90H21EOLACvtfcHk0lg8q55OaXsWHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltFCgsL0%253D&md5=ce3524488bcbdcef137b2a0af8e67a1a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3390%2Fapp5041803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fapp5041803%26sid%3Dliteratum%253Aachs%26aulast%3DLessing%26aufirst%3DT.%26aulast%3DM%25C3%25BCller%26aufirst%3DT.%26atitle%3DSequentially%2520Palladium-Catalyzed%2520Processes%2520in%2520One-Pot%2520Syntheses%2520of%2520Heterocycles%26jtitle%3DAppl.%2520Sci.%26date%3D2015%26volume%3D5%26spage%3D1803%26doi%3D10.3390%2Fapp5041803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stouten, P. F. W.</span></span> <span> </span><span class="NLM_article-title">The Design and Application of Target-Focused Compound Libraries</span>. <i>Comb. Chem. High Throughput Screening</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">521</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.2174/138620711795767802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.2174%2F138620711795767802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=21521154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVSmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=521-531&author=C.+J.+Harrisauthor=R.+D.+Hillauthor=D.+W.+Sheppardauthor=M.+J.+Slaterauthor=P.+F.+W.+Stouten&title=The+Design+and+Application+of+Target-Focused+Compound+Libraries&doi=10.2174%2F138620711795767802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The design and application of target-focused compound libraries</span></div><div class="casAuthors">Harris, C. John; Hill, Richard D.; Sheppard, David W.; Slater, Martin J.; Stouten, Pieter F. W.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">521-531</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Target-focused compd. libraries are collections of compds. which are designed to interact with an individual protein target or, frequently, a family of related targets (such as kinases, voltage-gated ion channels, serine/cysteine proteases).  They are used for screening against therapeutic targets in order to find hit compds. that might be further developed into drugs.  The design of such libraries generally utilizes structural information about the target or family of interest.  In the absence of such structural information, a chemogenomic model that incorporates sequence and mutagenesis data to predict the properties of the binding site can be employed.  A third option, usually pursued when no structural data are available, utilizes knowledge of the ligands of the target from' which focused libraries can be developed via scaffold hopping.  Consequently, the methods used for the design of target-focused libraries vary according to the quantity and quality of structural or ligand data that is available for each target family.  This article describes examples of each of these design approaches and illustrates them with case studies, which highlight some of the issues and successes obsd. when screening target-focused libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKS2t0qb2xBbVg90H21EOLACvtfcHk0lg8q55OaXsWHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVSmu70%253D&md5=9070e45f5b842fccfee38c15e6cb6127</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.2174%2F138620711795767802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620711795767802%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DHill%26aufirst%3DR.%2BD.%26aulast%3DSheppard%26aufirst%3DD.%2BW.%26aulast%3DSlater%26aufirst%3DM.%2BJ.%26aulast%3DStouten%26aufirst%3DP.%2BF.%2BW.%26atitle%3DThe%2520Design%2520and%2520Application%2520of%2520Target-Focused%2520Compound%2520Libraries%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2011%26volume%3D14%26spage%3D521%26epage%3D531%26doi%3D10.2174%2F138620711795767802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garrett, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Anticancer Therapy with Checkpoint Inhibitors: What, Where and When?</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2011.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.tips.2011.02.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=308-316&author=M.+D.+Garrettauthor=I.+Collins&title=Anticancer+Therapy+with+Checkpoint+Inhibitors%3A+What%2C+Where+and+When%3F&doi=10.1016%2Fj.tips.2011.02.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2011.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2011.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DAnticancer%2520Therapy%2520with%2520Checkpoint%2520Inhibitors%253A%2520What%252C%2520Where%2520and%2520When%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D308%26epage%3D316%26doi%3D10.1016%2Fj.tips.2011.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendahl, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheikh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheema, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aardalen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Embry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moler, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes de Menezes, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hibner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gesner, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, G. K.</span></span> <span> </span><span class="NLM_article-title">Chir-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons in Vitro and in Vivo</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">591</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-1424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1158%2F1078-0432.CCR-06-1424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=17255282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=591-602&author=A.+N.+Tseauthor=K.+G.+Rendahlauthor=T.+Sheikhauthor=H.+Cheemaauthor=K.+Aardalenauthor=M.+Embryauthor=S.+Maauthor=E.+J.+Molerauthor=Z.+J.+Niauthor=D.+E.+Lopes+de+Menezesauthor=B.+Hibnerauthor=T.+G.+Gesnerauthor=G.+K.+Schwartz&title=Chir-124%2C+a+Novel+Potent+Inhibitor+of+Chk1%2C+Potentiates+the+Cytotoxicity+of+Topoisomerase+I+Poisons+in+Vitro+and+in+Vivo&doi=10.1158%2F1078-0432.CCR-06-1424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo</span></div><div class="casAuthors">Tse, Archie N.; Rendahl, Katherine G.; Sheikh, Tahir; Cheema, Haider; Aardalen, Kim; Embry, Millicent; Ma, Sylvia; Moler, Edward J.; Ni, Zhi Jie; Lopes de Menezes, Daniel E.; Hibner, Barbara; Gesner, Thomas G.; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chk1 kinase is a crit. regulator of both S and G2-M phase cell cycle checkpoints in response to DNA damage.  This study aimed to evaluate the biochem., cellular, and antitumor effects of a novel Chk1 inhibitor, CHIR124.  CHIR-124 was evaluated for its ability to abrogate cell cycle checkpoints, to potentiate cytotoxicity, and to inhibit Chk1-mediated signaling induced by topoisomerase I poisons in human tumor cell line and xenograft models.  CHIR-124 is a quinolone-based small mol. that is structurally unrelated to other known inhibitors of Chk1.  It potently and selectively inhibits Chk1 in vitro (IC50 = 0.0003 μmol/L).  CHIR-124 interacts synergistically with topoisomerase poisons (e.g., camptothecin or SN-38) in causing growth inhibition in several p53-mutant solid tumor cell lines as detd. by isobologram or response surface anal.  CHIR-124 abrogates the SN-38-induced S and G2-M checkpoints and potentiates apoptosis in MDA-MD-435 breast cancer cells.  The abrogation of the G2-M checkpoint and induction of apoptosis by CHIR-124 are enhanced by the loss of p53.  We have also shown that CHIR-124 treatment can restore the level of cdc25A protein, which is normally targeted by Chk1 for degrdn. following DNA damage, indicating that Chk1 signaling is suppressed in the presence of CHIR-124.  Finally, in an orthotopic breast cancer xenograft model, CHIR-124 potentiates the growth inhibitory effects of irinotecan by abrogating the G2-M checkpoint and increasing tumor apoptosis.  CHIR-124 is a novel and potent Chk1 inhibitor with promising antitumor activities when used in combination with topoisomerase I poisons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tD5w3RW7tbVg90H21EOLACvtfcHk0ljKdn1NC6mvqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSktQ%253D%253D&md5=59760855db149f99eba0e10828042816</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1424%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DA.%2BN.%26aulast%3DRendahl%26aufirst%3DK.%2BG.%26aulast%3DSheikh%26aufirst%3DT.%26aulast%3DCheema%26aufirst%3DH.%26aulast%3DAardalen%26aufirst%3DK.%26aulast%3DEmbry%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMoler%26aufirst%3DE.%2BJ.%26aulast%3DNi%26aufirst%3DZ.%2BJ.%26aulast%3DLopes%2Bde%2BMenezes%26aufirst%3DD.%2BE.%26aulast%3DHibner%26aufirst%3DB.%26aulast%3DGesner%26aufirst%3DT.%2BG.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DChir-124%252C%2520a%2520Novel%2520Potent%2520Inhibitor%2520of%2520Chk1%252C%2520Potentiates%2520the%2520Cytotoxicity%2520of%2520Topoisomerase%2520I%2520Poisons%2520in%2520Vitro%2520and%2520in%2520Vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D591%26epage%3D602%26doi%3D10.1158%2F1078-0432.CCR-06-1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bartek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukas, J.</span></span> <span> </span><span class="NLM_article-title">Chk1 and Chk2 Kinases in Checkpoint Control and Cancer</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(03)00110-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2FS1535-6108%2803%2900110-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=12781359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktlyiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=421-429&author=J.+Bartekauthor=J.+Lukas&title=Chk1+and+Chk2+Kinases+in+Checkpoint+Control+and+Cancer&doi=10.1016%2FS1535-6108%2803%2900110-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chk1 and Chk2 kinases in checkpoint control and cancer</span></div><div class="casAuthors">Bartek, Jiri; Lukas, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">421-429</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Accumulation of mutations and chromosomal aberrations is one of the hallmarks of cancer cells.  This enhanced genetic instability is fueled by defects in the genome maintenance mechanisms including DNA repair and cell cycle checkpoint pathways.  Here, we discuss the emerging roles of the mammalian Chk1 and Chk2 kinases as key signal transducers within the complex network of genome integrity checkpoints, as candidate tumor suppressors disrupted in sporadic as well as some hereditary malignancies and as potential targets of new anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWikvk94O98rVg90H21EOLACvtfcHk0lhros6kWJZQHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktlyiurg%253D&md5=95b281b62ec5dc57ed0073693bcfd9fc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900110-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900110-7%26sid%3Dliteratum%253Aachs%26aulast%3DBartek%26aufirst%3DJ.%26aulast%3DLukas%26aufirst%3DJ.%26atitle%3DChk1%2520and%2520Chk2%2520Kinases%2520in%2520Checkpoint%2520Control%2520and%2520Cancer%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D421%26epage%3D429%26doi%3D10.1016%2FS1535-6108%2803%2900110-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design, Discovery and Development of Checkpoint Kinase Inhibitors as Potential Anti-Cancer Therapies</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1517/17460441.2013.788496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1517%2F17460441.2013.788496" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=621-640&author=T.+P.+Matthewsauthor=A.+M.+Jonesauthor=I.+Collins&title=Structure-Based+Design%2C+Discovery+and+Development+of+Checkpoint+Kinase+Inhibitors+as+Potential+Anti-Cancer+Therapies&doi=10.1517%2F17460441.2013.788496"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.788496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.788496%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DJones%26aufirst%3DA.%2BM.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DStructure-Based%2520Design%252C%2520Discovery%2520and%2520Development%2520of%2520Checkpoint%2520Kinase%2520Inhibitors%2520as%2520Potential%2520Anti-Cancer%2520Therapies%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26spage%3D621%26epage%3D640%26doi%3D10.1517%2F17460441.2013.788496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aris, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pommier, Y.</span></span> <span> </span><span class="NLM_article-title">Potentiation of the Novel Topoisomerase I Inhibitor Indenoisoquinoline LMP-400 by the Cell Checkpoint and Chk1-Chk2 Inhibitor Azd7762</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">979</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-2579</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1158%2F0008-5472.CAN-11-2579" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=979-989&author=S.+M.+Arisauthor=Y.+Pommier&title=Potentiation+of+the+Novel+Topoisomerase+I+Inhibitor+Indenoisoquinoline+LMP-400+by+the+Cell+Checkpoint+and+Chk1-Chk2+Inhibitor+Azd7762&doi=10.1158%2F0008-5472.CAN-11-2579"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-2579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-2579%26sid%3Dliteratum%253Aachs%26aulast%3DAris%26aufirst%3DS.%2BM.%26aulast%3DPommier%26aufirst%3DY.%26atitle%3DPotentiation%2520of%2520the%2520Novel%2520Topoisomerase%2520I%2520Inhibitor%2520Indenoisoquinoline%2520LMP-400%2520by%2520the%2520Cell%2520Checkpoint%2520and%2520Chk1-Chk2%2520Inhibitor%2520Azd7762%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D979%26epage%3D989%26doi%3D10.1158%2F0008-5472.CAN-11-2579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brnardic, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garbaccio, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraley, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasber, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steen, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arrington, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudkin, V. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stirdivant, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drakas, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardwick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobell, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepp-Lorenzino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikuta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munshi, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreatsoulas, C.</span></span> <span> </span><span class="NLM_article-title">Optimization of a Pyrazoloquinolinone Class of Chk1 Kinase Inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5989</span>– <span class="NLM_lpage">5994</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.07.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.bmcl.2007.07.051" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5989-5994&author=E.+J.+Brnardicauthor=R.+M.+Garbaccioauthor=M.+E.+Fraleyauthor=E.+S.+Tasberauthor=J.+T.+Steenauthor=K.+L.+Arringtonauthor=V.+Y.+Dudkinauthor=G.+D.+Hartmanauthor=S.+M.+Stirdivantauthor=B.+A.+Drakasauthor=K.+Rickertauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=J.+Hardwickauthor=W.+Taoauthor=S.+C.+Beckauthor=X.+Maoauthor=R.+B.+Lobellauthor=L.+Sepp-Lorenzinoauthor=Y.+Yanauthor=M.+Ikutaauthor=S.+K.+Munshiauthor=L.+C.+Kuoauthor=C.+Kreatsoulas&title=Optimization+of+a+Pyrazoloquinolinone+Class+of+Chk1+Kinase+Inhibitors&doi=10.1016%2Fj.bmcl.2007.07.051"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.07.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.07.051%26sid%3Dliteratum%253Aachs%26aulast%3DBrnardic%26aufirst%3DE.%2BJ.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DTasber%26aufirst%3DE.%2BS.%26aulast%3DSteen%26aufirst%3DJ.%2BT.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DDudkin%26aufirst%3DV.%2BY.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DStirdivant%26aufirst%3DS.%2BM.%26aulast%3DDrakas%26aufirst%3DB.%2BA.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DHardwick%26aufirst%3DJ.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DLobell%26aufirst%3DR.%2BB.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DIkuta%26aufirst%3DM.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DKuo%26aufirst%3DL.%2BC.%26aulast%3DKreatsoulas%26aufirst%3DC.%26atitle%3DOptimization%2520of%2520a%2520Pyrazoloquinolinone%2520Class%2520of%2520Chk1%2520Kinase%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5989%26epage%3D5994%26doi%3D10.1016%2Fj.bmcl.2007.07.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gaulton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellis, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bento, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hersey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Light, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGlinchey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalovich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Lazikani, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span> <span> </span><span class="NLM_article-title">Chembl: A Large-Scale Bioactivity Database for Drug Discovery</span>. <i>Nucleic Acids Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">D1100</span>– <span class="NLM_lpage">D1107</span>, <span class="refDoi"> DOI: 10.1093/nar/gkr777</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1093%2Fnar%2Fgkr777" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=21948594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=D1100-D1107&author=A.+Gaultonauthor=L.+J.+Bellisauthor=A.+P.+Bentoauthor=J.+Chambersauthor=M.+Daviesauthor=A.+Herseyauthor=Y.+Lightauthor=S.+McGlincheyauthor=D.+Michalovichauthor=B.+Al-Lazikaniauthor=J.+P.+Overington&title=Chembl%3A+A+Large-Scale+Bioactivity+Database+for+Drug+Discovery&doi=10.1093%2Fnar%2Fgkr777"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">ChEMBL: a large-scale bioactivity database for drug discovery</span></div><div class="casAuthors">Gaulton, Anna; Bellis, Louisa J.; Bento, A. Patricia; Chambers, Jon; Davies, Mark; Hersey, Anne; Light, Yvonne; McGlinchey, Shaun; Michalovich, David; Al-Lazikani, Bissan; Overington, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">D1</span>),
    <span class="NLM_cas:pages">D1100-D1107</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">ChEMBL is an Open Data database contg. binding, functional and ADMET information for a large no. of drug-like bioactive compds.  These data are manually abstracted from the primary published literature on a regular basis, then further curated and standardized to maximize their quality and utility across a wide range of chem. biol. and drug-discovery research problems.  Currently, the database contains 5.4 million bioactivity measurements for more than 1 million compds. and 5200 protein targets.  Access is available through a web-based interface, data downloads and web services at: https://www.ebi.ac.uk/chembldb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9e9jRENTtubVg90H21EOLACvtfcHk0lh-M1pxRrjQzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12htbjN&md5=aedf7793e1ca54b6a4fa272ea3ef7d0e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fnar%2Fgkr777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252Fgkr777%26sid%3Dliteratum%253Aachs%26aulast%3DGaulton%26aufirst%3DA.%26aulast%3DBellis%26aufirst%3DL.%2BJ.%26aulast%3DBento%26aufirst%3DA.%2BP.%26aulast%3DChambers%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DM.%26aulast%3DHersey%26aufirst%3DA.%26aulast%3DLight%26aufirst%3DY.%26aulast%3DMcGlinchey%26aufirst%3DS.%26aulast%3DMichalovich%26aufirst%3DD.%26aulast%3DAl-Lazikani%26aufirst%3DB.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26atitle%3DChembl%253A%2520A%2520Large-Scale%2520Bioactivity%2520Database%2520for%2520Drug%2520Discovery%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2012%26volume%3D40%26spage%3DD1100%26epage%3DD1107%26doi%3D10.1093%2Fnar%2Fgkr777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kulagowski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bull, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyke, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghilardi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bir Kohli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendonca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narukulla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubhayakar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Abbema, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waszkowycz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zak, M.</span></span> <span> </span><span class="NLM_article-title">Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">5901</span>– <span class="NLM_lpage">5921</span>, <span class="refDoi"> DOI: 10.1021/jm300438j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300438j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5901-5921&author=J.+J.+Kulagowskiauthor=W.+Blairauthor=R.+J.+Bullauthor=C.+Changauthor=G.+Deshmukhauthor=H.+J.+Dykeauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=T.+K.+Harrisonauthor=P.+R.+Hewittauthor=M.+Liimattaauthor=C.+A.+Hurleyauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=P.+Bir+Kohliauthor=R.+J.+Maxeyauthor=R.+Mendoncaauthor=K.+Mortaraauthor=J.+Murrayauthor=R.+Narukullaauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=B.+Waszkowyczauthor=M.+Zak&title=Identification+of+Imidazo-Pyrrolopyridines+as+Novel+and+Potent+JAK1+Inhibitors&doi=10.1021%2Fjm300438j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span></div><div class="casAuthors">Kulagowski, Janusz J.; Blair, Wade; Bull, Richard J.; Chang, Christine; Deshmukh, Gauri; Dyke, Hazel J.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Harrison, Trevor K.; Hewitt, Peter R.; Liimatta, Marya; Hurley, Christopher A.; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Bir Kohli, Pawan; Maxey, Robert J.; Mendonca, Rohan; Mortara, Kyle; Murray, Jeremy; Narukulla, Raman; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Waszkowycz, Bohdan; Zak, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5901-5921</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway.  Examn. of the preferred binding conformation of clin. effective, pan-JAK inhibitor 1 led to identification of a novel, tricyclic hinge binding scaffold 3.  Exploration of SAR through a series of cycloamino and cycloalkylamino analogs demonstrated this template to be highly tolerant of substitution, with a predisposition to moderate selectivity for the JAK1 isoform over JAK2.  This study culminated in the identification of subnanomolar JAK1 inhibitors such as 22 and 49, having excellent cell potency, good rat pharmacokinetic characteristics, and excellent kinase selectivity.  Detn. of the binding modes of the series in JAK1 and JAK2 by X-ray crystallog. supported the design of analogs to enhance affinity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpamrk0bG1MK7Vg90H21EOLACvtfcHk0lh-M1pxRrjQzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D&md5=d91bc0e24abf14adcf44caf61e3e879f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm300438j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300438j%26sid%3Dliteratum%253Aachs%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DBull%26aufirst%3DR.%2BJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DT.%2BK.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNarukulla%26aufirst%3DR.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DZak%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Imidazo-Pyrrolopyridines%2520as%2520Novel%2520and%2520Potent%2520JAK1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5901%26epage%3D5921%26doi%3D10.1021%2Fjm300438j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Epps, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiamengo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmunds, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ericsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedken, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotecki, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merta, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morytko, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shekhar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wishart, N.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Tricyclic Cores for Kinase Inhibition</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">693</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.11.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.bmcl.2012.11.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=23265875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVyiurbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=693-698&author=S.+Van%0AEppsauthor=B.+Fiamengoauthor=J.+Edmundsauthor=A.+Ericssonauthor=K.+Frankauthor=M.+Friedmanauthor=D.+Georgeauthor=J.+Georgeauthor=E.+Goedkenauthor=B.+Koteckiauthor=G.+Martinezauthor=P.+Mertaauthor=M.+Morytkoauthor=S.+Shekharauthor=B.+Skinnerauthor=K.+Stewartauthor=J.+Vossauthor=G.+Wallaceauthor=L.+Wangauthor=N.+Wishart&title=Design+and+Synthesis+of+Tricyclic+Cores+for+Kinase+Inhibition&doi=10.1016%2Fj.bmcl.2012.11.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Design and synthesis of tricyclic cores for kinase inhibition</span></div><div class="casAuthors">Van Epps, Stacy; Fiamengo, Bryan; Edmunds, Jeremy; Ericsson, Anna; Frank, Kristine; Friedman, Michael; George, Dawn; George, Jonathan; Goedken, Eric; Kotecki, Brian; Martinez, Gloria; Merta, Philip; Morytko, Michael; Shekhar, Shashank; Skinner, Barbara; Stewart, Kent; Voss, Jeffrey; Wallace, Grier; Wang, Lu; Wishart, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-698</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Interest in therapeutic kinase inhibitors continues to grow beyond success in oncol.  To date, ATP-mimetic kinase inhibitors have focused primarily on monocyclic and bicyclic heterocyclic cores.  We sought to expand on the repertoire of potential cores for kinase inhibition by exploring tricyclic variants of classical bicyclic hinge binding motifs such as pyrrolopyridine and pyrrolopyrazine.  Herein we describe the syntheses of eight alternative tricyclic cores as well as in vitro screening results for representative kinases of potential therapeutic interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw43t_VvXMbbVg90H21EOLACvtfcHk0lispxdwnTbQ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVyiurbJ&md5=59cb993b841a73569309f0fca703b4c4</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.11.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.11.108%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BEpps%26aufirst%3DS.%26aulast%3DFiamengo%26aufirst%3DB.%26aulast%3DEdmunds%26aufirst%3DJ.%26aulast%3DEricsson%26aufirst%3DA.%26aulast%3DFrank%26aufirst%3DK.%26aulast%3DFriedman%26aufirst%3DM.%26aulast%3DGeorge%26aufirst%3DD.%26aulast%3DGeorge%26aufirst%3DJ.%26aulast%3DGoedken%26aufirst%3DE.%26aulast%3DKotecki%26aufirst%3DB.%26aulast%3DMartinez%26aufirst%3DG.%26aulast%3DMerta%26aufirst%3DP.%26aulast%3DMorytko%26aufirst%3DM.%26aulast%3DShekhar%26aufirst%3DS.%26aulast%3DSkinner%26aufirst%3DB.%26aulast%3DStewart%26aufirst%3DK.%26aulast%3DVoss%26aufirst%3DJ.%26aulast%3DWallace%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWishart%26aufirst%3DN.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Tricyclic%2520Cores%2520for%2520Kinase%2520Inhibition%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D693%26epage%3D698%26doi%3D10.1016%2Fj.bmcl.2012.11.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gehringer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfaffenrot, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Design and Synthesis of Tricyclic JAK3 Inhibitors with Picomolar Affinities as Novel Molecular Probes</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1002%2Fcmdc.201300520" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=277-281&author=M.+Gehringerauthor=E.+Pfaffenrotauthor=S.+Bauerauthor=S.+A.+Laufer&title=Design+and+Synthesis+of+Tricyclic+JAK3+Inhibitors+with+Picomolar+Affinities+as+Novel+Molecular+Probes&doi=10.1002%2Fcmdc.201300520"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300520%26sid%3Dliteratum%253Aachs%26aulast%3DGehringer%26aufirst%3DM.%26aulast%3DPfaffenrot%26aufirst%3DE.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DDesign%2520and%2520Synthesis%2520of%2520Tricyclic%2520JAK3%2520Inhibitors%2520with%2520Picomolar%2520Affinities%2520as%2520Novel%2520Molecular%2520Probes%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D277%26epage%3D281%26doi%3D10.1002%2Fcmdc.201300520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamagishi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moritomo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamori, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morio, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirakami, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of Tricyclic Dipyrrolopyridine Derivatives as Novel JAK Inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">5311</span>– <span class="NLM_lpage">5326</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2017.07.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.bmc.2017.07.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=28789911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yrs77M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=5311-5326&author=H.+Yamagishiauthor=T.+Inoueauthor=Y.+Nakajimaauthor=J.+Maedaauthor=H.+Tominagaauthor=H.+Usudaauthor=T.+Hondoauthor=A.+Moritomoauthor=F.+Nakamoriauthor=M.+Itoauthor=K.+Nakamuraauthor=H.+Morioauthor=Y.+Higashiauthor=M.+Inamiauthor=S.+Shirakami&title=Discovery+of+Tricyclic+Dipyrrolopyridine+Derivatives+as+Novel+JAK+Inhibitors&doi=10.1016%2Fj.bmc.2017.07.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of tricyclic dipyrrolopyridine derivatives as novel JAK inhibitors</span></div><div class="casAuthors">Yamagishi, Hiroaki; Inoue, Takayuki; Nakajima, Yutaka; Maeda, Jun; Tominaga, Hiroaki; Usuda, Hiroyuki; Hondo, Takeshi; Moritomo, Ayako; Nakamori, Fumihiro; Ito, Misato; Nakamura, Koji; Morio, Hiroki; Higashi, Yasuyuki; Inami, Masamichi; Shirakami, Shohei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5311-5326</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) play a crucial role in cytokine mediated signal transduction.  JAK inhibitors have emerged as effective immunomodulative agents for the prevention of transplant rejection.  The authors previously reported that the tricyclic imidazo-pyrrolopyridinone 2 (I) is a potent JAK inhibitor; however, it had poor oral absorption due to low membrane permeability.  Here, the authors report the structural modification of compd. 2 into the tricyclic dipyrrolopyridine 18a (3-[(3R,4R)-3-(dipyrrolo[2,3-b:2',3'-d]pyridin-1(6H)-yl)-4-methyl- piperidin-1-yl]-3-oxopropanenitrile ) focusing on redn. of polar surface area (PSA), which exhibits potent in vitro activity, improved membrane permeability and good oral bioavailability.  Compd. 18a showed efficacy in rat heterotopic cardiac transplants model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzFUxnoMs5O7Vg90H21EOLACvtfcHk0lispxdwnTbQ_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yrs77M&md5=24fc8058c7ca2091c3b2c980c21161a9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2017.07.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2017.07.043%26sid%3Dliteratum%253Aachs%26aulast%3DYamagishi%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DNakajima%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DTominaga%26aufirst%3DH.%26aulast%3DUsuda%26aufirst%3DH.%26aulast%3DHondo%26aufirst%3DT.%26aulast%3DMoritomo%26aufirst%3DA.%26aulast%3DNakamori%26aufirst%3DF.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DNakamura%26aufirst%3DK.%26aulast%3DMorio%26aufirst%3DH.%26aulast%3DHigashi%26aufirst%3DY.%26aulast%3DInami%26aufirst%3DM.%26aulast%3DShirakami%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Tricyclic%2520Dipyrrolopyridine%2520Derivatives%2520as%2520Novel%2520JAK%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D5311%26epage%3D5326%26doi%3D10.1016%2Fj.bmc.2017.07.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K.-s.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Y.</span></span> <span> </span><span class="NLM_article-title">Benzimidazole Derivatives as Potent JAK1-Selective Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">7596</span>– <span class="NLM_lpage">7602</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01263</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01263" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=7596-7602&author=M.+K.+Kimauthor=H.+Shinauthor=K.-s.+Parkauthor=H.+Kimauthor=J.+Parkauthor=K.+Kimauthor=J.+Namauthor=H.+Chooauthor=Y.+Chong&title=Benzimidazole+Derivatives+as+Potent+JAK1-Selective+Inhibitors&doi=10.1021%2Facs.jmedchem.5b01263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01263%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DShin%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DK.-s.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DNam%26aufirst%3DJ.%26aulast%3DChoo%26aufirst%3DH.%26aulast%3DChong%26aufirst%3DY.%26atitle%3DBenzimidazole%2520Derivatives%2520as%2520Potent%2520JAK1-Selective%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D7596%26epage%3D7602%26doi%3D10.1021%2Facs.jmedchem.5b01263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendonca, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balazs, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVoss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dragovich, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghilardi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbons, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gradl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanan, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harstad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenny, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, M. F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bir
Kohli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulagowski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labadie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liimatta, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxey, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ubhayakar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ultsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Abbema, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Y.</span></span> <span> </span><span class="NLM_article-title">Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6176</span>– <span class="NLM_lpage">6193</span>, <span class="refDoi"> DOI: 10.1021/jm300628c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300628c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1SmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6176-6193&author=M.+Zakauthor=R.+Mendoncaauthor=M.+Balazsauthor=K.+Barrettauthor=P.+Bergeronauthor=W.+S.+Blairauthor=C.+Changauthor=G.+Deshmukhauthor=J.+DeVossauthor=P.+S.+Dragovichauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=S.+Gradlauthor=C.+Hammanauthor=E.+J.+Hananauthor=E.+Harstadauthor=P.+R.+Hewittauthor=C.+A.+Hurleyauthor=T.+Jinauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=M.+F.+T.+Koehlerauthor=P.+Bir%0AKohliauthor=J.+J.+Kulagowskiauthor=S.+Labadieauthor=J.+Liaoauthor=M.+Liimattaauthor=Z.+Linauthor=P.+J.+Lupardusauthor=R.+J.+Maxeyauthor=J.+M.+Murrayauthor=R.+Pulkauthor=M.+Rodriguezauthor=S.+Savageauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=L.+Xiaoauthor=Y.+Xiao&title=Discovery+and+Optimization+of+C-2+Methyl+Imidazopyrrolopyridines+as+Potent+and+Orally+Bioavailable+JAK1+Inhibitors+with+Selectivity+over+JAK2&doi=10.1021%2Fjm300628c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2</span></div><div class="casAuthors">Zak, Mark; Mendonca, Rohan; Balazs, Mercedesz; Barrett, Kathy; Bergeron, Philippe; Blair, Wade S.; Chang, Christine; Deshmukh, Gauri; DeVoss, Jason; Dragovich, Peter S.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Gradl, Stefan; Hamman, Chris; Hanan, Emily J.; Harstad, Eric; Hewitt, Peter R.; Hurley, Christopher A.; Jin, Tian; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Koehler, Michael F. T.; Bir Kohli, Pawan; Kulagowski, Janusz J.; Labadie, Sharada; Liao, Jiangpeng; Liimatta, Marya; Lin, Zhonghua; Lupardus, Patrick J.; Maxey, Robert J.; Murray, Jeremy M.; Pulk, Rebecca; Rodriguez, Madeleine; Savage, Scott; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Xiao, Ling; Xiao, Yisong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6176-6193</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we report the discovery of the C-2 Me substituted imidazopyrrolopyridine series and its optimization to provide potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2.  The C-2 Me substituted inhibitor 4 exhibited not only improved JAK1 potency relative to unsubstituted compd. 3 but also notable JAK1 vs JAK2 selectivity (20-fold and >33-fold in biochem. and cell-based assays, resp.).  Features of the X-ray structures of 4 in complex with both JAK1 and JAK2 are delineated.  Efforts to improve the in vitro and in vivo ADME properties of 4 while maintaining JAK1 selectivity are described, culminating in the discovery of a highly optimized and balanced inhibitor (20).  Details of the biol. characterization of 20 are disclosed including JAK1 vs JAK2 selectivity levels, preclin. in vivo PK profiles, performance in an in vivo JAK1-mediated PK/PD model, and attributes of an X-ray structure in complex with JAK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpogQqQMRvwKbVg90H21EOLACvtfcHk0lhXi1Bd7KaulA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1SmtLg%253D&md5=8c57a4cb02fc245ed12f6f4efdb82318</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm300628c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300628c%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DM.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGradl%26aufirst%3DS.%26aulast%3DHamman%26aufirst%3DC.%26aulast%3DHanan%26aufirst%3DE.%2BJ.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520Optimization%2520of%2520C-2%2520Methyl%2520Imidazopyrrolopyridines%2520as%2520Potent%2520and%2520Orally%2520Bioavailable%2520JAK1%2520Inhibitors%2520with%2520Selectivity%2520over%2520JAK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6176%26epage%3D6193%26doi%3D10.1021%2Fjm300628c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnett, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frank, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frauchiger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hekmat-Nejad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendricks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henningsen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hilgenkamp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsu, P.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaime-Figueroa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahangir, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuglstatter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutach, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Railkar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vu, M. D.</span></span> <span> </span><span class="NLM_article-title">3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">356</span>, <span class="refDoi"> DOI: 10.1021/jm301646k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301646k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVSqtrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=345-356&author=M.+Sothauthor=J.+C.+Hermannauthor=C.+Yeeauthor=M.+Alamauthor=J.+W.+Barnettauthor=P.+Berryauthor=M.+F.+Brownerauthor=K.+Frankauthor=S.+Frauchigerauthor=S.+Harrisauthor=Y.+Heauthor=M.+Hekmat-Nejadauthor=T.+Hendricksauthor=R.+Henningsenauthor=R.+Hilgenkampauthor=H.+Hoauthor=A.+Hoffmanauthor=P.-Y.+Hsuauthor=D.-Q.+Huauthor=A.+Itanoauthor=S.+Jaime-Figueroaauthor=A.+Jahangirauthor=S.+Jinauthor=A.+Kuglstatterauthor=A.+K.+Kutachauthor=C.+Liaoauthor=S.+Lynchauthor=J.+Menkeauthor=L.+Niuauthor=V.+Patelauthor=A.+Railkarauthor=D.+Royauthor=A.+Shaoauthor=D.+Shawauthor=S.+Steinerauthor=Y.+Sunauthor=S.-L.+Tanauthor=S.+Wangauthor=M.+D.+Vu&title=3-Amido+Pyrrolopyrazine+JAK+Kinase+Inhibitors%3A+Development+of+a+JAK3+vs+JAK1+Selective+Inhibitor+and+Evaluation+in+Cellular+and+in+Vivo+Models&doi=10.1021%2Fjm301646k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models</span></div><div class="casAuthors">Soth, Michael; Hermann, Johannes C.; Yee, Calvin; Alam, Muzaffar; Barnett, Jim W.; Berry, Pamela; Browner, Michelle F.; Frank, Karl; Frauchiger, Sandra; Harris, Seth; He, Yang; Hekmat-Nejad, Mohammad; Hendricks, Than; Henningsen, Robert; Hilgenkamp, Ramona; Ho, Hoangdung; Hoffman, Ann; Hsu, Pei-Yuan; Hu, Dong-Qing; Itano, Andrea; Jaime-Figueroa, Saul; Jahangir, Alam; Jin, Sue; Kuglstatter, Andreas; Kutach, Alan K.; Liao, Cheng; Lynch, Stephen; Menke, John; Niu, Linghao; Patel, Vaishali; Railkar, Aruna; Roy, Douglas; Shao, Ada; Shaw, David; Steiner, Sandra; Sun, Yongliang; Tan, Seng-Lai; Wang, Sandra; Vu, Minh Diem</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">345-356</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Janus kinases (JAKs) are involved in multiple signaling networks relevant to inflammatory diseases, and inhibition of one or more members of this class may modulate disease activity or progression.  We optimized a new inhibitor scaffold, 3-amido-5-cyclopropylpyrrolopyrazines, to a potent example with reasonable kinome selectivity, including selectivity for JAK3 vs. JAK1, and good biopharmaceutical properties.  Evaluation of this analog in cellular and in vivo models confirmed functional selectivity for modulation of a JAK3/JAK1-dependent IL-2 stimulated pathway over a JAK1/JAK2/Tyk2-dependent IL-6 stimulated pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd-C6Aby3wN7Vg90H21EOLACvtfcHk0lhXi1Bd7KaulA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVSqtrrP&md5=026b7d9b52cb5e374617ac2e5863eda4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm301646k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301646k%26sid%3Dliteratum%253Aachs%26aulast%3DSoth%26aufirst%3DM.%26aulast%3DHermann%26aufirst%3DJ.%2BC.%26aulast%3DYee%26aufirst%3DC.%26aulast%3DAlam%26aufirst%3DM.%26aulast%3DBarnett%26aufirst%3DJ.%2BW.%26aulast%3DBerry%26aufirst%3DP.%26aulast%3DBrowner%26aufirst%3DM.%2BF.%26aulast%3DFrank%26aufirst%3DK.%26aulast%3DFrauchiger%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHekmat-Nejad%26aufirst%3DM.%26aulast%3DHendricks%26aufirst%3DT.%26aulast%3DHenningsen%26aufirst%3DR.%26aulast%3DHilgenkamp%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DA.%26aulast%3DHsu%26aufirst%3DP.-Y.%26aulast%3DHu%26aufirst%3DD.-Q.%26aulast%3DItano%26aufirst%3DA.%26aulast%3DJaime-Figueroa%26aufirst%3DS.%26aulast%3DJahangir%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DKutach%26aufirst%3DA.%2BK.%26aulast%3DLiao%26aufirst%3DC.%26aulast%3DLynch%26aufirst%3DS.%26aulast%3DMenke%26aufirst%3DJ.%26aulast%3DNiu%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DV.%26aulast%3DRailkar%26aufirst%3DA.%26aulast%3DRoy%26aufirst%3DD.%26aulast%3DShao%26aufirst%3DA.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DSteiner%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DS.-L.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DVu%26aufirst%3DM.%2BD.%26atitle%3D3-Amido%2520Pyrrolopyrazine%2520JAK%2520Kinase%2520Inhibitors%253A%2520Development%2520of%2520a%2520JAK3%2520vs%2520JAK1%2520Selective%2520Inhibitor%2520and%2520Evaluation%2520in%2520Cellular%2520and%2520in%2520Vivo%2520Models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D345%26epage%3D356%26doi%3D10.1021%2Fjm301646k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Juchum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Günther, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Döring, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sievers-Engler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lämmerhofer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span> <span> </span><span class="NLM_article-title">Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act as Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4636</span>– <span class="NLM_lpage">4656</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00178</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00178" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnt1Ciu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4636-4656&author=M.+Juchumauthor=M.+G%C3%BCntherauthor=E.+D%C3%B6ringauthor=A.+Sievers-Englerauthor=M.+L%C3%A4mmerhoferauthor=S.+Laufer&title=Trisubstituted+Imidazoles+with+a+Rigidized+Hinge+Binding+Motif+Act+as+Single+Digit+nM+Inhibitors+of+Clinically+Relevant+EGFR+L858R%2FT790M+and+L858R%2FT790M%2FC797S+Mutants%3A+An+Example+of+Target+Hopping&doi=10.1021%2Facs.jmedchem.7b00178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act As Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping</span></div><div class="casAuthors">Juchum, Michael; Guenther, Marcel; Doering, Eva; Sievers-Engler, Adrian; Laemmerhofer, Michael; Laufer, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4636-4656</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Trisubstituted imidazoles with a rigidized 7-azaindole hinge binding motif such as I were prepd. as inhibitors of EGFR tyrosine kinase with L858R/T790M/C797S mutations (against which current EGFR inhibitors are ineffective) for potential use in the treatment of non-small-cell lung cancer.  II [X = (CH2)2, (CH2)4] reversibly inhibited the clin. challenging EGFR tyrosine kinase triple mutant L858R/T790M/C797S with IC50 values in the low nanomolar range.  I inhibited EGFR tyrosine kinase irreversibly with IC50 value of 1 nM against the EGFR L858R/T790M double mutant; I was selective for EGFR tyrosine kinase over other related kinases except for MAP4K4, MAP4K5, and MINK.  The kinetics of target inhibition, aq. soly, and metabolites were detd. for I and for selected compds.; mol. docking calcns. were also performed for selected compds. with EGFR isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzeDYy9aSCrLVg90H21EOLACvtfcHk0lhb3mrFJr53ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnt1Ciu78%253D&md5=a7003c8160b506ce964edce6adf7c3ff</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00178%26sid%3Dliteratum%253Aachs%26aulast%3DJuchum%26aufirst%3DM.%26aulast%3DG%25C3%25BCnther%26aufirst%3DM.%26aulast%3DD%25C3%25B6ring%26aufirst%3DE.%26aulast%3DSievers-Engler%26aufirst%3DA.%26aulast%3DL%25C3%25A4mmerhofer%26aufirst%3DM.%26aulast%3DLaufer%26aufirst%3DS.%26atitle%3DTrisubstituted%2520Imidazoles%2520with%2520a%2520Rigidized%2520Hinge%2520Binding%2520Motif%2520Act%2520as%2520Single%2520Digit%2520nM%2520Inhibitors%2520of%2520Clinically%2520Relevant%2520EGFR%2520L858R%252FT790M%2520and%2520L858R%252FT790M%252FC797S%2520Mutants%253A%2520An%2520Example%2520of%2520Target%2520Hopping%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4636%26epage%3D4656%26doi%3D10.1021%2Facs.jmedchem.7b00178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W. C. F.</span>; <span class="NLM_string-name">Burns, D. M.</span>; <span class="NLM_string-name">Zhuo</span></span> <span> </span><span class="NLM_article-title">Azetidinyl Phenyl, Pyridyl or Pyrazinyl Carboxamide Derivatives as JAK Inhibitors</span>. U.S. Patent <span class="NLM_patent">US20170253598</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=W.+C.+F.+Yao&author=D.+M.+Burns&author=+Zhuo&title=Azetidinyl+Phenyl%2C+Pyridyl+or+Pyrazinyl+Carboxamide+Derivatives+as+JAK+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DW.%2BC.%2BF.%26atitle%3DAzetidinyl%2520Phenyl%252C%2520Pyridyl%2520or%2520Pyrazinyl%2520Carboxamide%2520Derivatives%2520as%2520JAK%2520Inhibitors%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferraccioli, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carenzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rombolà, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catellani, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 6-Phenanthridinones and Their Heterocyclic Analogues through Palladium-Catalyzed Sequential Aryl–Aryl and <i>N</i>-Aryl Coupling</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">4759</span>– <span class="NLM_lpage">4762</span>, <span class="refDoi"> DOI: 10.1021/ol0479949</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol0479949" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlSgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=4759-4762&author=R.+Ferraccioliauthor=D.+Carenziauthor=O.+Rombol%C3%A0author=M.+Catellani&title=Synthesis+of+6-Phenanthridinones+and+Their+Heterocyclic+Analogues+through+Palladium-Catalyzed+Sequential+Aryl%E2%80%93Aryl+and+N-Aryl+Coupling&doi=10.1021%2Fol0479949"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-phenanthridinones and their heterocyclic analogues through palladium-catalyzed sequential aryl-aryl and N-aryl coupling</span></div><div class="casAuthors">Ferraccioli, Raffaella; Carenzi, Davide; Rombola, Ottavio; Catellani, Marta</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">4759-4762</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">6-Phenanthridinones, e.g., I, and their heterocyclic analogs were synthesized through a one-pot procedure based on consecutive Pd-catalyzed aryl-aryl and N-aryl coupling from iodoarenes ortho-substituted by electron-releasing substituents and amides of o-bromoarene- and heteroarenecarboxylic acids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEYy1SEXPfOrVg90H21EOLACvtfcHk0lhb3mrFJr53ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlSgtbk%253D&md5=f9208feb3a8a8f58aaa6cb08e2392278</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fol0479949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0479949%26sid%3Dliteratum%253Aachs%26aulast%3DFerraccioli%26aufirst%3DR.%26aulast%3DCarenzi%26aufirst%3DD.%26aulast%3DRombol%25C3%25A0%26aufirst%3DO.%26aulast%3DCatellani%26aufirst%3DM.%26atitle%3DSynthesis%2520of%25206-Phenanthridinones%2520and%2520Their%2520Heterocyclic%2520Analogues%2520through%2520Palladium-Catalyzed%2520Sequential%2520Aryl%25E2%2580%2593Aryl%2520and%2520N-Aryl%2520Coupling%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D4759%26epage%3D4762%26doi%3D10.1021%2Fol0479949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yip, K.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Law, K.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, N.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span> <span> </span><span class="NLM_article-title">Pd(II)-Catalyzed Enantioselective Oxidative Tandem Cyclization Reactions. Synthesis of Indolines through C–N and C–C Bond Formation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">3130</span>– <span class="NLM_lpage">3131</span>, <span class="refDoi"> DOI: 10.1021/ja060291x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja060291x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlOrsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2006&pages=3130-3131&author=K.-T.+Yipauthor=M.+Yangauthor=K.-L.+Lawauthor=N.-Y.+Zhuauthor=D.+Yang&title=Pd%28II%29-Catalyzed+Enantioselective+Oxidative+Tandem+Cyclization+Reactions.+Synthesis+of+Indolines+through+C%E2%80%93N+and+C%E2%80%93C+Bond+Formation&doi=10.1021%2Fja060291x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pd(II)-Catalyzed Enantioselective Oxidative Tandem Cyclization Reactions. Synthesis of Indolines through C-N and C-C Bond Formation</span></div><div class="casAuthors">Yip, Kai-Tai; Yang, Min; Law, Ka-Lun; Zhu, Nian-Yong; Yang, Dan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3130-3131</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient Pd(II)-catalyzed enantioselective oxidative tandem cyclization strategy using mol. oxygen as a green oxidant for the double 5-exo-trig cyclizations of N-(2-allylaryl) amides to afford a variety of indolines in good yields without the formation of undesired monocyclization products ir reported.  By employing Pd(TFA)2/(-)-sparteine as the chiral catalyst, tandem cyclization products with high enantioselectivity (up to 91% ee) were obtained .</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2OYS_FCT0DrVg90H21EOLACvtfcHk0libMlk3PMo1yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlOrsrg%253D&md5=a41a0cfa8d0acba22fcf3388d44caf47</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja060291x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja060291x%26sid%3Dliteratum%253Aachs%26aulast%3DYip%26aufirst%3DK.-T.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DLaw%26aufirst%3DK.-L.%26aulast%3DZhu%26aufirst%3DN.-Y.%26aulast%3DYang%26aufirst%3DD.%26atitle%3DPd%2528II%2529-Catalyzed%2520Enantioselective%2520Oxidative%2520Tandem%2520Cyclization%2520Reactions.%2520Synthesis%2520of%2520Indolines%2520through%2520C%25E2%2580%2593N%2520and%2520C%25E2%2580%2593C%2520Bond%2520Formation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2006%26volume%3D128%26spage%3D3130%26epage%3D3131%26doi%3D10.1021%2Fja060291x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trend, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramtohul, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoltz, B. M.</span></span> <span> </span><span class="NLM_article-title">Oxidative Cyclizations in a Nonpolar Solvent Using Molecular Oxygen and Studies on the Stereochemistry of Oxypalladation</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">17778</span>– <span class="NLM_lpage">17788</span>, <span class="refDoi"> DOI: 10.1021/ja055534k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja055534k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SrsLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=17778-17788&author=R.+M.+Trendauthor=Y.+K.+Ramtohulauthor=B.+M.+Stoltz&title=Oxidative+Cyclizations+in+a+Nonpolar+Solvent+Using+Molecular+Oxygen+and+Studies+on+the+Stereochemistry+of+Oxypalladation&doi=10.1021%2Fja055534k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidative Cyclizations in a Nonpolar Solvent Using Molecular Oxygen and Studies on the Stereochemistry of Oxypalladation</span></div><div class="casAuthors">Trend, Raissa M.; Ramtohul, Yeeman K.; Stoltz, Brian M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">17778-17788</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oxidative cyclizations of a variety of heteroatom nucleophiles onto unactivated olefins are catalyzed by palladium(II) and pyridine in the presence of mol. oxygen as the sole stoichiometric oxidant in a nonpolar solvent (toluene).  Reactivity studies of a no. of N-ligated palladium complexes show that chelating ligands slow the reaction.  Nearly identical conditions are applicable to five different types of nucleophiles: phenols, primary alcs., carboxylic acids, a vinylogous acid, and amides.  Electron-rich phenols are excellent substrates, and multiple olefin substitution patterns are tolerated.  Primary alcs. undergo oxidative cyclization without significant oxidn. to the aldehyde, a fact that illustrates the range of reactivity available from various Pd(II) salts under differing conditions.  Alcs. can form both fused and spirocyclic ring systems, depending on the position of the olefin relative to the tethered alc.; the same is true of the acid derivs.  The racemic conditions served as a platform for the development of an enantioselective reaction.  Expts. with stereospecifically deuterated primary alc. substrates rule out a Wacker-type mechanism involving anti oxypalladation and suggest that the reaction proceeds by syn oxypalladation for both mono- and bidentate ligands.  But cyclizations of deuterium-labeled carboxylic acid substrates undergo anti oxypalladation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBG5bvitLQtrVg90H21EOLACvtfcHk0libMlk3PMo1yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SrsLrL&md5=2f2860e14e79e8eaa482326f332b6983</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja055534k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja055534k%26sid%3Dliteratum%253Aachs%26aulast%3DTrend%26aufirst%3DR.%2BM.%26aulast%3DRamtohul%26aufirst%3DY.%2BK.%26aulast%3DStoltz%26aufirst%3DB.%2BM.%26atitle%3DOxidative%2520Cyclizations%2520in%2520a%2520Nonpolar%2520Solvent%2520Using%2520Molecular%2520Oxygen%2520and%2520Studies%2520on%2520the%2520Stereochemistry%2520of%2520Oxypalladation%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26spage%3D17778%26epage%3D17788%26doi%3D10.1021%2Fja055534k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagihara, M.</span>; <span class="NLM_string-name">Izumi, N.</span>; <span class="NLM_string-name">Tsuzaki, Y.</span>; <span class="NLM_string-name">Matsugi, T.</span>; <span class="NLM_string-name">Nakajima, T.</span>; <span class="NLM_string-name">Hatano, M.</span>; <span class="NLM_string-name">Hara, H.</span></span> <span> </span><span class="NLM_article-title">Novel Olefin Derivative</span>. <span class="NLM_patent">WO2005035501A1</span>, <span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=M.+Hagihara&author=N.+Izumi&author=Y.+Tsuzaki&author=T.+Matsugi&author=T.+Nakajima&author=M.+Hatano&author=H.+Hara&title=Novel+Olefin+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHagihara%26aufirst%3DM.%26atitle%3DNovel%2520Olefin%2520Derivative%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elsayed, M.
S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griggs, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Benzo[1,6]naphthyridinones Using the Catellani Reaction</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">5228</span>– <span class="NLM_lpage">5232</span>, <span class="refDoi"> DOI: 10.1021/acs.orglett.8b02171</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.orglett.8b02171" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOksLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=5228-5232&author=M.%0AS.+A.+Elsayedauthor=B.+Griggsauthor=M.+Cushman&title=Synthesis+of+Benzo%5B1%2C6%5Dnaphthyridinones+Using+the+Catellani+Reaction&doi=10.1021%2Facs.orglett.8b02171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Benzo[1,6]naphthyridinones Using the Catellani Reaction</span></div><div class="casAuthors">Elsayed, Mohamed S. A.; Griggs, Brittany; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5228-5232</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the presence of Pd(TFA)2, norbornene, and XPhos, bromoaryl amides such as 2-BrC6H4CONHR underwent Catellani reactions with 4-bromoquinoline and fused bromopyridines to yield benzonaphthyridinones such as I in 67-98% yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCsM7MtzwtaLVg90H21EOLACvtfcHk0lh22zICdlAtTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOksLfJ&md5=45100be43be33417b1687b8dcb1adf48</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.orglett.8b02171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.orglett.8b02171%26sid%3Dliteratum%253Aachs%26aulast%3DElsayed%26aufirst%3DM.%2BS.%2BA.%26aulast%3DGriggs%26aufirst%3DB.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520Benzo%255B1%252C6%255Dnaphthyridinones%2520Using%2520the%2520Catellani%2520Reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2018%26volume%3D20%26spage%3D5228%26epage%3D5232%26doi%3D10.1021%2Facs.orglett.8b02171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villarino, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferdinand, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Shea, J. J.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of JAK/STAT Signaling in Immunity and Disease</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>194</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1401867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.4049%2Fjimmunol.1401867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=25527793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWls7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2015&pages=21-27&author=A.+V.+Villarinoauthor=Y.+Kannoauthor=J.+R.+Ferdinandauthor=J.+J.+O%E2%80%99Shea&title=Mechanisms+of+JAK%2FSTAT+Signaling+in+Immunity+and+Disease&doi=10.4049%2Fjimmunol.1401867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of Jak/STAT Signaling in Immunity and Disease</span></div><div class="casAuthors">Villarino, Alejandro V.; Kanno, Yuka; Ferdinand, John R.; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">194</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-27</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">A review.  More than two decades ago, expts. on the antiviral mechanisms of IFNs led to the discovery of JAKs and their downstream effectors, the STAT proteins.  This pathway has since become a paradigm for membrane-to-nucleus signaling and explains how a broad range of sol. factors, including cytokines and hormones, mediate their diverse functions.  Jak/STAT research has not only impacted basic science, particularly in the context of intercellular communication and cell-extrinsic control of gene expression, it also has become a prototype for transition from bench to bedside, culminating in the development and clin. implementation of pathway-specific therapeutics.  This brief review synthesizes our current understanding of Jak/STAT biol. while taking stock of the lessons learned and the challenges that lie ahead.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotOsFFpF-ChLVg90H21EOLACvtfcHk0lh22zICdlAtTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWls7rF&md5=777f0f64db038ca8a7f17554931e0655</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1401867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1401867%26sid%3Dliteratum%253Aachs%26aulast%3DVillarino%26aufirst%3DA.%2BV.%26aulast%3DKanno%26aufirst%3DY.%26aulast%3DFerdinand%26aufirst%3DJ.%2BR.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DMechanisms%2520of%2520JAK%252FSTAT%2520Signaling%2520in%2520Immunity%2520and%2520Disease%26jtitle%3DJ.%2520Immunol.%26date%3D2015%26volume%3D194%26spage%3D21%26epage%3D27%26doi%3D10.4049%2Fjimmunol.1401867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chong, Y.</span></span> <span> </span><span class="NLM_article-title">Novel JAK1-Selective Benzimidazole Inhibitors with Enhanced Membrane Permeability</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3213</span>– <span class="NLM_lpage">3215</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.05.078</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.bmcl.2016.05.078" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=27261178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC28XptVymsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3213-3215&author=H.+Kimauthor=M.+K.+Kimauthor=H.+Chooauthor=Y.+Chong&title=Novel+JAK1-Selective+Benzimidazole+Inhibitors+with+Enhanced+Membrane+Permeability&doi=10.1016%2Fj.bmcl.2016.05.078"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel JAK1-selective benzimidazole inhibitors with enhanced membrane permeability</span></div><div class="casAuthors">Kim, Hyungmi; Kim, Mi Kyoung; Choo, Hyunah; Chong, Youhoon</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3213-3215</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The previously identified Janus kinase 1 (JAK1)-selective inhibitor, 1-(2-aminoethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole-5-carboxamide, suffered from low cell permeability, which resulted in poor pharmacokinetic properties.  In this study, by introducing less polar hydrogen bond donors at N1 (a hydroxyalkyl or a methylaminoalkyl group) and C2 (a cyclohexanol group) positions, a series of novel benzimidazole derivs. I (R 1 = (CH2)2OH, (CH2)3OH, (CH2)2NHMe, (CH2)3NH2, (R)-CH2CHOHMe) and II (R2 = (CH2)2NHMe, (CH2)3NH2) were prepd., which exhibited selective JAK1 inhibitory activity (IC50 against JAK1 = 0.08-0.15 μM; JAK1-selectivity = 26-40 fold vs JAK2, 12-23 fold vs JAK3, and 38-54 fold vs Tyk2) along with significantly increased lipophilicity (3.3-15.8 times) as well as membrane permeability (6.3-12 times).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHBsrUVqqnmbVg90H21EOLACvtfcHk0lh22zICdlAtTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XptVymsbc%253D&md5=8c7888e1b158c7fed9f84a47b43984bf</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.05.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.05.078%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DM.%2BK.%26aulast%3DChoo%26aufirst%3DH.%26aulast%3DChong%26aufirst%3DY.%26atitle%3DNovel%2520JAK1-Selective%2520Benzimidazole%2520Inhibitors%2520with%2520Enhanced%2520Membrane%2520Permeability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3213%26epage%3D3215%26doi%3D10.1016%2Fj.bmcl.2016.05.078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Korn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oukka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchroo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettelli, E.</span></span> <span> </span><span class="NLM_article-title">Th17 Cells: Effector T Cells with Inflammatory Properties</span>. <i>Semin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">362</span>– <span class="NLM_lpage">371</span>, <span class="refDoi"> DOI: 10.1016/j.smim.2007.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1016%2Fj.smim.2007.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=18035554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVSrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2007&pages=362-371&author=T.+Kornauthor=M.+Oukkaauthor=V.+Kuchrooauthor=E.+Bettelli&title=Th17+Cells%3A+Effector+T+Cells+with+Inflammatory+Properties&doi=10.1016%2Fj.smim.2007.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Th17 cells: Effector T cells with inflammatory properties</span></div><div class="casAuthors">Korn, Thomas; Oukka, Mohamed; Kuchroo, Vijay; Bettelli, Estelle</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">362-371</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Upon activation, naive CD4+ T cells differentiate into effector T cells with specific effector functions and cytokine profiles.  The Th1/Th2 paradigm has recently been reevaluated to include a third population of T helper cells, producing IL-17 and designated Th17.  The differentiation of Th17 cells requires the coordinate and specific action of the proinflammatory cytokine IL-6 and the immunosuppressive cytokine TGF-β.  In addn., the IL-12 family member IL-23 is involved in the maintenance of these cells.  Analogous to other T helper cell subsets, Th17 commitment is initiated by sequential involvement of STAT mols., i.e.  STAT3 downstream of cytokine receptors, and specific transcription factors, i.e.  ROR-γt.  Recent data also support the existence of a complex network of cytokines regulating Th17 cells.  Clearly, the specific effector functions of Th17 cells expand beyond previously described effects of Th1 and Th2 immunity, with specific roles in host defense against certain pathogens and in organ-specific autoimmunity.  The potential dynamics of Th17 cell populations and their interplay with other inflammatory cells in the induction of tissue inflammation in host defense and organ-specific autoimmunity are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR5FYZfodfSrVg90H21EOLACvtfcHk0ljhK4AHirljSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVSrsLs%253D&md5=e2af9e1d737ac9573876631aab9ff1b5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.smim.2007.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.smim.2007.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DKorn%26aufirst%3DT.%26aulast%3DOukka%26aufirst%3DM.%26aulast%3DKuchroo%26aufirst%3DV.%26aulast%3DBettelli%26aufirst%3DE.%26atitle%3DTh17%2520Cells%253A%2520Effector%2520T%2520Cells%2520with%2520Inflammatory%2520Properties%26jtitle%3DSemin.%2520Immunol.%26date%3D2007%26volume%3D19%26spage%3D362%26epage%3D371%26doi%3D10.1016%2Fj.smim.2007.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whyte, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudarsanam, S.</span></span> <span> </span><span class="NLM_article-title">The Protein Kinase Complement of the Human Genome</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>298</i></span>,  <span class="NLM_fpage">1912</span>– <span class="NLM_lpage">1934</span>, <span class="refDoi"> DOI: 10.1126/science.1075762</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+Protein+Kinase+Complement+of+the+Human+Genome&doi=10.1126%2Fscience.1075762"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0ljhK4AHirljSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520Protein%2520Kinase%2520Complement%2520of%2520the%2520Human%2520Genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934%26doi%3D10.1126%2Fscience.1075762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, I.</span></span> <span> </span><span class="NLM_article-title">Measuring and Interpreting the Selectivity of Protein Kinase Inhibitors</span>. <i>J. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">151</span>, <span class="refDoi"> DOI: 10.1007/s12154-009-0023-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1007%2Fs12154-009-0023-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=19568781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=131-151&author=L.+A.+Smythauthor=I.+Collins&title=Measuring+and+Interpreting+the+Selectivity+of+Protein+Kinase+Inhibitors&doi=10.1007%2Fs12154-009-0023-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Measuring and interpreting the selectivity of protein kinase inhibitors</span></div><div class="casAuthors">Smyth Lynette A; Collins Ian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of chemical biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">131-51</span>
        ISSN:<span class="NLM_cas:issn">1864-6158</span>.
    </div><div class="casAbstract">Protein kinase inhibitors are a well-established class of clinically useful drugs, particularly for the treatment of cancer.  Achieving inhibitor selectivity for particular protein kinases often remains a significant challenge in the development of new small molecules as drugs or as tools for chemical biology research.  This review summarises the methodologies available for measuring kinase inhibitor selectivity, both in vitro and in cells.  The interpretation of kinase inhibitor selectivity data is discussed, particularly with reference to the structural biology of the protein targets.  Measurement and prediction of kinase inhibitor selectivity will be important for the development of new multi-targeted kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzU9rA5WZcz9FxYDaSSP8XfW6udTcc2eYm-YWY-SXf5rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrkslGqtA%253D%253D&md5=f78ff1202a949a71ffd65e804298c37f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs12154-009-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12154-009-0023-9%26sid%3Dliteratum%253Aachs%26aulast%3DSmyth%26aufirst%3DL.%2BA.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMeasuring%2520and%2520Interpreting%2520the%2520Selectivity%2520of%2520Protein%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Chem.%2520Biol.%26date%3D2009%26volume%3D2%26spage%3D131%26epage%3D151%26doi%3D10.1007%2Fs12154-009-0023-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marlin, M. C.</span>; <span class="NLM_string-name">Li, G.</span></span> <span> </span><span class="NLM_article-title">Biogenesis and Function of the NGF/TrkA Signaling Endosome</span>. In  <i>International Review of Cell and Molecular Biology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, K. W.</span></span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Amsterdam</span>, <span class="NLM_year">2015</span>; Vol.  <span class="NLM_volume">314</span>, Chapter Six, pp  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">257</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=239-257&author=M.+C.+Marlin&author=G.+Liauthor=K.+W.+Jeon&title=International+Review+of+Cell+and+Molecular+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMarlin%26aufirst%3DM.%2BC.%26atitle%3DBiogenesis%2520and%2520Function%2520of%2520the%2520NGF%252FTrkA%2520Signaling%2520Endosome%26btitle%3DInternational%2520Review%2520of%2520Cell%2520and%2520Molecular%2520Biology%26aulast%3DJeon%26aufirst%3DK.%2BW.%26pub%3DAcademic%2520Press%26date%3D2015%26volume%3D314%26spage%3D239%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jannasch, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span> <span> </span><span class="NLM_article-title">Short-Chain Fatty Acids Induce Both Effector and Regulatory T Cells by Suppression of Histone Deacetylases and Regulation of the mTOR-S6K Pathway</span>. <i>Mucosal Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">80</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1038/mi.2014.44</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=10.1038%2Fmi.2014.44" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=24917457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsFCjtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=80-93&author=J.+Parkauthor=M.+Kimauthor=S.+G.+Kangauthor=A.+H.+Jannaschauthor=B.+Cooperauthor=J.+Pattersonauthor=C.+H.+Kim&title=Short-Chain+Fatty+Acids+Induce+Both+Effector+and+Regulatory+T+Cells+by+Suppression+of+Histone+Deacetylases+and+Regulation+of+the+mTOR-S6K+Pathway&doi=10.1038%2Fmi.2014.44"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway</span></div><div class="casAuthors">Park, J.; Kim, M.; Kang, S. G.; Jannasch, A. H.; Cooper, B.; Patterson, J.; Kim, C. H.</div><div class="citationInfo"><span class="NLM_cas:title">Mucosal Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-93</span>CODEN:
                <span class="NLM_cas:coden">MIUMAK</span>;
        ISSN:<span class="NLM_cas:issn">1933-0219</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Microbial metabolites, such as short-chain fatty acids (SCFAs), are highly produced in the intestine and potentially regulate the immune system.  We studied the function of SCFAs in the regulation of T-cell differentiation into effector and regulatory T cells.  We report that SCFAs can directly promote T-cell differentiation into T cells producing interleukin-17 (IL-17), interferon-γ, and/or IL-10 depending on cytokine milieu.  This effect of SCFAs on T cells is independent of GPR41 or GPR43, but dependent on direct histone deacetylase (HDAC) inhibitor activity.  Inhibition of HDACs in T cells by SCFAs increased the acetylation of p70 S6 kinase and phosphorylation rS6, regulating the mTOR pathway required for generation of Th17 (T helper type 17), Th1, and IL-10+ T cells.  Acetate (C2) administration enhanced the induction of Th1 and Th17 cells during Citrobacter rodentium infection, but decreased anti-CD3-induced inflammation in an IL-10-dependent manner.  Our results indicate that SCFAs promote T-cell differentiation into both effector and regulatory T cells to promote either immunity or immune tolerance depending on immunol. milieu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolvxiBTpZ0Q7Vg90H21EOLACvtfcHk0lhsVom5momBpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsFCjtr4%253D&md5=8204251b262779d7297131d404f4b46b</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fmi.2014.44&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmi.2014.44%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DKang%26aufirst%3DS.%2BG.%26aulast%3DJannasch%26aufirst%3DA.%2BH.%26aulast%3DCooper%26aufirst%3DB.%26aulast%3DPatterson%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DC.%2BH.%26atitle%3DShort-Chain%2520Fatty%2520Acids%2520Induce%2520Both%2520Effector%2520and%2520Regulatory%2520T%2520Cells%2520by%2520Suppression%2520of%2520Histone%2520Deacetylases%2520and%2520Regulation%2520of%2520the%2520mTOR-S6K%2520Pathway%26jtitle%3DMucosal%2520Immunol.%26date%3D2015%26volume%3D8%26spage%3D80%26epage%3D93%26doi%3D10.1038%2Fmi.2014.44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LXK','PDB','3LXK'); return false;">PDB: 3LXK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5C" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4I5C','PDB','4I5C'); return false;">PDB: 4I5C</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i101"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00510">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80654"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00510">10.1021/acs.jmedchem.8b00510</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Table for the % growth of the NCI-60 cell lines, gels monitoring Top1-mediated DNA cleavage, table of kinome selectivity data, kinome maps, EC<sub>50</sub> determination curves and experimental procedure for the JAK3-mediated STAT-5 phosphorylation assay, mouse paw collagen-induced inflammation assay (RA paw volume and percent weight change results) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_008.pdf">PDF</a>)</p></li><li><p class="inline">SMILES molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_007.csv">CSV</a>)</p></li><li><p class="inline"><a id="rightTab-" class=" internalNav" href="#fig9">Figure <a id="rightTab-" class=" internalNav" href="#fig9">9</a></a> JAK1 molecular model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb">PDB</a>)</p></li><li><p class="inline"><a id="rightTab-" class=" internalNav" href="#fig9">Figure <a id="rightTab-" class=" internalNav" href="#fig9">9</a></a> JAK3 molecular model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_002.pdb">PDB</a>)</p></li><li><p class="inline"><a id="rightTab-" class=" internalNav" href="#fig10">Figure <a id="rightTab-" class=" internalNav" href="#fig10">10</a></a> JAK1 molecular model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_003.pdb">PDB</a>)</p></li><li><p class="inline"><a id="rightTab-" class=" internalNav" href="#fig10">Figure <a id="rightTab-" class=" internalNav" href="#fig10">10</a></a> JAK3 molecular model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_004.pdb">PDB</a>)</p></li><li><p class="inline"><a id="rightTab-" class=" internalNav" href="#fig11">Figure <a id="rightTab-" class=" internalNav" href="#fig11">11</a></a> JAK1 molecular model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_005.pdb">PDB</a>)</p></li><li><p class="inline"><a id="rightTab-" class=" internalNav" href="#fig11">Figure <a id="rightTab-" class=" internalNav" href="#fig11">11</a></a> JAK3 molecular model (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_006.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_001.pdb">jm8b00510_si_001.pdb (186.64 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_002.pdb">jm8b00510_si_002.pdb (357.38 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_003.pdb">jm8b00510_si_003.pdb (186.94 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_004.pdb">jm8b00510_si_004.pdb (357.68 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_005.pdb">jm8b00510_si_005.pdb (188.05 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_006.pdb">jm8b00510_si_006.pdb (358.79 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_007.csv">jm8b00510_si_007.csv (4.26 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00510/suppl_file/jm8b00510_si_008.pdf">jm8b00510_si_008.pdf (1.52 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00510&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-23%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00510%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00510" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b771bf9cbd19b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
